Molecular dissection of Pax6 DNA-binding domains and their roles in mouse cerebral cortex development by Walcher, Tessa
Molecular dissection of Pax6 DNA-binding 
domains and their roles in mouse cerebral 
cortex development
Dissertation der Fakultät für Biologie der 
Ludwig-Maximilian-Universität München
 
Angefertigt in der Arbeitsgruppe von Prof. Dr. Magdalena 
Götz am Institut für Stammzellforschung, Helmholtz Zentrum 
München
Tessa Walcher
05.09.2012
Einreichung der Dissertation bei der Fakultät für Biologie: 05. September 2012
Tag der mündlichen Prüfung (Disputation): 31. Januar 2013
1. Gutachter: Prof. Heinrich Leonhardt
2. Gutachter: PD. Dr. Mario Wullimann
3. Gutachter: Prof. Barbara Conradt
4. Gutachter: PD Dr. Katrin Philippar (Protokoll)
5. Gast: Prof. Magdalena Götz
Eidesstattliche Erklärung
Ich versichere hiermit an Eides statt, dass die vorgelegte Dissertation von mir selbständig 
und ohne unerlaubte Hilfe angefertigt ist.
München, den ...........................................          ..........................................................
            (Unterschrift)

Table of Contents
          Table of Contents........................................................................................................ I
         Abstract.......................................................................................................................1
        Zusammenfassung.....................................................................................................3
1         Introduction...............................................................................5
     1.1   Early brain development – generation of the cerebral cortex..........................6
     1.2   Generation of cell diversity in the cerebral cortex..........................................10
1.2.1         Neural stem and progenitor cells in the developing telencephalon...........10
1.2.2         Neuronal cell diversity forming the six layers of the cerebral cortex........14
1.2.3      Molecular fate determinants in cortical development..................................15
  1.2.3.1         Extrinsic cues....................................................................................16
  1.2.3.2         Intrinsic cues......................................................................................11 
1.3   The transcription factor Pax6 – a master regulator.........................................20
1.3.1      Pax6 Expression..............................................................................................20
1.3.2      The role of Pax6 in forebrain development...................................................22
  1.3.2.1         Pax6 function in dorso-ventral patterning..........................................22
1.3.2.2         Pax6 function in area patterning........................................................23
       1.3.2.3         Pax6 function in the olfactory system................................................24
  1.3.2.4         Pax6 function in proliferation and neurogenesis................................25
1.3.3      Complexity of Pax6 – structure and isoforms...............................................27
1.3.4    Molecular mechanisms underlying the multiple functions of Pax6............31
     1.4    A fate determinant from the RNA world: the microRNA.................................33
1.4.1      The microRNA pathway...................................................................................33
1.4.2     The role of microRNAs in the developing nervous system.........................34
1.4.3      MicroRNAs in embryonic stem cells..............................................................37 
1.5    Aim of the thesis................................................................................................38
2  Results......................................................................................39
      2.1    Relevance of the Pax6 homeodomain during cortical development............39
2.1.1      Gene expression analysis of the homeodomain mutant Pax64NEU during 
       forebrain development....................................................................................39
      2.2    Functional dissection of the paired-domain of Pax6 during cortical 
    development.......................................................................................................42
2.2.1      Gross phenotypical differences of Pax6Leca4 (PAI-domain) and Pax6Leca2  
(RED-domain) mutant mice.............................................................................42 
- I -
Table of Contents
2.2.1.3         Pax6Leca2, but not Pax6Leca4 mice survive into adulthood.....................44
      2.2.1.2         Pax6Leca4 and Pax6Leca2 mice exhibit no ‘olfactory bulb-like structure           
                    (OBLS)’................................................................................................45
 2.2.1.3         Pax6Leca2 mutants lack TH+ interneurons in the adult olfactory bulb...45
2.2.2      Telencephalic development in Pax6Leca4 (PAI-domain) and Pax6Leca2    
                            (RED-domain) mutant mice.............................................................................48
2.2.3      Progenitor proliferation is differently affected in the cerebral cortex of   
                 Pax6Leca4 (PAI domain) and Pax6Leca2 (RED domain) mutant mice................51
            2.2.3.1         Progenitor identity in Pax6Leca4 and Pax6Leca2 mutant mice..................54
2.2.4      The role of the PAI and the RED subdomain in dorso-ventral patterning of 
                 the telencephalon............................................................................................56
            2.2.4.1         Molecular specification in Pax6Sey/Gsx2 double mutants....................63
2.2.5      The role of the PAI and the RED subdomain in the regulation of 
                  neurogenesis...................................................................................................65
            2.2.5.1         Effect of Pax6Leca4 and Pax6Leca2 mutation on neurogenesis in-vitro....68
2.2.6      Cell death analysis in the Pax6Leca2 and Pax6Leca4 mutant cortex at 
                 midneurogenesis ............................................................................................72
2.2.7      Genome-wide expression analysis in the Pax6Leca4 (PAI domain) and 
                 Pax6Leca2 (RED doamin) mutant cerebral cortex............................................74
            2.2.7.1         Differentially expressed genes in the Pax6Leca4 mutant cortex............76
            2.2.7.2         Differentially expressed genes in the Pax6Leca2 mutant cortex............77
            2.2.7.3        Comparison of differentially expressed genes between the Pax6Leca4 
                               and Pax6Leca2 mutant cortex.................................................................77
            2.2.7.4        Comparison of differentially expressed genes between the Pax6 Leca 
                               mutant cortices and the functional Pax6 null mutant Pax6Sey..............78
            2.2.7.5        Comparison of the differentially expressed genes in the Pax6 Leca 
                               mutant cortices and Pax6-Chip data
2.2.8       Superactivation by the RED domain mutation of Pax6...............................80
      2.3    Fate determinants at post-transcriptional level: microRNA expression 
               during neuronal differentiation........................................................................82
2.3.1       The screening system: in-vitro differentiation from ESC to glutamatergic 
                  neurons............................................................................................................82
2.3.2      Differentially expressed microRNAs during differentiation........................84
- II -
Table of Contents
3   Discussion...............................................................................87
     3.1   Summary..............................................................................................................87
      3.2   The paired subdomains - PAI and RED - of Pax6 are crucial for Pax6 
              function and show selective roles during cortical development...................88
3.2.1      The PAI and the RED subdomain of Pax6 regulate dorso-ventral 
                  patterning in a redundant manner.................................................................88
3.2.2      The PAI and the RED subdomains of Pax6 exert distinct and opposing 
                  functions on progenitor proliferation...........................................................90
3.2.3      The PAI subdomain of Pax6 is responsible for its neurogenic function....93
3.2.4      The Leca mutations in the PAI and the RED subdomain of Pax6 affect its 
                  function through distinct binding sites........................................................96
3.2.5      The Leca mutation in the RED subdomain of Pax6 leads to enhanced tran
                 scriptional activation in vitro.........................................................................99
      3.3   The role of the homeodomain and region-specific differences of the 
              function of the different DNA-binding domains of Pax6..............................100
      3.4    Identification of new microRNA candidates during neuronal differentiation..
               ..........................................................................................................................102
4  Material and Methods............................................................104
      4.1  Materials............................................................................................................104
4.1.1      Chemicals.......................................................................................................104
4.1.2      Kits..................................................................................................................105
4.1.3      Culture reagents and media..........................................................................105
            4.1.3.1          General tissue culture reagents.......................................................105
            4.1.3.2          Embryonic stem cell culture reagents..............................................106
4.1.4      Cell lines.........................................................................................................108
4.1.5      Cloning and expression plasmids................................................................108
4.1.6      Primary antibodies.........................................................................................109
4.1.7      Primers used for q-PCR analysis..................................................................110
4.1.8      General Buffers and Solutions......................................................................111
4.2    Methods.............................................................................................................112
4.2.1       Animals and genotyping...............................................................................112
            4.2.1.1          Animals.............................................................................................112
            4.2.1.2         Mouse tail DNA extraction.................................................................112
            4.2.1.3         PCR Genotyping...............................................................................113
- III -
Table of Contents
            4.2.1.4         Sequencing........................................................................................114
            4.2.1.5         Fixation of mouse brains and cryosectioning....................................114
4.2.2      Immunostainings ..........................................................................................115
4.2.3      In situ hybridization - mRNA ....................................................................... 116
4.2.4         In situ hybridization - microRNA .................................................................117
4.2.5      Molecular Biology..........................................................................................118
            4.2.5.1        Cloning of constructs..........................................................................118
            4.2.5.2        Transformation into chemically competent E.coli...............................118
            4.2.5.3        Bacterial liquid cultures and DNA purification.....................................118
            4.2.5.4        Restriction digestion of DNA..............................................................119
            4.2.5.5        Ligation...............................................................................................119
4.2.6     Cell Culture......................................................................................................119
            4.2.6.1        Preparation of primary embryonic cerebral cortical cell culture.........119
            4.2.6.2        Clonal analysis in primary culture......................................................120
            4.2.6.3        Dual-luciferase reporter assay...........................................................120
4.2.7      Embryonic stem cell differentiation culture protocol................................120
4.2.8      RNA isolation and microarray analysis.......................................................121
4.2.9      MicroRNA extraction and miRNA-array analysis........................................122
4.2.10      CDNA synthesis and quantative pcr analysis.............................................123
4.2.11      Data analysis..................................................................................................123
            4.2.11.1      Statistics.............................................................................................124
5  Appendix.................................................................................125
     5.1    Abbreviations...................................................................................................125
     5.2    Tables................................................................................................................126
6  References..............................................................................146
7 Acknowledgments..................................................................166
      Publications..............................................................................................................167
- IV -
Table of Contents
- 1 -
Abstract
Abstract
Generation of the brain depends on proper regulation of progenitor proliferation and diffe-
rentiation during development. Many such factors known to affect proliferation and differen-
tiation are transcription factors. In particular, the transcription factor Pax6 has received much 
attention because of its potency to control various aspects of brain development. During de-
velopment of the telencephalon Pax6 regulates patterning, cell proliferation and neurogene-
sis, but how Pax6 mediates and coordinates these diverse functions at the molecular level 
is not well understood. It has previously been demonstrated that the homeodomain of Pax6 
plays a role in establishing the pallial-subpallial boundary. However it is not involved in other 
processes during telencephalic development as shown by the analysis of Pax64NEU mice, 
which are characterized by a point-mutation in the DNA-binding helix of the homeodomain. 
In order to gain more insights into the molecular network underlying the mild homeodomain 
function in the developing telencephalon, transcriptome analysis with Pax64NEU mice was 
performed. Almost no transcriptional changes were detected, suggesting that transcriptio-
nal regulation by the homeodomain of Pax6 has no major impact on forebrain development. 
Additionally, these results implied that the majority of effects exerted through Pax6 during 
telencephalic development are mediated by the bipartite paired-domain (PD). Therefore the 
main focus of this thesis was to examine the specific roles of the Pax6 paired-domain and 
its individual DNA-binding subdomains (PAI and RED) during forebrain development. The 
role of these DNA-binding domains was examined using mice with point-mutations in the 
PAI (Pax6Leca4, N50K) and RED (Pax6Leca2 R128C) subdomains and showed that the mu-
tations in these subdomains exert opposing roles regulating proliferation in the developing 
cortex. While the mutated PAI domain resulted in reduced proliferation of both apical and 
basal progenitors, the mutated RED domain provoked increased proliferation. However, the 
PAI domain largely mediates the neurogenic function of Pax6. Additionally, genome-wide 
transcriptome analysis was able to unravel the key signatures mediated by the distinct 
domains. In summary, Pax6 exerts its key roles during forebrain development by use of 
distinct subdomains to regulate proliferation and differentiation. Thus Pax6 is able to coor-
dinate and fine tune patterning, neurogenesis and proliferation in a simultaneous manner in 
different radial glial subpopulations.
The transcriptional regulation through Pax6 may not only be restricted to protein coding 
genes, but may also include control of microRNA (miRNA) expression. Such small RNA 
molecules have recently been implicated in proliferation and differentiation during deve-
lopment, however expression and the role of single microRNAs is still poorly understood. 
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Towards this end, miRNA expression profiling was performed using an embryonic stem 
cell differentiation system at different stages of neuronal differentiation in order to identify 
new miRNAs involved in radial glia specification and differentiation. This analysis revealed 
a number of microRNAs induced during differentiation from neural progenitors to neurons. 
Most strikingly only four miRNA candidates were found with exclusively high expression in 
progenitor cells. These data suggest that also Pax6 may play a role in transcriptional regu-
lation beyond mRNAs.
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Zusammenfassung
Während der Entwicklung des Gehirns regulieren und koordinieren verschiedene Mecha-
nismen die Proliferation von Vorläuferzellen und deren Differenzierung so dass sich das 
Gehirn letztlich normal entwickelt. Zu den Faktoren welche diese beiden Mechanismen 
beeinflussen gehören viele Transkriptionsfaktoren. Einer dieser Faktoren ist der Transkrip-
tionsfaktor Pax6, welcher eine besondere Stellung einnimmt, da er ein wichtiger Regulator 
für viele verschiedener Aspekte der Gehirnentwicklung ist. Während der Entwicklung des 
Vorderhirns besitzt Pax6 verschiedene Funktionen wie die Kontrolle Zellproliferation und 
Neurogenese oder die korrekte Regionalisierung verschiedener Gehirndomänen  Aber bis 
heute ist unklar wie Pax6 diese unterschiedlichen Aufgaben auf molekularer Ebene kont-
rolliert. Es wurde kürzlich gezeigt dass die Homeodomäne von Pax6 eine Funktion in der 
Etablierung der Pallialen-Subpallialen Grenze ausübt, aber an anderen Prozessen wäh-
rend der Entwicklung des Vorderhirns nicht beteiligt ist. Dies wurde mithilfe einer Maus-
linie untersucht, die eine Punktmutation in der Homeodomäne (HD) besitzt wodurch die 
DNA bindende Helix zerstört ist (Pax64NEU). Um aber die mögliche molekulare Regulation 
der spezifischen HD–Funktion im sich entwickelnden Vorderhirn zu untersuchen, wurde 
eine Transkriptomanalyse der Pax64NEU Mauslinie durchgeführt. Diese zeigte fast keine Ver-
änderungen des Transkriptoms, was zur Schlussfolgerung führte, dass die HD von Pax6 
keine Regulation auf transkriptioneller Ebene im sich entwickelnden Vorderhirn ausübt. 
Dieses Ergebnis impliziert, dass die meisten von Pax6 ausgeübten Funktionen im sich 
entwickelnden Vorderhirn von der zweiten DNA bindenden Domäne – der PAIRED Domä-
ne – ausgeübt wird. Diese Domäne besitzt eine zweiteilige Struktur und kann demnach 
also in zwei Subeinheiten (genannt PAI und RED) unterteilt werden. Die verschiedenen 
Rollen dieser beiden Subdomänen wurden mithilfe zweier Mauslinien untersucht. Diese 
Mauslinien besitzen jeweils eine Punktmutation innerhalb der PAI-Subdomäne (N50K in 
der Pax6Leca4 Mauslinie) bzw. der RED-Subdomäne (R128C in der Pax6Leca2 Mauslinie). Es 
konnte gezeigt werden, dass diese Mutationen eine gegensätzliche Rolle in der Kontrolle 
der Zellproliferation ausüben. Während die Mutation in der PAI-Subdomäne zu einer ver-
minderten Proliferation der apikal und basal gelegenen Vorläuferzellen führte, resultierte 
die Mutation in der RED-Subdomäne hingegen in verstärkter Proliferation. Im Gegensatz 
dazu konnte gezeigt werden dass die neurogene Funktion von Pax6 nur abhängig von der 
PAI-Subdomäne ist und dass beide Subdomänen die Regionalisierung in einem überwie-
gend redundanten Maß kontrollieren. Diese Ergebnisse wurden untermauert durch eine 
Genomanalyse der beiden Mutanten, die es auch erlaubte wichtige Regulationskandidaten 
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der beiden Subdomänen zu identifizieren. Abschließend lässt sich sagen, dass Pax6 im 
sich entwickelnden Vorderhirn seine unterschiedlichen Funktionen durch die differenzielle 
Verwendung der einzelnen Subdomänen ausübt und somit Zellproliferation, Neurogenese 
und Regionalisierung kontrolliert. 
Pax6 übt seine transkriptionelle Kontrolle möglicherweise nicht nur auf Protein-kodierende 
Gene aus, sondern auch auf die Expression von microRNA (miRNA) Molekülen. Diese klei-
nen RNA Moleküle spielen ebenfalls eine Rolle in der Regulation von Proliferation und Dif-
ferenzierung während der Enwicklung. Jedoch ist die Expression und spezifische Funktion 
einzelner miRNAs noch nicht gut verstanden. Um neue miRNA Moleküle zu identifizieren 
die eine Rolle in der Spezifizierung und Differenzierung von Pax6+ Vorläuferszellen spielen 
wurde mithilfe eines auf embryonalen Stammzellen beruhenden Differenzierungssystems 
ein miRNA Expressionprofil zu verschiedenen Stadien der Differenzierung erstellt. Das ver-
wendete System spiegelt die Pax6 abhängige Neurogenese - ähnlich wie sie im sich entwi-
ckelnden Vorderhirn abläuft - wieder. Diese Analyse deckte miRNAs auf deren Expression 
während der Differenzierung von Vorläuferzellen zu Neuronen induziert wird. Im Besonde-
ren, konnten vier miRNA Moleküle identifiziert werden die spezifisch nur im Stadium der 
neuronalen Vorläuferzellen -in denen die Pax6 Expression am stärksten ist - expremiert 
werden. Diese Daten zeigen dass Pax6 ein wichtiger Regulator in der Gehirnentwicklung ist 
und möglicherweise auch eine Rolle in der transkriptionellen Kontrolle jenseits von mRNA 
kodierenden Genen spielt. 
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1 Introduction 
The adult mammalian brain consists of an enormous variety of cell types. At first glance, the 
two main cell types found are neurons and glial cells. Amongst neurons, there are different 
types, i.e. excitatory and inhibitory neurons - which can be even further classified by the dif-
ferent neurotransmitters they manufacture such as glutamate, GABA, Dopamine and many 
others. Accordingly, many different glial cells exist such as astrocytes, oligodendrocytes and 
ependymal cells. 
Considering this plethora of different cell types in an adult brain, one major question is how 
these cell types arise from pluripotent stem cells during development. For a long time it had 
been believed that neurons and glia originate from distinct progenitor pools (Virchow et al., 
1846; Jacobson  et al., 1991; Kriegstein and Alvarez-Buylla, 2009). However, in the late 
20th century a common origin for glia and neurons could be demonstrated in the rodent 
brain (Malatesta et al., 2000; Miyata et al., 2001; Noctor et al., 2001a). As both cell types 
share a common origin there certainly need to be different factors that determine the distinct 
fate of these stem cells during development. Indeed, today many different factors including 
extrinsic and intrinsic cues have been shown to influence the neuronal and glial output of 
progenitors during development. The accurate combination of these factors interplaying to 
form the correct number of each specific cell type at the right time and in the right place is 
the key for proper brain development (Guillemot et al., 2006; Johansson et al., 2010; Lui et 
al., 2011; Tiberi et al., 2012). Therefore elucidating the molecular mechanisms controlling 
forebrain development is crucial to understand the distinctive output from originally one 
multipotent stem cell pool. The present thesis has looked in detail on molecular fate deter-
minants regulating embryonic neurogenesis. In particular, the transcription factor Pax6 and 
its molecular characteristics in regulating multiple functions during forebrain development 
were main focus of this thesis. Furthermore, on transcriptional level Pax6 may not only 
regulate expression of mRNAs, but also of miRNA genes. Therefore as a second part, a 
screen for miRNA expression during neuronal differentiation was performed.   
Before describing Pax6, as well as miRNAs as fate determinants in more detail, the following 
sections will guide through and describe broad concepts of telencepahlic development.
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1.1 Early brain development – generation of the cerebral cortex
Early development of the nervous system comprises three key steps: (i) induction, (ii) neu-
rulation and (iii) formation of the brain vesicles. After the three germ layers have formed, 
the first step - the conversion of naive ectoderm into neuroectoderm - is induced (Fig.1-
1A). Many studies between the 1920s and 1980s have revealed that a region within the 
mesoderm, known as “Spemann’s organizer” in amphibians or the “node” in mice, secrets 
neuralization and regionalization signals (Spemann and Mangold, 1924; Mangold, 1933, 
Nakamura und Toivonen, 1978). These signals between mesoderm and ectoderm together 
with signals within the ectoderm are important for neural induction (Ruiz I Altaba, 1993). 
However, until more recently, the nature of these signals had remained un-identified. Seve-
ral studies have now shown that inhibitors of the bone morphogenic protein (BMP) signaling 
pathway represent the neuralizing factors that allow the ectoderm to acquire neural proper-
ties. In contrast, the BMP molecules act as epidermal inducers within the ectoderm (Sasai 
and DeRobertis, 1997; Wilson and Hemmati-Brivanlou, 1997). After the neuroectoderm has 
transformed into the neural plate, neurulation begins. A groove forms in the neural plate 
which then wraps in on itself and finally constricts to form the neural tube (Fig.1-1B). In hu-
mans this process takes place around the fourth post-ovulatory week, which corresponds to 
embryonic days 7-9 in mice. The anterior part of the neural tube then gives rise to the brain, 
while the posterior part develops into the spinal cord. For brain development, the neural 
tube differentiates into three primary brain vesicles: the forebrain vesicle (prosencephalon), 
the midbrain vesicle (mesencephalon) and the hindbrain vesicle (rhombencephalon) (Fig1-
1C). These then give rise to five secondary brain vesicles that - as the vertebrate grows - dif-
ferentiate into various adult structures. Hereby, the hindbrain vesicle further divides into the 
metencephalon (forming the pons and cerebellum) and the myelencephalon (forming the 
medulla) (Melton et al., 2004). The forebrain vesicle gives rise to the diencephalon (forming 
amongst others, the thalamus, the retina and the optic nerve) and to the telencephalon. The 
telencephalon is again subdivided into the cerebral cortex (ctx; pallium) located dorsally and 
into the ganglionic eminences (GE; subpallium) located ventrally with the pallial-subpallial 
boundary sharply separating both regions. The pallium can be further separated into ventral, 
lateral, medial and dorsal domains as depicted within Fig.1-2. The GE forms bulges into the 
ventricle and thus is subdivided into the lateral-, medial- and caudal ganglionic eminence 
(LGE, MGE, CGE respectively) that finally give rise to the striatum and pallidum in the adult 
forebrain. The cerebral cortex itself can be subdivided into three regions in the adult: the 
archicortex (includes amongst others the hippocampus), the paleocortex (olfactory cortex) 
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and the neocortex (being positioned in-between the other two structures). The neocortex 
represents the part of the brain that accounts most for the increase in overall brain size and 
complexity found in more advanced mammals (Krubitzer and Kaas, 2005). 
Figure 1-1  Schematic depictions of the three key steps in early nervous system de-
velopment: from induction to neurulation followed by formation of the brain vesicles 
(taken  from Sanes, Reh and Harris; Development of the Nervous System; Second edition)
(A) Model of neuroectoderm induction in Xenopus laevis (as example). The release of BMP-
antagonists, such as noggin, from the Spemann organiser induces the neuroectoderm.
(B) When the neuroectoderm has formed the neural plate (light red) it rolls up forming a tube that 
delaminates from the rest of the ectoderm. At the same time, the organiser differentiates into the 
notochord and also into some somite- and head-mesodermal tissue. At the point where the neural 
tube fuses, a group of cells, known as the neural crest cells (bright red) arise. These generate the 
peripheral nervous system, while the central nervous system emanates from the neural tube. 
(C) Schematic depicting the generation of the primary and secondary brain vesicles using the 
example of a human embryo (lateral view: top panels; dorsal view: bottom panels). First, the three 
primary brain vesicles develop, known as: forebrain (prosencephalon), midbrain (mesencephalon) 
and hindbrain (rhombencephalon). As development proceeds, the forebrain further divides and 
generates the paired telencephalic vesicles, the diencephalon and the rhombencephalon. The latter 
furthermore splits into the metencephalon and the myelencephalon. 
Abbreviation: BMP, bone morphogenic protein; BMP R,bone morphogenetic protein receptor; Chd, 
chordin; IMZ, involuting marginal zone; Ng, noggin.
C
A B
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During early development, the identities of the dorsal and the ventral telencephalon are 
specified by signaling molecules that are expressed from early patterning centers. Amongst 
these the Wingless-Int protein (Wnt), the Bone morphogenic protein (BMP), Sonic hedghoc 
(Shh) and Fibroblast growth factor families (Fgf) (Lumsden and Krumlauf, 1996; Ruben-
stein et al., 1998; Takahashi and Liu, 2006; Rash and Grove, 2007). These signals act by 
regulating the expression of a specific set of transcription factors that establish the mole-
cular identities and characteristics of the locally generated cell types. Transcription factors 
important for dorsal fate specification comprise the empty spiracle homologs (Emx) 1 and 
2 and the paired-box transcription factor Pax6. Besides specifying dorsal precursors both 
also act antagonistically to further pattern distinct area identities and thus are expressed 
in opposing gradients (Bishop et al., 2000; Bishop et al., 2002; Muzio et al., 2002b; Muzio 
and Mallamaci, 2003). The gradient of Pax6 in the cortex is defined as rostral high to caudal 
low and laterally high to medial low. However, its expression is found already at the neural 
plate stage throughout the telencephalic anlagen, but is then down-regulated at the neural 
tube stage in the region that will give rise to the ventral telencephalon (Inoue et al., 2000; 
Hebert and Fishell, 2008). The down regulation of Pax6 in the region that will later become 
the ventral forebrain goes along with the up-regulation of the transcription factor Nkx2.1 in 
the same region that determines ventral fate (Corbin et al., 2003; Hebert and Fishell, 2008). 
As a result, the boundary between both transcription factors represents the initial dorsal-
ventral border (Hebert and Fishell, 2008). Slightly later, the transcription factor Gsx2 starts 
to be expressed in a domain between Nkx2.1 and Pax6 (Hebert and Fishell, 2008). This 
ultimately leads to the formation of the pallial-subpallial boundary (PSB). At this stage the 
Gsx2 and Pax6 expression domains slightly overlap, but become separated later during 
development (Hebert and Fishell, 2008). Structurally, this boundary lies at the interface of 
the dorsal most region of the LGE with the ventral pallium (Hebert and Fishell, 2008). As 
development proceeds the regionalization becomes more defined, including structural and 
expression refinements of important transcription factors. For a better understanding, im-
portant transcription factors and their genetic interactions underlying the regionalization of 
the telencephalon are depicted in Fig.1-2.
Boundary fascicles at the PSB furthermore restrict the migration of cells across the border 
and loss of Pax6 function results in a disturbed PSB with an increased migration of cells 
between the GE and the cortex (Stoykova et al., 1997; Gotz et al., 1998; Chapouton et al., 
1999). Moreover, Pax6 expression in progenitors of the PSB plays an important role in the 
generation of different neuronal subtypes later populating the olfactory bulb and amygdala 
(Cocas et al., 2011). In addition, Pax6 is expressed in the largest pallial regions – the medial 
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and dorsal pallium – and is crucial for the establishment of a correct glutamatergic phenoty-
pe (Schuurmans and Guillemot, 2002; Kroll and O'Leary, 2005).  
Figure 1-2  Summary of regionalized transcription factors and their genetic interac-
tions in the developing telencephalon (taken from Schuurmans and Guillemont et al., 
2002)
Schematic drawing of a coronal section through the telencephalon of a E12.5 mouse brain, showing 
dorsal and ventral subdomains, as defined by their unique patterns of gene expression. The dorsal 
telencephalon shows high expression levels of Pax6, Ngn1/2, Emx1, Emx2 and Lhx2. In contrast, 
high expression of Mash1, Gsh1/2 (Gsx1/2), Dlx1/2/5/6 is found in the lateral ganglionic eminence 
(LGE) of the ventral telencephalon. Whereas Lhx6, Lhx7 and Nkx2.1 are only found in the medial 
ganglionic eminence (MGE). The dorsal telencephalon can be further subdivided into different 
domains: medial pallium (MP), dorsal pallium (DP), lateral pallium (LP) and ventral pallium (VP). The 
LGE can be further subdivided into the dorsal LGE (dLGE) and ventral LGE (vLGE) compartments 
on the basis of higher levels of Pax6, Gsx2, Mash1 and Dlx2 in the dLGE and exclusive expression 
of Gsx1 in the vLGE.
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1.2 Generation of cell diversity in the cerebral cortex
The cerebral cortex is the most complex structure in the mammalian brain, composed of 
hundreds of different neuronal subtypes (Tiberi et al., 2012). The generation of this neuro-
nal cell diversity is a complex process which involves a number of tightly coordinated steps 
(Guillemot et al., 2006). These include the generation of different progenitor types that show 
distinct proliferation behaviors, their commitment to a neuronal fate, the migration away 
from the progenitor zones towards a particular laminar position building up the complex six-
layered structure of the cerebral cortex and the acquisition of differentiated features (Guille-
mot et al., 2006). All of these steps require distinct molecular regulatory mechanisms, some 
of which will be discussed after introduction of the distinct progenitor types and neurons 
present and produced during development of the cerebral cortex. 
1.2.1 Neural stem and progenitor cells in the developing telencephalon
The first neural stem cell type which is specified during the induction of the neuroectoderm, 
is the neuroepithelial cell. The morphology of this progenitor is characterized by a prominent 
bipolar polarity, spanning the wall of the neural tube from apical (ventricular) to basal (pial). 
During cell-cycle, their nuclei move along their entire axis - from apical-to-basal in G1 pha-
se and from basal-to-apical in G2 phase, followed by mitosis exclusively at the ventricular 
surface. This process is known as interkinetic nuclear migration (INM) and leads to a pseud-
stratified appearance of the neuroepithelium (Takahashi et al., 1996). Before the onset of 
neurogenesis, the neuroepithelial cell population undergoes symmetric divisions to expand 
the progenitor pool and thereby also increases the surface area of the tissue (lateral expan-
sion) (Murciano et al., 2002). With the onset of neurogenesis (around E10.5 in the mouse) 
they switch to an asymmetric mode of division, generating a neuroepithelial cell that stays 
in the ventricular zone (VZ) and one daughter cell that differentiates and migrates outwards 
along the radial process (Fig.1-3). These are the first neurons generated in the developing 
cortex and are designated to settle in the preplate (Casanova and Trippe, 2006; Pinto and 
Gotz, 2007). Now, the tissue also starts to grow in thickness (radial expansion), which is 
accompanied by the lengthening of the radial processes. This goes along with some mo-
lecular changes resulting in the transformation of neuroepithelial cells to radial glial cells. 
These include the expression of glial markers such as the astrocyte specific glutamate 
transporter (GLAST) or the brain-lipid binding protein (BLBP) but also expression of inter-
mediate filament proteins like nestin, vimentin and the RC1 and RC2 epitopes has been 
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described (Hartfuss et al., 2001; Malatesta et al., 2003b; Mori et al., 2005; Pinto and Gotz, 
2007; Alvarez-Buylla et al., 2009). Radial glial cells maintain the bipolar polarity of neuro-
epithelial cells with a basal end-foot at the pial surface and a single ciliated apical end-foot 
lining the ventricle. But, compared to neuroepithelial cells that are connected at the apical-
most end of their plasma membrane via tight junctions (TJ), adherens junctions (AJ) and 
gap junctions, radial glial cells loose the tight junctional connections (Shoukimas and Hinds, 
1978; Astrom and Webster, 1991; Aaku-Saraste et al., 1996; Gotz and Huttner, 2005). On 
the other hand they form specialized contacts with endothelial cells of the developing ce-
rebral vasculature (Takahashi et al., 1990; Misson et al., 1991). Another change appears 
in regard to INM. Radial glial cells still undergo INM, however the movement of their nuclei 
becomes restricted to the VZ due to the thickening of the tissue and the arising neuronal 
layer on top of the progenitor zone (Gotz and Huttner, 2005). It has been shown that RG 
cells undergo self-renewing divisions, expanding the progenitor pool, but also producing all 
remaining neurons that originate from the cerebral cortex (Fig.1-3) (Malatesta et al., 2003a). 
The predominant mode of division is asymmetric with about 30% of the radial glial cells 
that still undergo symmetric self-renewing divisions around midneurogenesis (Konno et al., 
2008). The asymmetric self-renewing divisions of radial glial cells produce a progenitor 
and a daughter cell that is either a neuron or a second type of neural progenitor with more 
restricted potential (Noctor et al., 2001a; Huttner and Kosodo, 2005). In rodents, the most 
abundant progenitor type, originating from RG in the telencephalon is the basal progenitor 
(BP or intermediate progenitor IPC). These progenitors delaminate from the apical surface 
and translocate their nucleus to the basal site of the ventricular zone and this way form a 
second germinal layer, the subventricular zone (SVZ) (Farkas et al., 2008). Before mitosis, 
they have also retracted both their apical and basal processes. Frequently they possess 
multipolar processes, but these are too short to contact the ventricle or the pial surface. 
Time-lapse imaging studies have shown that in contrast to RG, the majority of BPs in the 
cerebral cortex divides in a symmetric mode of division. In terms of daughter cell fate, these 
symmetric divisions predominantly produce two neurons and much less frequently (~10% 
of the divisions) produce two additional BPs (Haubensak et al., 2004; Miyata et al., 2004; 
Noctor et al., 2004; Huttner and Kosodo, 2005; Wu et al., 2005; Fietz et al., 2010). A recent 
description has raised the possibility that proliferation behaviour and fate of basal progeni-
tors may be influenced by signals from the developing vasculature as it was shown that BPs 
localize preferentially close to the blood vessels during cortical neurogenesis (Javaherian 
and Kriegstein, 2009; Stubbs et al., 2009). 
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As described above, the majority of secondary progenitors derived from radial glial cells 
are the basal progenitors. Recent work has identified additional progenitors – radial glia-
like (oRG) progenitor cells and short neural precursors (SNP) - present in the developing 
rodent cortex. While imaging studies have proven that oRGs derive from radial glial cells 
(Shitamukai et al., 2011; Wang et al., 2011b), the RG-ancestry of SNPs has just been hypo-
thesized (Gal et al., 2006). Short neural precursors exhibit apical polarity but in contrast to 
RG their basal process is not reaching the pial surface and is retracted during mitosis. They 
have been identified by GFP expression driven by the tubulin alpha1 promoter (Fietz et al., 
2010), which is solely active in the SNPs and were found in substantial numbers between 
E13.5-E16.5 – the major birth period of neurons in the developing cerebral cortex. Moreo-
ver, genetic fate mapping has revealed that SNPs produce rather neurons than BPs (Gal et 
al., 2006; Stancik et al., 2010). Short neural precursors and oRGs have one feature in com-
mon– the expression of the transcription factor Pax6. But, in contrast to SNPs, oRGs pos-
sess only basal polarity inherited from their radial glial mother cell. Elegant imaging studies 
have furthermore shown that these progenitors undergo asymmetric self-renewing divisions 
located basally of the SVZ (Shitamukai et al., 2011; Wang et al., 2011b). In mice oRGs are 
present in low numbers (~5% at E14), which is in contrast to humans and primates that are 
populated by a large number of the corresponding outer-subventricular zone (OSVZ) proge-
nitors contributing to the cortical expansion in higher mammals (Lui et al., 2011).  
Taken together, within the developing cerebral cortex diversity in progenitor populations 
exist – NE cells, RG cells, SNP cells, BP cells, oRG cells – all contributing to the generation 
of distinct neuronal subtypes. 
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Figure 1-3  Generation of cell diversity in the brain: different subtypes of progeni-
tors contribute to cortical neurogenesis (taken from Kriegstein and Alvarez-Buylla et 
al., 2009)
Early in development, neuroepithelial cells (NEC) expand by symmetric divisions. As development 
proceeds, the NECs elongate and convert into radial glial cells (RG). RGs divide mainly asymmetric, 
generating neurons directly or indirectly through intermediate progenitors (IPC; also known as basal 
progenitors). The progeny of RG and IPC migrates basally for differentiation. The brain gains in 
thickness and RG cells further elongate their process. RG cells possess an apical (down) to basal 
(up) polarity and contact the ventricle, where they project a single primary cilium. On the basal side, 
RG cells contact the basal lamina at the meninges and blood vessels. At the end of embryonic 
development most RG start to detach from the apical surface and then either convert into astrocytes 
or continue with oligodendrocyte production (oPC). 
Abbreviations: CP, cortical plate; IPC, intermediate progenitor cell; IZ, intermediate zone; MA, mantle; 
MZ, marginal zone; NE, neuroepithelium; nIPC, neurogenic progenitor cell; oIPC, oligodendrocytic 
progenitor cell; RG, radial glia; SVZ, subventricular zone; VZ, ventricular zone.
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1.2.2 Neuronal cell diversity forming the six layers of the cerebral cortex
The cerebral cortex is organized radially into six layers and tangentially into distinct areas. 
Each layer contains pyramidal neurons of a specific subtype with distinct morphology, pro-
jection pattern, function and gene-expression profile and are generated from the progenitor 
populations described above in a tightly controlled temporal order (Casanova and Trippe, 
2006; Molyneaux et al., 2007). In mouse the birth period of these neurons takes place 
between E10.5 to E17.5 and the postmitotic neurons position themselves in an inside-out 
manner (Fig.1-4) (Molyneaux et al., 2007). That is, later born neurons migrate radially past 
early born neurons settling on top of them. The earliest born neurons that appear in the 
dorsal cortex form a transient structure called the preplate, which than splits into the upper 
marginal zone and the lower subplate. The neurons of the marginal zone are termed Cajal-
Retzius cells and noteworthy, they not only originate from cortical neuroepithelial progeni-
tors (Shen et al., 2006) but also from other region including the cortical hem (Garcia-Moreno 
et al., 2007). Cajal-Retzius cells secrete the molecule Reelin, which is important for the 
correct positioning of the postmitotic neurons within the six-layered structure (D'Arcangelo 
et al., 1995; Ogawa et al., 1995; D'Arcangelo et al., 1997; Schiffmann et al., 1997). Procee-
ding in development, the cortical plate develops in between the marginal zone and subplate 
and subsequently gives rise to the multilayered cortex. Its different neuronal subtypes are 
generated in overlapping temporal waves that begin a bit earlier rostro-laterally: neurons of 
the deeper layers 6 and 5 are generated around E12.5 and E13.5 respectively and neurons 
of the upper layers 4 and 3/2 are born around E14.5 and E15.5 respectively (Molyneaux et 
al., 2007). Neurogenesis caudo-medially slightly lags behind (Molyneaux et al., 2007). As 
mentioned before, the cortical layers can be distinguished by a specific gene expression 
pattern of their neurons. For example, deep layer neurons 6 and 5 can be distinguished by 
the expression of Foxp2 and Er81 respectively (Molyneaux et al., 2007). Another marker 
gene present in both deep-layers is Ctip2 - which is expressed at high levels in the lower 
portion of layer 5 neurons (5b; subcerebral neurons) and with lower levels in layer 6 neu-
rons (Molyneaux et al., 2007). The neurons of the upper layers 2, 3 and 4 express many 
genes in common such as Cux1 and Cux2 or Svet1 (Molyneaux et al., 2007). However, they 
also possess some individual marker gene expression like Rorß, which is restricted to layer 
4 neurons. Moreover expression of some genes is found in both upper and deep layers, 
such as Tbr1 (Molyneaux et al., 2007). Besides their different gene expressions and other 
complexities, such as the brain region they project to, all these subtypes of neurons have 
two things in common - they originate from cortical progenitors and are all pyramidal shaped 
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excitatory projection neurons using glutamate for neuronal transmission (Molyneaux et al., 
2007). 
In contrast, a second class of cortical neurons – inhibitory interneurons – is generated pri-
marily from ventral telencephalic progenitors and uses gamma-aminobutyric acid (GABA) 
as neurotransmitter (Gotz and Sommer, 2005). These neurons migrate via distinct roots 
tangentially into the cortex and finally form local connections with the excitatory projection 
neurons (Gotz and Sommer, 2005; Wonders and Anderson, 2006). Taken together, the 
cerebral cortex possesses a unique six-layered structure consisting of diverse neuronal 
subtypes all generated during embryonic neurogenesis. 
Figure 1-4  Schematic depicting the generation of the six-layered structure of the 
cortex (adapted from Molyneaux et al., 2007)
The earliest born neurons from VZ progenitors form the preplate (PP), which is later split into the 
upper -marginal zone (MZ) and the deeper located subplate (SP). As a next step, the cortical plate 
(CP) develops in between the MZ and SP. As development proceeds, the cortical plate gives rise 
to the layered cortex; neurons born at later stages migrate past early born neurons, settle on top of 
them and this way generate the multilayered structure of the cortex via an inside-out mechanism. 
Different classes of projection neurons are born in overlapping temporal waves between E10.5-E16.5 
in the mouse.
Abbreviations: CH, cortical hem; E, embryonic day; Ncx, neocortex; IZ, intermediate zone; LGE, 
lateral ganglionic eminence; MGE, medial ganglionic eminence; SVZ, subventricular zone; VZ, 
ventricular zone; WM, white matter.
1.2.3 Molecular fate determinants in cortical development
The generation of pyramidal neurons in the developing cerebral cortex requires tight con-
trol of proliferation, cell fate specification and differentiation of the cortical progenitors. One 
important question then is – what are the molecular determinants involved? Two classes 
of regulators have emerged: extrinsic and intrinsic factors that interplay to control cortical 
neurogenesis (Guillemot et al., 2006; Johansson et al., 2010; Tiberi et al., 2012). 
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1.2.3.1    Extrinsic cues
A number of extracellular factors have been described, such as retinoic acid (RA), bone 
morphogenic proteins (BMPa), sonig hedgehog (Shh), fibroblast growth factors (FGFs), 
and Wingless-Int proteins (Wnts). In addition to cortical neurogenesis, the roles of the-
se classical morphogen families have been best studied in regional patterning as briefly 
mentioned before. The family of Wnts are secreted signalling molecules and expression of 
distinct Wnts and their receptors or antagonists are found in different compartments in the 
developing cortex (Chenn, 2008). For example, several Wnts (including Wnt3a, 5a, 2b, 7b 
and 8b) originate from a caudomedial structure called the cortical hem (Grove et al., 1998). 
In contrast, the laterally located anti-hem expresses Wnt antagonists, like the secreted 
frizzled related protein 2 (Sfrp2). The dorsal pallium has a high abundance of Wnt-ligands 
and ß-catenin (a major component of the canonical Wnt-signalling pathway) as well as of 
the frizzled family receptors. Interestingly, they are found in different cortical compartments. 
While the ventricular zone expresses Wnt-receptors (mFz-5, mFz-8), Wnt7a and ß-catenin, 
the ligand Wnt7b is absent from the VZ and instead is found in the subventricular zone 
and developing cortical plate (Grove et al., 1998; Rubenstein et al., 1999; Kim et al., 2001; 
Chenn and Walsh, 2002; Funatsu et al., 2004). Wnt proteins activate different intracellular 
signaling pathways including the ß-catenin/TCF pathway (known as the canonical Wnt pa-
thway) (Wodarz and Nusse, 1998; Brantjes et al., 2002) and non-canonical pathways, like 
the planar cell polarity pathway mediated by Jun N-terminal kinase (JNK) or the Wnt/Ca2+ 
pathway (Kuhl et al., 2000; Huelsken and Birchmeier, 2001; Habas et al., 2003; Hirabayashi 
et al., 2004). Their effects during cortical development are diverse and appear to depend on 
the progenitor state and developmental time. It has been reported that the canonical Wnt 
pathway promotes self-renewal of progenitor cells during early neurogenesis; expression 
of stabilized ß-catenin has been shown to result in an increased number of progenitors and 
suppression of neuronal differentiation (Chenn and Walsh, 2002). Conversely, loss of Wnt 
signalling lead to a decrease in cortical neuronal production (Woodhead et al., 2006; Zhou 
et al., 2006). On the contrary, recent reports have shown that Wnt-ligands can exert pro-
neurogenic effects during mid-neurogenesis (Hirabayashi et al., 2004; Israsena et al., 2004; 
Kuwahara et al., 2010). For example, the ligand Wnt7a promotes neuronal differentiation 
in part by direct regulation of the proneuronal factor Ngn1 (Hirabayashi et al., 2004). Most 
recently, a comparison of activating or inhibiting Wnt-ligands demonstrated a dual role of 
Wnt-signalling in cortical neurogenesis (Munji et al., 2011). While Wnt-signalling regulates 
self-renewal in radial glial cells, its activation in basal progenitors is required for neuronal 
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production at mid and late stages of neurogenesis. Thus Wnt regulators are an important 
extrinsic cue during cortical neurogenesis.
The morphogen retinoic acid is a hormone derived from vitamin A (retinol) (Chambon, 1996). 
During cortical neurogenesis, RA is released from a neural crest derived structure – the 
meninges, which overlays the neuroectoderm (Siegenthaler et al., 2009). This structure in 
addition expresses the proteins that bind and chaperone RA (e.g. CRABP I, II and CRBP1) 
and are implicated in titrating the RA exposure to the radial glial endfeet (Ruberte et al., 
1993; Napoli, 1999; Siegenthaler et al., 2009). Furthermore, CRABP II is also expressed in 
the ventricular zone, where it is suggested to aid in the intracellular transport of RA through 
the cytoplasm of the radial glial fiber up to the nucleus (Ruberte et al., 1993; Siegenthaler 
et al., 2009). Moreover a recent report identified another transport protein (of the RA precur-
sors retinol and retinalaldehyde) in the ventricular zone - CRALBP (also known as Rlbp1) 
and showed that CRALBP expression is directly controlled by the transcription factor Pax6 
(Boppana et al., 2012). The role of RA in cortical neurogenesis was investigated in a recent 
study and unraveled an impact of RA on basal progenitor specification (Siegenthaler et al., 
2009). This was revealed examining Foxc1 mutants, which displayed defects in the formati-
on of the meninges accompanied by lack of secreted retinoic acid (Tiberi et al., 2012). Loss 
of meningeal cell derived RA resulted in a decreased generation of basal progenitors from 
radial glial cells (Siegenthaler et al., 2009). This finding is especially interesting as for many 
years retinoic acid has been used to induce neural differentiation from pluripotent embryo-
nic stem cells (Bain et al., 1995; Bain et al., 1996; Guan et al., 2001; Bibel et al., 2004; Bibel 
et al., 2007).   
Taken together, various extracellular cues, like the morphogens Wnt or RA (or others see 
for example (Johansson et al., 2010) play an important role in cortical neurogenesis and 
furthermore cooperate with different intrinsic factors to regulate cortical development. 
1.2.3.2     Intrinsic cues
Intrinsic factors that control cortical differentiation involve many transcription factors, post-
transcriptional regulators like miRNAs as well as regulators of cell-polarity and mitosis. All 
these different intrinsic factors act at the level of at least one type of progenitor to control 
cortical neurogenesis (Gotz and Huttner, 2005; Pinto and Gotz, 2007; Kriegstein and Alva-
rez-Buylla, 2009; Fietz and Huttner, 2011; Tiberi et al., 2012). Interestingly, however within 
the lineage of progenitors, many aspects of cortical neurogenesis seem to be programmed 
(Tiberi et al., 2012). This notion of an intrinsic programme is supported by lineage studies 
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of isolated progenitors. When cultured, the progenitors were able to generate the different 
subtypes of neurons in an order that resembled the one observed in-vivo (Qian et al., 2000; 
Shen et al., 2006). However, while earlier transplantation experiments support the presence 
of such a cell-intrinsic programme, they also imply that extrinsic factors cooperate to deter-
mine neuronal fate, in particular by influencing final mitosis. When early progenitors (iso-
lated when deep-layer neurons were generated) were transplanted into a developmentally 
more progressed environment, they only switched to the generation of upper-layer neurons 
when the progenitor was in its S-phase of the cell cycle (Desai and McConnell, 2000). 
Conversely, early progenitors transplanted late in their cell-cycle state (G2-phase) were not 
able to switch (McConnell and Kaznowski, 1991; Frantz and McConnell, 1996; Desai and 
McConnell, 2000). In contrast, progenitors of a later stage (determined to generate upper-
layer neurons) were restricted to an upper-layer fate (Desai and McConnell, 2000). Thus, 
as the developmental programme unfolds, progenitors lose their capacity to generate deep 
layer neurons. 
As mentioned above one large class of intrinsic factors regulating the developmental pro-
gramme are transcription factors. In the mammalian brain, commitment to a neuronal fate 
involves the expression of proneural basic helix-loop-helix (bHLH) transcription factors such 
as Neurogenin1 and Neurogenin2 (Neurog1&2) as well as the mammalian achaete-scute 
homolog1 (Mash1) (Fode et al., 2000; Nieto et al., 2001). Their expression patterns are lar-
gely complementary within the telencephalon and important for the specification of distinct 
neuronal fates (Guillemot et al., 2006). Expression of Neurogenins is restricted solely to the 
dorsal telencephalon and induce a regional character by promoting the expression of dif-
ferentiation genes such as NeuroD1/2, Math2/3 and Nscl1 that are sequentially expressed 
during neuronal differentiation (Schuurmans et al., 2004; Guillemot et al., 2006). In addition, 
both Neurogenins are important for activating a program that provides neurons with a glut-
amatergic phenotype in the dorsal telencephalon (Guillemot et al., 2006). In contrast, high 
Mash1 expression is confined to the progenitors of the ventral telencephalon that produce 
mainly GABAergic neurons. The specification of neuron identity has been demonstrated by 
loss- and gain-of function experiments. Intriguingly, loss of Neurog1&2 results in ectopic 
expression of ventral and GABAergic genes, while these remain low in the cerebral cortex 
of Neurog2/Mash1 double mutants (Guillemot et al., 2006). This suggests that Neurog1&2 
may specify cortical neuron identity by repression of Mash1 expression (Fode et al., 2000; 
Schuurmans et al., 2004; Guillemot et al., 2006). 
Another regulatory gene that depends on the function of Ngn1/2 is the T-box gene Tbr2 
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(Englund et al., 2005). Tbr2 is abundantly expressed in basal progenitors and promotes 
their generation from radial glial cells (Englund et al., 2005). Moreover, recent studies have 
identified additional transcription factors that add to the specification of basal progenitors. 
Amongst them Ap2gamma and Fezf1/2, which both are expressed in radial glial cells (Fietz 
et al., 2010). While Ap2gamma promotes BP specification by directly activating Tbr2, Fezf1/2 
drives Tbr2 expression indirectly by a mechanism that involves derepression of Ngn2 (Pinto 
et al., 2009; Fietz et al., 2010; Shimizu et al., 2010). As mentioned before, BPs form the 
SVZ which can be recognized as a distinct compartment during mid and late stages of 
neurogenesis - the time when upper layer neurons are produced. However, several studies 
including time-lapse imaging have revealed that BPs are abundant during all cortical stages 
of neurogenesis and do generate neurons of all cortical layers including the earliest born 
preplate neurons (Arnold et al., 2008; Sessa et al., 2008; Kowalczyk et al., 2009). However, 
the precise contribution of BPs to each layer remains to be defined (Pontious et al., 2008). 
In addition to transcription factors that promote their fate, basal progenitors express seve-
ral molecular factors of upper-layer neurons, such as the cut-like homeobox transcription 
factors 1 and 2 (Cux1/2). Their expression is detected at or before the onset of upper layer 
neurogenesis and it has been shown that Cux2 regulates the cell-cycle exit rate of basal 
progenitors and thereby controls in particular the number of upper cortical neurons genera-
ted (Nieto et al., 2004; Cubelos et al., 2008).
Another important transcription factor expressed in radial glia cells and involved in BP spe-
cification through directly activating Ngn2 and Tbr2 is Pax6 (Scardigli et al., 2003; Sansom 
et al., 2009). Pax6 is one of the most intensely studied transcription factors during brain 
development (Osumi et al., 2008; Georgala et al., 2011a) and has been shown to play mul-
tiple roles in the development of the cerebral cortex. Although many functions of Pax6 have 
been reported and recent advances in identifying Pax6 target genes have been made, the 
mechanisms of how Pax6 can exert these functions on the molecular level are poorly cha-
racterized. Therefore the main part of this thesis work concentrated on dissecting the role of 
distinct DNA-binding domains of Pax6 in cortical development. Hence, the next chapter de-
scribes the transcription factor Pax6 and its various functions during cortical development. 
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1.3 The transcription factor Pax6 – a master regulator
1.3.1 Pax6 Expression
The expression of Pax6 in mammals has been observed in the pancreas, the gut, the pi-
tuitary, in nasal structures, the brain and the spinal cord (Walther and Gruss, 1991). Pax6 
expression is important for survival and loss of functional Pax6 in mice leads to death im-
mediately after birth (Hogan et al., 1986). In the developing nervous system of the mouse 
embryo, Pax6 expression starts as early as E8 in regions of the anterior neural plate that will 
give rise to the telencephalon, the eyes and the diencephalon as well as in neuroepithelium 
of the presumptive spinal cord and hindbrain (Fig1-5) (Walther et al., 1991; Stoykova and 
Gruss, 1994). Within the developing telencephalon Pax6 expression becomes restricted to 
the radial glial cells that mask the ventricular zone of the dorsal telencephalon and occurs in 
a gradient with rostral high to caudal low and lateral high to medial low expression (Bishop et 
al., 2000; Bishop et al., 2002; Muzio et al., 2002b; Muzio and Mallamaci, 2003). During em-
bryonic neurogenesis, Pax6 expression remains in the VZ that gradually becomes thinner 
as development proceeds. In contrast, Pax6 expression is down-regulated during transition 
of radial glial cells to the second major progenitor population in the dorsal telencephalon - 
the basal progenitors (Gotz et al., 1998; Englund et al., 2005). The high expression of Pax6 
in the dorsal VZ extends to the border between the dorsal and ventral telencephalon, where 
Pax6 expression is found in a small stripe of cells along this pallial-subpallial boundary 
(PSB) (Stoykova and Gruss, 1994; Stoykova et al., 1996). Within the ventral telencephalon 
low expression of Pax6 is detected in the ventricular zone of the lateral ganglionic eminence 
(LGE) but is absent in the medial ganglionic eminence (MGE) (Fig.1-5). On cellular level, 
Pax6 protein in the mouse telencephalon has so far been detected exclusively in the nuc-
leus of radial glial cells. Interestingly, a recent report determined extracellular expression of 
Pax6 in the embryonic chick spinal cord with paracrine activity (Di Lullo et al., 2011).
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Figure 1-5  Expression of Pax6 in the developing mouse brain
(A) Schematic drawing of an E13.5 mouse brain (sagital view), showing the regions of Pax6 
expression in red; (taken from PhD-thesis of Nicole Haubst 2005; modified from Stoykova and 
Gruss 1994). 
(B) Micrographs depicting Pax6 expression in one hemisphere of a dorsal section of an E14 
mouse telencephalon (coronal view; corresponding to the level indicated by the blue line in A). 
The border between the dorsal telencephalon (cortex; pallium) and the ventral telencephalon 
(ganglionic eminences; subpallium) is delineated by the pallial-subpallial boundary (PSB). The 
ventral telencephalon is further subdivided into the lateral ganglionic eminence (LGE) and medial 
ganlionic eminence (MGE). High expression of Pax6 is found in the dorsal telencepahlon and low 
levels in the progenitor zone of the LGE. In contrast, Pax6 expression is absent from the MGE. In 
the dorsal telencephalon Pax6 is expressed in a gradient, showing rostral high to caudal low and 
laterally high to medial low expression. 
Abbreviations: Cb (cerebellum), Cfr (frontal cortex), DT (dorsal thalamus), egl (external granular 
layer of the cerebellum), ET (epithalamus), GE (ganglionic eminence), LV (lateral ventricle), Ms 
(mesencephalon), My (myelencephalon), OB (olfactory bulb), ORE (optic recess), PC (posterios 
commissure), Pn (pons), POA (Anterior preoptic area), PT (pretectum), SE 8septum), 4V (fourth 
ventricle).
A
B
Pax6
LGE
LGE
LGE
MGE
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1.3.2 The role of Pax6 in forebrain development
The activity of Pax6 is very complex and most knowledge about Pax6 function comes from 
studies examining the phenotypes of mutant lines of mice and rats with a mutation in the 
Pax6 gene that leads to loss of Pax6 function. In mice the Small eye mouse strain (Sey or 
SeyNeu; termed Pax6Sey in this study) is characterized by a natural occurring point muta-
tion that truncates the C-terminal half of Pax6 and creates a truncated protein considered 
functionally inactive (Hill et al., 1991). In addition, more recent studies either conditionally 
deleting Pax6 in the cortex (Pinon et al., 2008; Tuoc et al., 2009) or using a gain-of function 
mouse line have confirmed and revealed more detailed phenotypes (Manuel et al., 2007; 
Georgala et al., 2011a).
In the developing eye, gross morphological analyses of heterozygote Pax6Sey mutants have 
shown that these mutants possess a small eye phenotype, while homozygous Pax6 mutants 
completely lack their eyes (Hogan et al., 1986; Osumi et al., 2008). Furthermore detailed 
analyses have shown that Pax6 function is essential for proper development of the lens and 
retina (Ashery-Padan et al., 2000; Ashery-Padan and Gruss, 2001; Kozmik, 2005; Graw, 
2010). In the developing telencephalon, the gross morphological phenotype after loss of full 
Pax6 function is a smaller and shorter cerebral cortex with a thinner cortical plate (Schmahl 
et al., 1993; Heins et al., 2002; Asami et al., 2011). In fact, Pax6 function in the developing 
telencephalon is essential for various processes such as cell proliferation, neurogenesis, 
cortical arealization and regionalization of the telencephalon which is in turn coupled to the 
establishment of the pallial-subpallial boundary (Georgala et al., 2011b). Therefore in the 
following sections some of these Pax6 functions will be explained in more detail.
1.3.2.1     Pax6 function in dorso-ventral patterning
As described before, the subdivision of the dorsal (pallial) and ventral (subpallial) telence-
phalon, including the establishment of the pallial-subpallial boundary involves Pax6 func-
tion. The PSB itself is molecularly defined with high or restricted expression of factors like 
Ngn2, Tbr2, Dbx and Pax6 on the dorsal side and factors such as Gsx2, Nkx2.2, Olig2 or 
Mash1 on the ventral side (Toresson et al., 2000; Yun et al., 2001; Campbell, 2003). In ad-
dition also a physical boundary in form of radial glial fascicles develops (Neyt et al., 1997; 
Stoykova et al., 1997). Loss of functional Pax6 leads to disruption of this molecular and also 
physical boundary (Stoykova et al., 1997). In particular, the expression of Ngn2 and Tbr2 
in the dorsal telencephalon is lost (Stoykova et al., 2000; Toresson et al., 2000; Yun et al., 
2001; Haubst et al., 2004), whereas many transcription factors of the ventral telencephalon 
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such as Gsx1/2, Mash1, Dlx1/2 or Olig2 are misexpressed into the Pax6Sey mutant cortex 
(Stoykova and Gruss, 1994; Stoykova et al., 1996; Stoykova et al., 1997; Toresson et al., 
2000; Yun et al., 2001; Heins et al., 2002). Moreover an increase in dorsally migrating cells 
has been reported (Chapouton et al., 1999). Some of these ventral genes such as Gsx2, 
play complementary roles to that of Pax6 in establishing the boundary. Indeed in functional 
Gsx2 null-mutants an opposite phenotype, with ectopic expression of dorsal markers ven-
trally has been described (Toresson et al., 2000; Yun et al., 2001). Gsx2 itself is important 
for the maintenance of molecular identity of early striatal progenitors and loss of Gsx2 not 
only results in ectopic expression of dorsal genes ventrally, but also to the loss of other 
ventral regulatory genes such as Mash1 or Dlx (Toresson et al., 2000). Accordingly, some 
phenotypes of the Pax6 or Gsx2 single mutants are improved in Gsx2/Pax6 double mutants 
(Toresson et al., 2000). For example, expression of the regulatory genes Mash1 and Dlx 
is restored in ventral progenitors and the development of the cerebral cortex in general is 
improved (Toresson et al., 2000).        
1.3.2.2     Pax6 function in area patterning
Similar to dorso-ventral patterning, the first evidence for Pax6 function in area patterning 
came from gene marker analysis in the Small eye mouse. These implicated that Pax6 is 
important for specifying rostral and lateral area identities associated with motor and so-
matosensory areas (Bishop et al., 2000; Bishop et al., 2002; Muzio et al., 2002b; Muzio 
and Mallamaci, 2003). As mentioned above Pax6 is expressed in a gradient with highest 
expression in the anterior progenitors that give rise to these areas and opposite to the ex-
pression of Emx2, which specifies caudal and lateral areas (Bishop et al., 2000; Bishop et 
al., 2002; Muzio et al., 2002b; Muzio and Mallamaci, 2003). Loss of functional Emx2 leads 
to the expansion of Pax6 expression into caudal regions of the cerebral cortex, resulting in 
expansion of motor and somatosensory areas into these regions. And vice versa, in Pax6Sey 
mice rostral cortical areas at the level of the motor cortex are compressed and primary vi-
sual areas are shifted rostral. (Bishop et al., 2002; Muzio et al., 2002a; Muzio et al., 2002b; 
Muzio and Mallamaci, 2003). Recent work using cortex-specific conditional Pax6 knockout 
mice detected a similar rostral shift of area markers as detected in the Pax6Sey mice (Pinon 
et al., 2008). However, the distribution of the area specific projections (thalamocortical and 
corticofugal) were not affected (Pinon et al., 2008). This suggests that cortical area identi-
ties and thalamic connections are uncoupled processes and Pax6 is mainly involved in the 
former (Pinon et al., 2008). In addition examining Pax6-overexpressing mice, it has been 
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suggested that the relative levels and not the absolute levels of Pax6 expression are impor-
tant for specifying area identities (Manuel et al., 2007). Or alternatively that the gradient of 
Pax6 expression is less important, as Pax6-overexpressing mice (transgenic mice carrying 
several copies of the human PAX6 locus; termed Pax77) did not exhibit significant shifts of 
cortical domains (Manuel et al., 2007). 
1.3.2.3     Pax6 function in the olfactory system
Pax6 plays different roles in the olfactory system as revealed by analysis of homozygote 
and heterozygote (which survive into adult stages) Pax6 deficient mice or rats (Nomura et 
al., 2007). These showed several abnormalities, including dysgenesis of the olfactory epi-
thelium (Matsuo et al., 1993; Davis and Reed, 1996; Anchan et al., 1997) and mislocation 
of specific neuronal subtypes in the olfactory cortex and olfactory bulb (Lopez-Mascaraque 
et al., 1998; Jimenez et al., 2000; Hirata et al., 2002; Nomura and Osumi, 2004; Nomura et 
al., 2006; Nomura et al., 2007). 
The olfactory system develops early during development. The first olfactory sensory neu-
rons (which capture the odorant information) of the olfactory placode (later the olfactory 
– nasal epithelium) send initial axons to the olfactory bulb (OB) primordium (De Carlos 
et al., 1995). The OB primordium is specified from rostral areas of the dorsal telencepha-
lon and generates the olfactory bulb in form of a protrusion. The olfactory bulb functions 
as primary processing center of the odorant information (Lopez-Mascaraque et al., 1998; 
Lopez-Mascaraque and de Castro, 2002) and consists of two types of neurons: (i) projec-
tion neurons including mitral and tufted cells and (ii) interneurons produced mainly in the 
GE, but also from dorsal telencephalic progenitors with many originating especially from the 
ventral pallium (Toresson and Campbell, 2001; Wichterle et al., 2001; Gorski et al., 2002; 
Willaime-Morawek et al., 2006; Kohwi et al., 2007; Ventura and Goldman, 2007; Young et 
al., 2007; Nomura et al., 2007; Cocas et al., 2011). Pax6Sey mice do not develop an olfactory 
bulb at the rostral part. Instead an olfactory-bulb like structure (OBLS) is formed at the late-
ral part of the telencephalon (Lopez-Mascaraque et al., 1998; Jimenez et al., 2000; Hirata 
et al., 2002; Lopez-Mascaraque et al., 2005; Nomura et al., 2007). This structure contains 
accumulated mitral cells and this mislocation seems to be the primary defect in this abnor-
mal development (Lopez-Mascaraque et al., 1998; Jimenez et al., 2000; Hirata et al., 2002; 
Lopez-Mascaraque et al., 2005; Nomura et al., 2007). 
Pax6 function is also important for generation of some interneuron subtypes. Interneurons 
of the OB can be subdivided into granule cells (GCs) and periglomerular cells (PGCs). 
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While GCs all express GABA as neurotransmitter, PGCs are more heterogeneous including 
GABAergic dopaminergic and glutamatergic neurotransmitter types (Nomura et al., 2007). 
The generation of olfactory-bulb interneurons continues after birth and is in particular inves-
tigated as model of adult neurogenesis (Nomura et al., 2007; Kriegstein and Alvarez-Buylla, 
2009) from neural stem cells that reside in the telencephalic subependymal zone (SEZ). 
Pax6 expression is found in these adult stem cells as well as in neuroblasts that migrate 
along the rostral-mirgatory stream towards the OB (Hack et al., 2005; Kohwi et al., 2005). 
Upon arrival in the olfactory bulb, the vast majority of neuroblasts loose Pax6 expression, 
except the subset destined for dopaminergic neuronal fate (Hack et al., 2005; Brill et al., 
2009; Ninkovic et al., 2010). Gain-of Pax6 function by overexpression in-vivo increases the 
number of dopaminergic thyrosine hydroxylase positive (TH+) PGCs (Hack et al., 2005; Brill 
et al., 2008). Conversely, the generation of dopaminergic neurons is reduced in the adult 
olfactory bulb of Pax6 mutant mice (Dellovade et al., 1998; Kohwi et al., 2005; Ninkovic et 
al., 2010). Thus Pax6 is necessary for specification of dopaminergic periglomerular neurons 
in the olfactory bulb. 
1.3.2.4     Pax6 function in proliferation and neurogenesis
The role of Pax6 in proliferation appears complex and in a context-dependent manner. 
In the developing cortex, Pax6 deletion has been described to increase proliferation, in 
particular at non-apical positions (Gotz et al., 1998; Estivill-Torrus et al., 2002; Haubst et 
al., 2004; Quinn et al., 2007; Tuoc et al., 2009). This phenotype goes along with several 
influential changes, one of which as described before the ventralization of dorsal progenitor 
identity. Moreover, loss of functional Pax6 was reported to result in premature delamination 
from the apical surface contributing to the non-apical proliferating progenitor increase (Asa-
mi et al., 2011). In contrast to the telencephalon, decreased cell proliferation was reported 
in other regions of Pax6 expression in Pax6 mutants, like the diencephalon (Warren and 
Price, 1997) and the developing eye (Marquardt et al., 2001). However no change in cell 
proliferation was detected in the cerebellum of Pax6Sey mice (Engelkamp et al., 1999). Thus 
Pax6 regulates cell proliferation on a rather region- and cell type-specific manner. Notably, 
on transcriptional level Pax6 has been observed to control both – proliferation promoting 
and inhibiting factors – even in the same cell type (Holm et al., 2007; Osumi et al., 2008; 
Sansom et al., 2009).
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Neurogenesis is tightly linked to proliferation, as to become a neuron a cell has to leave 
the cell cycle and differentiate. Several studies with different Pax6 mutants including the 
Pax6Sey (Estivill-Torrus et al., 2002), Pax6-/-/Pax6+/+ chimeric mice (Quinn et al., 2007) and 
conditional deletion of Pax6 in a cortex specific manner (Tuoc et al., 2009) have shown that 
loss of Pax6 leads to an accelerated withdrawal from the mitotic cycle and results in pre-
mature differentiation of the progenitors at early stages (E12/ E13) (Georgala et al., 2011b). 
Interestingly, overexpression of Pax6 leads to changes of the proliferation rate of late proge-
nitors (E15.5) and also promotes cell-cycle exit at late stages of corticogenesis (Manuel et 
al., 2007; Georgala et al., 2011b). In any case, the progenitor pool is affected and influences 
the production of correct neuronal numbers. Indeed, Pax6Sey mice are characterized by a 
thinner cortical plate (Schmahl et al., 1993; Caric et al., 1997; Gotz et al., 1998; Warren 
et al., 1999; Fukuda et al., 2000; Haubst et al., 2004). But also after conditional deletion 
and overexpression of Pax6 reduced numbers of neurons have been reported (Tuoc et al., 
2009; Georgala et al., 2011b). 
As described before, cortical progenitors give rise to different neuronal subtypes with earlier 
born neurons found in deep-layers and later born neurons found at earlier stages. Studies 
examining the generation of distinct layers in Pax6Sey mice suggested that specifically up-
per-layer neurons are reduced (Stoykova et al., 1996; Caric et al., 1997; Gotz et al., 1998; 
Tarabykin et al., 2001; Nieto et al., 2004; Schuurmans et al., 2004). However, a more recent 
report has examined the layer production after conditional deletion of Pax6, which has had 
the advantage of analyzing the mutant cortex at juvenile stages (postnatal day 8) (Tuoc et 
al., 2009). This is the time when all neurons have reached their final location. Conditionally 
deleting Pax6 from early cortical progenitors resulted in an increase of early born neuronal 
subsets in the marginal zone and of deep cortical layers (Tuoc et al., 2009). As a conse-
quence the progenitor pool for later-born, upper layer neurons was affected with almost 
complete loss of upper layer neuronal subtypes (Tuoc et al., 2009). Interestingly, in contrast, 
the conditional deletion of Pax6 at later stages - when the deep layer neurons were already 
born - did not affect upper-layer genesis. This suggests that cortical progenitors at different 
stages must have different requirements for Pax6 or alternatively Pax6 performs different 
functions at different stages (Tuoc et al., 2009).  
As described before, cortical neurons arise from both apical and basal progenitors and 
Pax6 expression in radial glial cells promotes the generation of basal progenitors. Recent 
studies have identified several factors important for generation of basal progenitors and 
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neurogenesis, which are transcriptionally regulated by Pax6. Amongst them, Ngn2 which is 
expressed in a subset of neuronal committed apical progenitors (Schuurmans et al., 2004; 
Guillemot, 2005). Pax6 positively regulates Ngn2 via an enhancer (Scardigli et al., 2001), 
but also synergizes with Ngn2 in the generation of basal progenitors (Scardigli et al., 2001; 
Miyata et al., 2004; Britz et al., 2006; Guillemot et al., 2006). Both transcription factors 
promote expression of Tbr2/Eomes, a key factor of basal progenitor identity in the dorsal 
cortex (Englund et al., 2005; Quinn et al., 2007; Arnold et al., 2008; Sessa et al., 2008; 
Sansom et al., 2009). Pax6 deficiency results in almost complete loss of Ngn2 and Tbr2 
expression leading to abnormally specified basal progenitors (Haubst et al., 2004; Quinn et 
al., 2007). Indeed the non-apical dividing cells in chimeric mice do not express Tbr2 (Quinn 
et al., 2007). This is of course part of the influences contributing to the altered production of 
cortical neurons. 
In addition to its function in proliferation, Pax6 is an important neurogenic fate determinant 
in radial glial cells (Gotz et al., 1998; Hack et al., 2004a). Loss of Pax6 results in a reduced 
neurogenic potential of radial glial cells (Heins et al., 2002; Haubst et al., 2004). Conversely 
overexpression of Pax6 in cultured cells enhanced neuron production from radial glial cells 
(Heins et al., 2002; Haubst et al., 2004). This neurogenic potential of Pax6 is not restricted 
to time and region, as overexpression of Pax6 in cultures from postnatal astrocytes (Heins 
et al., 2002) or from adult neurospheres (Hack et al., 2004b) likewise increased neuroge-
nesis. 
1.3.3 Complexity of Pax6 – structure and isoforms
The transcription factor Pax6 belongs to the Pax (paired box) family of developmentally 
regulated transcription factors which commonly share an amino-terminal DNA-binding do-
main known as the paired domain (PD) (Chalepakis et al., 1992). This domain consists of 
128 amino acids and is in itself structured in a bipartite, modular manner divided into its 
N-terminal PAI-subdomain (3aa-76aa) and its C-terminal RED-subdomain (77aa-131aa) 
(‘PAI-RED’) that coincide with an exon boundary (Fig.1-6) (Walther et al., 1991; Czerny et 
al., 1993; Epstein et al., 1994a; Epstein et al., 1994b; Jun and Desplan, 1996; Xu et al., 
1999). Crystallographic analyses using only a PD peptide have shown that both subdo-
mains are comprised of helix-turn helix folds. These can interact with specific DNA-binding 
sites independently or in a cooperative manner (Epstein et al., 1994a; Yamaguchi et al., 
1997). For example, the PAI- subdomain showed direct contacts to its annotated Pax6 
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consensus site P6CON (Epstein et al., 1994a), while the RED-subdomain contributed to 
DNA binding by contacting adjacent nucleotides (Epstein et al., 1994b; Xu et al., 1999). In 
addition, DNA-contact was also established between the N-terminal ß-sheets and a linker 
region between the subdomains (Xu et al., 1999). 
The third DNA-binding domain of Pax6, the paired-like homeodomain (HD) is connected to 
the PD via a glycine-rich linker, followed by a C-terminal transactivation domain (Fig.1-6) 
(Bouchard, 2003). Similar to other HDs, it harbors a globular domain with three alpha he-
lices (60aa long) and its critical DNA-binding residues are located in helix3. In contrast to 
sequence specific DNA-binding proteins that use only one DNA-binding domain, Pax6 can 
use its multiple DNA-binding parts (PAI, ß-sheet, linker, RED and HD) or take advantage 
of a range of their combinations to bind to DNA (Xie and Cvekl, 2011). Earlier studies have 
defined individual consensus sites for the Pax6 PD (Epstein et al., 1994a) and the HD (Wil-
son et al., 1993; Czerny and Busslinger, 1995). However, using for example the P6CON 
consensus sequence to predict and confirm candidate Pax6-binding sites has proven to be 
difficult (Shimoda et al., 2002; Visel et al., 2007; Wolf et al., 2009). But, recent work has 
identified several novel variants of Pax6 DNA-binding motifs to which different combinations 
of the Pax6 binding subdomains bind in-vivo (Xie and Cvekl, 2011) (Fig.1-7).
The PAX6 gene generates multiple transcript variants by alternative splicing or transcription 
from an alternative promoter. One of the two most commonly expressed Pax6 transcripts 
that encode a functionally distinct protein is the Pax6(5a) isoform (Fig.1-6). It is generated 
upon alternative splicing of exon 5a (14 amino acids) which is inserted into the N-terminal 
PAI subdomain (Walther and Gruss, 1991; Glaser et al., 1992; Puschel et al., 1992). This 
insertion leads to the abolishment of PAI-subdomain DNA-binding activity, but retains RED-
subdomain activity (Epstein et al., 1994b; Kozmik et al., 1997; Anderson et al., 2002). Both 
splice products, the canonical Pax6 and the Pax6(5a) isoform are found in the brain, de-
veloping eye, spinal cord and olfactory epithelium (Walther and Gruss, 1991; Glaser et al., 
1992). However the Pax6(5a) transcript is expressed at lower levels and the ratio of both 
isoforms seems to be critical as reported for eye development (Chauhan et al., 2004). 
The second major Pax6 isoform lacks the whole paired domain, restricting its activity to 
the homeodomain and thus is termed PD-less (Fig.1-6) (Mishra et al., 2002). It is present 
in brain, eye and pancreas (Mishra et al., 2002) and unlike the Pax6(5a) isoform which is 
vertebrate specific, variants of the PD-less isoform have also been found in invertebrates. 
Two studies exist, one reporting that the murine PD-less form of Pax6 is generated by al-
ternative splicing (Mishra et al., 2002), the other reporting that the murine PD-less form is 
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generated through the usage of an alternative promoter (Kim and Lauderdale, 2006). The 
quail variant is generated through the use of an alternative start codon for translation in the 
sequence between the PD and the HD (Carriere et al., 1993) and the PD-less form found 
in C.elegans is transcribed from an internal promoter (Zhang and Emmons, 1995). The PD-
less form has been shown to bind to the classical P2 HD Pax6 consensus site, but without 
activating transcription (Mishra et al., 2002). However, transcriptional activation through the 
interaction of the PD-less form with the full length Pax6 has been reported in- vitro (Mikkola 
et al., 2001) and in-vivo (Ninkovic et al., 2010). In the latter study, this interaction has been 
shown to regulate expression of αA crystallin, which is important to control survival rates of 
mature dopaminergic neurons in the adult olfactory bulb.
Figure 1-6  Schematic drawing depicting the domain structure of Pax6 and its two 
most abundant isoforms
Canonical Pax6 (422AA) consists of a paired-domain (PD) with bipartite character; subdivided 
into the N-terminal PAI and the C-terminal RED subdomains (PAI-RED). The PD is linked to the 
homeodomain (HD) of Pax6 via a glycine rich linker region, followed by a transactivation domain 
(TA). The 5a-isoform (436AA) is characterized by the insertion of 14 amino acids into the PAI 
subdomain. The PD-less isoform completely lacks the PD and parts of the linker region of Pax6.
The red arrows indicate the site of mutation occuring in the different Pax6 mutants used in this study. 
The point mutation in the full mutant Pax6Sey creates a truncated protein (Hill et al., 1991), while 
the point mutation in the Pax6Leca4 and Pax6Leca2 mutant affect the DNA-binding of the PAI or RED 
subdomain, respectively (Thaung et al.,2002).
- 30 -
Introduction
Figure 1-7  Pax6 DNA-binding site variants (taken from Xie et al., 2011)
Summary showing novel variants of Pax6-binding sites recently identified by Selex (Systematic 
evolution of ligands by exponential enrichment) and subsequently identified natural sites in-vivo. 
These different motifs are bound by Pax6 using different combinations of its subdomains. The 
binding affinity of Pax6 has been confirmed by EMSA and Luciferase assay. 
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1.3.4 Molecular mechanisms underlying the multiple functions of Pax6
Recent advances have been made in identifying genes regulated by Pax6 that are impor-
tant for proliferation, neurogenesis and fate determination (Sansom et al., 2009; Wolf et 
al., 2009; Coutinho et al., 2011; Xie and Cvekl, 2011). One study using chromatin immu-
noprecipitation combined with promoter microarray analysis (Chip-on-chip) has reported 
that Pax6 positively regulates cohorts of genes that promote proliferation, basal progenitor 
generation and neurogenesis (Sansom et al., 2009). In addition, Pax6 is thought to inter-
play with other regulators of cortical neurogenesis that impact on one another. In these 
regards, it has been suggested that Pax6 functions to control the balance between proli-
feration and differentiation in cortical progenitor cells (Sansom et al., 2009). However, it is 
still poorly understood how Pax6 instructs its different functions on the molecular level. One 
option is to utilize its different DNA-binding domains. As described above, the Pax6 protein 
consists of the paired-domain (PD) carrying a bipartite DNA-binding motif (PAI- and RED-
subdomain) which is linked to a paired-like homeodomain (HD). A previous study from our 
lab used different mutant mouse lines with disruption of the paired-domain (Pax6Aey18) or the 
homeodomain (Pax64NEU) to investigate the impact of the different domains on telencepahlic 
development (Haubst et al., 2004). The Aey18 mutation in Pax6 creates a considerable 
deletion within the complete PD (Graw et al., 2005) and shows similar defects like the full 
Pax6 mutant Pax6Sey in telencephalic development (Haubst et al., 2004). However, it has 
then been shown that this mutation affects nuclear localization of the protein (Dames et al., 
2010), which explains the similarities to the full Pax6 mutant (Haubst et al., 2004; Graw et 
al., 2005). The analysis of the 4NEU mutation – which disrupts the DNA-binding property 
of the homeodomain – has shown that the HD of Pax6 plays a role in the establishment of 
the pallial-subpallial boundary during forebrain development. Pax64NEU mutants completely 
lacked the expression of the Wnt-inhibitor and boundary marker SFRP2. However, no other 
defects were detected in the boundary region and in cell proliferation and neurogenesis 
(Fig.1-8) (Haubst et al., 2004). Moreover, no defects during cortical development were ob-
served in another homeodomain mutant line – the Pax614NEU (Ninkovic et al., 2010). The 
homeodomain exerts subtle effects during telencepahlic development and one part of the 
present thesis was to understand the molecular network underlying these effects. Howe-
ver, this implies that the majority of effects Pax6 exerts during telencephalic development 
should be mediated by the bipartite paired-domain with potentially different contributions of 
its subdomains. Therefore, the main part of this work concentrated on dissecting the role of 
the different subdomains of the paired-domain of Pax6 during telencepahlic development.
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Figure 1-8  Effect of the Pax64NEU mutation (in the homeodomain) on telencephalic 
development (adapted from Haubst et al., 2004)
Short summary of the telencephalic phenotype observed after loss of homeodomain function in the 
Pax64NEU mutant (characterized by a point-mutation in the DNA-binding helix of the homeodomain). 
(A) No changes in neurogenesis and proliferation were detected in the Pax64NEU mutant compared 
to control mice as revealed by NeuN (labeling neurons) and PH3 (labeling mitotic cells) analysis in 
coronal sections of E14 mutant and WT embryos; micrographs showing examples are depicted. (B) 
Similar, dorso-ventral patterning was not changed as shown by Ngn2 (dorsal) and Mash1 (mainly 
ventral) immunostainings. (C) In contrast, expression of SFRP2 (secreted frizzled related protein) 2 
at the pallial-subpallial boundary is lost in Pax64NEU mice as depicted by in-situ hybridization. Thus, 
DNA-binding of the homeodomain of Pax6 is neccesary for the correct establishment of the pallial-
subpallial boundary. 
Abbreviations: CP, cortical plate; CTX, cortex; GE, ganlionic eminence; MZ, marginal zone; SVZ, 
subventricular zone; VZ, ventricular zone. 
A
B
C
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1.4 A fate determinant from the RNA world: the microRNA
Transcription factors not only regulate the expression of specific mRNAs, but also control 
expression of microRNAs (miRNAs). However, nothing is known about transcriptional con-
trol of microRNAs in the developing cortex. MicroRNAs were first discovered in nematodes 
in 1993. They are non-coding RNAs that are related to small interfering RNAs (siRNAs), the 
small RNAs that guide RNA interference (RNAi). The high abundance of miRNAs in the ner-
vous system suggests that miRNAs may represent important post-transcriptional regulators 
by shaping expression profiles that occur in neural cells (Li and Jin, 2010).
1.4.1 The microRNA pathway
To date, hundreds of genomically encoded miRNAs have been described in mice. Two 
classes of miRNAs can be distinguished dependant on their genomic location: (i) intergenic 
miRNAs, which are synthesized from their own promoters and (ii) intragenic miRNAs, which 
are found embedded in intronic or exonic regions and are transcribed as part of their host 
gene (Ying and Lin, 2005; Kim et al., 2009). The transcription of intergenic miRNA genes 
can be performed by RNA polymerase II or RNA polymerase III (Lee et al., 2004; Borchert et 
al., 2006; Kawahra et al., 2012). In contrast, intragenic miRNAs are exclusively transcribed 
by RNA polymerase II (Lee et al., 2004). Most miRNAs are synthesized by Pol III generating 
a several kilobases long miRNA precursor termed primary miRNA (pri-miRNA) (Kawahara 
et al., 2012). These pri-miRNAs are processed in the nucleus by cropping into 60-100nt 
long intermediates known as pre-miRNAs that form hairpins. This cleavage is performed by 
the enzymatic complex called microprocessor, which includes the RNase III enzyme Drosha 
and the dsRNA binding protein DGCR8 (DiGeorge syndrome critical region gene 8) (Gre-
gory et al., 2004). Recently it has been shown that some intronic miRNAs are processed as 
spliced-out introns and therefore were termed mirtrons (Okamura et al., 2007; Ruby et al., 
2007; Ozsolak et al., 2008; Kawahara et al., 2012). Their precursors (pre-mirtrons) have a 
shorter stem length than that of canonical miRNAs. In the next step, the pre-miRNAs and 
mirtron hairpins are exported from the nucleus to the cytoplasm by Exportin-5 and Ran-GTP 
(Yi et al., 2003). Following the export, the pre-miRNA is further processed by the cytoplas-
matic RNase III enzyme Dicer, which removes the terminal loop thereby generating a 22nt 
miRNA duplex that bears a 2-nt overhang on its 3’ prime end (Bernstein et al., 2001; Grishok 
et al., 2001; Hutvagner et al., 2001). This short-lived duplex contains the mature miRNA (the 
guide strand) and the miRNA* (the passenger strand). The latter may be degraded, while 
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the mature miRNA is incorporated into the RNA induced silencing complex (RISC). In case 
that two mature miRNAs originate from the opposite arms of the same pre-miRNA they are 
distinguished with a -3p or -5p suffix (Schwarz et al., 2003). The RISC complex then guides 
the mature miRNA to its target mRNA (Hammond et al., 2000; Martinez and Tuschl, 2004). 
The nucleotides 2-8 within the miRNA’s 5’ end are known as the “seed” sequence and are 
crucial for gene silencing (Bartel, 2009). Base-pair matching between this seed sequence 
of the miRNA with the target mRNA (mostly within the 3’ (or 5’) untranslated region (UTR) of 
target RNA) effects gene silencing (Kawahara et al., 2012). This silencing is achieved either 
by translational repression or target mRNA breakdown (Bartel, 2004; Du and Zamore, 2005; 
Kawahara et al., 2012). For summary of the microRNA biogenesis pathway see Fig.1-9. 
    
1.4.2 The role of microRNAs in the developing nervous system
To determine the role of microRNAs in neural differentiation and the developing nervous 
system, early studies have focused on animal models in which key components of the miR-
NA pathway have been inactivated globally or in a cell-type specific manner (Lau and Hud-
son, 2010). For instance, loss of Dicer in Zebrafish lead to defective neural tubes, providing 
the first evidence that miRNAs are important for brain development (Giraldez et al., 2005; 
Li and Jin et al., 2004). Similarly, deletion of Argonaute 2 protein in mice prevented neural 
tube closure (Liu et al., 2004). In contrast, global deletion of Dicer or DGCR8 in mice resul-
ted in more severe phenotypes with early embryonic lethality (Bernstein et al., 2003; Wang 
et al., 2007). This precluded analysis of neural development, and therefore several studies 
focused on inactivating Dicer in specific neural cell types, using the Cre-loxP system. For 
example Dicer was deleted from Purkinje cells (Schaefer et al., 2007), dopaminergic neu-
rons (Hebert and De Strooper, 2007; Kim et al., 2007) or in the retina (Damiani et al., 2008). 
In all cases, the conditional, cell-type specific loss of Dicer lead to progressive neurodege-
nerative phenotypes (Hebert and De Strooper, 2007; Schaefer et al., 2007; Damiani et al., 
2008). In the developing dorsal telencephalon, Dicer was conditionally deleted using an 
Emx1-Cre strain (De Pietri Tonelli et al., 2008). This recombination affected corticogenesis 
early in development as in-situ analysis evidenced the loss of miRNAs by E10.5. Interestin-
gly, this resulted in neuron loss (due to neuronal apoptosis) that occurred before problems 
were observed in progenitor cells. This led to the reduction of cortical size by E13.5 and 
defective cortical layering postnatally. Eventually, around midneurogenesis apical and basal 
progenitors showed proliferation defects and were depleted by apoptosis contributing to 
this phenotype (De Pietri Tonelli et al., 2008). These results suggest that microRNAs play 
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an indispensable role in neuronal differentiation. Moreover a recent study has determined 
the altered proteome after conditional deletion of cortical Dicer and suggested that normal 
Dicer activity is important for regulating neural stem cell development by maintaining proper 
signaling pathways related to cell survival and differentiation (Kawase-Koga et al., 2010). 
However, Dicer knockout studies have two disadvantages: on the one hand it is not clear 
if the observed defects are caused alone by an impaired miRNA pathway or through other 
classes of small regulatory RNAs that also require Dicer activity. On the other hand, these 
studies affect the miRNA repertoire, while it would be of specific interest to identify specific 
miRNAs required to alter a cellular program. 
Recent studies have provided some advances in identifying specific miRNAs and their func-
tion in neural differentiation. For example, miRNA-138, miR-338 and miR-219 were found 
to play a role in oligodendrocyte differentiation and are required for myelination (Lau et al., 
2008; Dugas et al., 2010; Zhao et al., 2010). Moreover important transcription factors (Sox6, 
Foxj3 and Zfp238) in regulating oligodendrocyte proliferation and the mitogen receptor Pdg-
fra were identified as direct targets of miR-219 in this context. Another example of a well-
studied miRNA in neuronal differentiation is miR-9, which is expressed exclusively in the 
brain. In-utero electroporation of miR-9 in the mouse cortex around midneurogenesis led 
to a decrease in proliferation of progenitor cells accompanied by premature differentiation 
(Zhao et al., 2009). Moreover this study showed that miR-9 forms a regulatory feeback loop 
with the nuclear receptor TLX and thus fine-tunes the balance between progenitor prolifera-
tion and differentiation (Zhao et al., 2009). Furthermore, a more recent study added additi-
onal factors to the list of miR-9 targets in the developing forebrain. The transcription factors 
Foxg1, Nr2e1, Gsx2 and Meis2 were identified as direct targets and found dysregulated in 
miR-9-2/3 double mutant mice. These showed defects in proliferation and differentiation of 
pallial and subpallial progenitors (Shibata et al., 2011), thus supporting a critical role for this 
miRNA during neuronal proliferation and differentiation. The authors furthermore suggested 
that miR-9 may indirectly control Pax6 levels through regulation of Meis2, as Pax6 levels 
were found reduced in the miR-9-2/3 double mutant telencephali and because Meis2 has 
been implicated in Pax6 regulation (Agoston and Schulte, 2009; Shibata et al., 2011).    
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Figure 1-9  MicroRNA biogenesis pathway (taken from Kawahara et al., 2012)
Model showing the generation of mature microRNAs including some regulations of RNA-binding 
proteins at different biogenesis steps (blue text). The process of miRNA generation proceeds from 
transcription through nuclear processing (cropping), nuclear export, cytoplasmic processing by the 
Dicer complex (dicing) or Ago2 and finally to incorporation into miRISC (miRNA-loaded RISC). The 
assembled miRISC can then target mRNAs by base-paring of the seed sequence. Gene silencing 
is achieved either by inhibiting translation of the targeted mRNA or by mRNA degradation via 
deadenylation of poly(A)-tails functions in the miRISC.
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1.4.3 MicroRNAs in embryonic stem cells 
Like the determination of miRNA function in-vivo - in the developing nervous system - the 
role of the miRNA pathway in embryonic stem cells (ESCs) has been established by loss-of-
function studies (Wang et al., 2009b). The conditional inactivation of Dicer in mouse ESCs 
affects the maturation of miRNAs and impairs the proliferation capacity as well as the cells’ 
differentiation potential (Wang et al., 2009b). However, although Dicer-deficient ESCs are 
viable, they fail to further differentiate to embryoid bodies (EBs) (Kanellopoulou et al., 2005; 
Murchison et al., 2005). 
The characterization of specific miRNAs in ESCs is also just at its beginning (Wang et al., 
2009b). Previously, a cluster of six miRNAs (miR-290 to miR-295) was identified specifically 
in undifferentiated mouse ESCs and implicated to regulate ESC maintenance and differenti-
ation (Houbaviy et al., 2003; Chen et al., 2007; Benetti et al., 2008; Sinkkonen et al., 2008). 
In correlation with embryonic neurogenesis in-vivo expression of miR-9 and miR-124 (ano-
ther brain specific miRNA) are induced during neuronal differentiation from mouse ESCs 
and affect neural lineage differentiation (Krichevsky et al., 2006). 
Taken together, microRNAs represent important regulators during development that add a 
level of regulation to the genetic programs orchestrated by transcription factors. Therefore 
understanding miRNA regulation as well as specific miRNA functions during nervous sys-
tem development is important. 
ESC differentiation systems are useful tools for profiling studies, therefore in this thesis the 
ESC differentiation system according to Bibel et al., 2004 / Bibel et al., 2007 was used to 
profile miRNA expression. This differentiation protocol allows the generation of a relatively 
homogeneous population of Pax6 positive radial glial cells from highly proliferative ES cells 
upon treatment with retinoic acid (RA). When further differentiated, these cells give rise to 
functional glutamatergic neurons in accordance to neurons derived of Pax6 expressing pre-
cursors in the developing mammalian cortex. Therefore this system with radial glia obtained 
through differentiating ES cells resembled a promising tool to study miRNA expression. 
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1.5 Aim of the thesis
Given the various functions the transcription factor Pax6 regulates during cerebral cortex 
development (Osumi et al., 2008; Georgala et al., 2011b), the main aim of my thesis was 
to investigate the different DNA-binding domains of Pax6 and their individual contributions 
to Pax6 function during cerebral cortical development. To dissect the importance of these 
individual DNA-binding domains and in particular of the subdomains of the paired domain 
of Pax6, I analyzed different mouse-mutant lines each harboring a point-mutation in one 
DNA-binding domain. 
Pax6 acts as a transcriptional regulator of many mRNA coding genes, but may also control 
expression of miRNA molecules. However, expression and the role of individual miRNAs 
are still poorly understood. To identify novel miRNA candidates, potentially regulated by 
Pax6, I performed a miRNA profiling analysis using an ESC-differentiation system (Bibel et 
al., 2004; Bibel et al., 2007) that comprised Pax6+ radial glial cells.
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2 Results
2.1 Relevance of the Pax6 homeodomain during cortical development
During development radial glial cells in the developing telencephalon are specified by the 
transcription factor Pax6, which, as explained before regulates various cellular functions. On 
the molecular level, Pax6 has several options to mediate its functions utilizing its different 
DNA-binding domains. Immunohistochemical analysis of the homeodomain mutant mouse 
line Pax64Neu, has attributed to the HD of Pax6 a role in the establishment of the pallial-
subpallial boundary during forebrain development (Favor et al., 2001; Haubst et al., 2004). 
However, other Pax6 regulated functions were unaffected (Favor et al., 2001; Haubst et 
al., 2004). This mouse line was generated in a mutagenesis screen for dominant mutations 
affecting eye morphology and carries a point mutation in the third helix of the homeodomain 
(Ser273Pro), critical for DNA-binding (Favor et al., 2001). In order to gain more insights into 
the molecular network underlying homeodomain function in the developing telencephalon, 
this homeodomain mutant line was used to perform a transcriptome analysis.
2.1.1 Gene expression analysis of the homeodomain mutant Pax64NEU during   
 forebrain development
To investigate homeodomain mediated effects of Pax6 on transcriptional level a genome 
wide expression analysis was performed on E12 cortical tissue from homozygous Pax64Neu 
and compared to corresponding wild type littermates. The time point E12 was chosen to 
minimize potential secondary effects and to compare the results to existing microarray data 
obtained from Pax6Sey mice at E12 (Holm et al., 2007). mRNA of three biological replicates 
for each genotype derived from three different litters were hybridised to whole-genome Affy-
metrix MOE430 2.0 arrays. Gene expression differences between WT and mutants were 
assessed by a filter consisting of statistical significance (FDR<10%) in at least two of the 
three statistical tests performed (see Material and Mehtods). Divisive clustering (Fig.2-1A) 
and agglomerative clustering (data not shown) of the samples showed that the samples 
did not cluster according to their genotype, likely due to the low expression changes obser-
ved. Furthermore, one of the WT samples clustered poorly with its corresponding Pax64Neu 
homozygous littermate and showed an up-regulation of Pax6 mRNA levels similar to the 
homozygous samples. As the mRNA level of Pax6 is known to be up-regulated in Pax6 
mutants due to Pax6’s negative auto regulatory function (Manuel et al., 2007), this was a 
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strong criterion to exclude this WT sample for further analysis. Finally, after exclusion of 
WT sample 3, the analysis revealed very few and very mild significant changes in gene ex-
pression between wild-type and Pax64Neu cortices. In total the expression of 36 genes was 
altered of which six genes were up-regulated and 30 genes were down-regulated (Fig.2-
1B). Amongst these two genes known to be regulated by Pax6, namely Pax6 itself and 
Cadherin4 were identified (Andrews and Mastick, 2003; Manuel et al., 2007), as well as 
three additional genes (Ngn1, Ctnnd2, Fhl1) that were found similarly down-regulated in the 
functional Pax6 null mice (Holm et al., 2007). However, no alterations in expression levels 
of pallial-subpallial boundary genes were detected. From the 36 genes, 14 genes were 
selected for q-PCR confirmation analysis. All but one gene showed the same expression 
trend, however using one-way Anova statistical analysis only one of these genes (Prr15) 
could be confirmed as significantly regulated (Fig.2-1C,C’). In conclusion, the very few and 
low expression changes observed in the Pax64Neu mutant with microarray analysis could not 
be validated applying q-PCR analysis as a second method. Thus transcriptional regulation 
by the homeodomain of Pax6 seems to play no impact on forebrain development, which 
is in strong contrast to e.g. the role of the homeodomain of Pax6 during eye development 
(Kozmik, 2005).  
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Figure 2-1 Transcriptome analysis of Pax64NEU cortices
(A) Divisive clustering analysis of E12 Pax64NEU and wild-type control cortical tissue (the label ko 
stands for homozygous Pax64NEU). (B) Heatmap representations of linear ratios of genes deregulated 
between Pax64NEU  and wild-type cortices. Colors indicate higher (red) or lower (green) expression 
values. (C and C‘) Histograms depicting the linear ratio of gene expression levels between Pax64NEU 
and the corresponding WT littermates measured by Affymetrix array analysis or quantitative RT-
PCR; Data are shown as mean ± SEM; 
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2.2 Functional dissection of the paired-domain of Pax6 during cortical                  
 development
The above and previously described observation, that the homeodomain plays hardly any 
role during telencephalic development (Haubst et al., 2004; Ninkovic et al., 2010), sugge-
sted that the multiple functions of Pax6 during forebrain development are mediated via its 
paired domain. To examine to which extent the two subdomains of the paired domain as-
certain specific Pax6 functions, two mouse mutants each carrying a point-mutation in one 
subdomain of the bipartite paired DNA-binding motif (PAI or RED domain respectively) were 
analysed. Both mouse lines (Pax6Leca4 and Pax6Leca2) were recently identified in an ENU-
induced screen for eye mutations (Thaung et al., 2002) and named lens-corneal adhesion 
(Leca) after the occasional occurrence of adhesion between the lens and the cornea in 
some of the four newly reported lines (Leca1-Leca4) (Thaung et al., 2002). The Pax6Leca4 
mutation results in a single base pair substitution of lysine for asparagine (N50K) in the 
PAI-subdomain and is predicted to disrupt DNA-binding ((Thaung et al., 2002) and in-silico 
analysis by our collaborator Dierk Niessing). The Pax6Leca2 mutation is the consequence of 
the substitution of cysteine for arginine (R128C) in the RED- subdomain, a mutation that 
has also been observed in patients (Azuma et al., 1996; Thaung et al., 2002). Previous 
studies and in-silico predictions have reported and proposed decreased or absent DNA-
binding ability for this mutation (Yamaguchi et al., 1997; Thaung et al., 2002; Chauhan et 
al., 2004; Shukla and Mishra, 2012). In order to investigate the individual roles of the PAI 
and RED subdomains of Pax6 during forebrain development, the phenotypes of these sub-
domain mutant mice were examined. Finally, the results obtained from the PAI- (Pax6Leca4) 
and RED-subdomain (Pax6Leca2) mutants were compared to the phenotype of the functional 
Pax6 null mice Pax6Sey (Hill et al., 1991).
2.2.1 Gross phenotypical differences of Pax6Leca4 (PAI-domain) and Pax6Leca2   
 (RED-domain) mutant mice
Morphological analysis of E14 old homozygote Pax6Leca4 and Pax6Leca2 mutant embryos 
revealed the presence of craniofacial defects with an abnormal development of frontonasal 
regions in both mutants (see arrows in Fig. 2-2B’ and C’). Moreover, both mutants displayed 
eye abnormalities (Fig. 2-2B’,C’), which have already been studied in more detail in the 
Pax6Leca4 mutant (Ramaesh et al., 2009). These two morphological phenotypes are similar 
to the phenotype found in the functional null allele (Fig.2-2A’) (Hill et al., 1991; Tzoulaki et 
al., 2005). Furthermore, morphological analysis of mutant telencephali at midneurogenesis 
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from E14 embryos of both mutants displayed clear defects in olfactory bulb (OB) develop-
ment. Pax6Leca4 and Pax6Leca2 mutant brains only possessed remnants of olfactory bulbs 
(Fig.2-2B’’’,C’’’). However, this phenotype was incompletely penetrant in the Pax6Leca2 mu-
tant with variable sizes of remnant olfactory bulbs ranging from small residual structures to 
clear olfactory bulbs, though always still smaller compared to wild-type controls (Fig.2-2C’’-
C’’’’). Nevertheless, this variability is similar to the reported incomplete penetrance of eye 
malformations in the Pax6Leca2 mutant (Thaung et al., 2002). 
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Figure 2-2 Mice harbouring a mutation in the PAI-
subdomain or in the RED-subdomain of the PAIRED DNA-
binding domain of Pax6 display cross morphological 
defects in forebrain development. 
(A, A’, B, B’, C, C’) E14 embryos of Pax6Sey, Pax6Leca4, Pax6Leca2, 
and control mice. Note the missing eye (arrow) and craniofacial 
abnormalities (arrow heads) in all three mutants. (A’’, A’’’, B’’, B’’‘, 
C’’, C’’’, C‘‘‘‘) E14 brains of Pax6Sey, Pax6Leca4, Pax6Leca2
and control mice. Note the reduction in olfactory bulb size in both Leca mutant mice and the 
complete absence in the Pax6Sey mutant. Also note the different penetrance of this phenotype 
in the Pax6Leca2 mutant. 
Abbreviations: Ob, olfactory bulb; tel, telencephalon; mb, midbrain.
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2.2.1.1     Pax6Leca2, but not Pax6Leca4 mice survive into adulthood
Most homozygous Pax6 mutants are lethal at birth, which is also the case for the Pax6Leca4 
mutant (Ramaesh et al., 2009). In contrast, homozygous Pax6Leca2 mutants developed to 
adulthood. However Mendelian distribution of the homozygous progeny analysed in 311 
pups was slightly abnormal at birth. Approximately 21% of the homozygous mice survived 
into adulthood compared to normal 25% (n=64/311) (Fig.2-3B). All adult Pax6Leca2 mutants 
showed growth retardations with reduced body size compared to controls (Fig.2-3A,A’). 
However, besides the incompletely penetrant OB-phenotype, brain size of Pax6Leca2 mutants 
compared to wild-type controls appeared normal (Fig.2-3C-C’’).
Figure 2-3 Pax6Leca2 mice survive into adulthood
(A,A’) Eight week old adult Pax6Leca2 and control littermate. (B) Histogram depicting the Mendelian 
distribution of Pax6Leca2 mice. (C-C‘‘) Brains of eight week old adult Pax6Leca2 and control mice. Note 
the variable penetrance of ob size in the Pax6Leca2 mutant.
Abbreviations: cb, cerebellum; ctx, cortex; ob, olfactory-bulb.  
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2.2.1.2     Pax6Leca4 and Pax6Leca2 mice exhibit no ‘olfactory bulb-like structure (OBLS)’
The full Pax6 mutant, Pax6Sey, completely lacks olfactory bulbs (Fig.2-2A’’’)(Hogan et al., 
1986) and instead develops an ‘olfactory bulb-like structure’ (OBLS,(Jimenez et al., 2000)) 
within the ventral telencephalon due to the aberrant assembly of mitral cells, the first diffe-
rentiating neurons in the OB. In order to investigate whether such an OBLS is also present 
in Pax6Leca4 or Pax6Leca2 mutant brains next to the remnant OBs, mitral cell localization in the 
ventral telencephalon was investigated using immunohistochemistry for reelin (Ogawa et 
al., 1995), an extracellular glycoprotein expressed by mitral cells (Perez-Garcia et al., 2004). 
No miss-localisation of reelin positive mitral cells in the ventral telencephalon was observed 
in Pax6Leca4 or Pax6Leca2 mutant brains (Fig.2-4A-B’) while the OBLS was readily detected 
in Pax6Sey mice (Fig.2-4C,C’). Thus no OBLS is present in both mutants initially forming an 
adequate olfactory bulb anlage, which then fails to normally extend in these mice.
2.2.1.3     Pax6Leca2 mutants lack TH+ interneurons in the adult olfactory bulb
Neuronal sub-populations in the olfactory bulb are in part derived from Pax6 positive proge-
nitors during development (Dellovade et al., 1998; Kohwi et al., 2005; Cocas et al., 2011). 
Moreover Pax6 is expressed in the adult OB in a subpopulation of periglomerular interneu-
rons (PGN) where it acts as a fate determinant of the dopaminergic PGN subtype (Hack et 
al., 2005; Brill et al., 2009). Given that OB structures, although reduced in size, do deve-
lop in Pax6Leca2 mutant mice, the presence of neuronal subpopulations were investigated 
in adult Pax6Leca2 mutants by immunohistochemistry. Dopaminergic PGNs were visualized 
by immunohistochemistry against tyrosine hydroxylase (TH, a rate limiting enzyme in the 
biosynthesis of dopamine) on sections from adult Pax6Leca2 mice that had a mild olfactory 
bulb reduction. Interestingly, homozygous Pax6Leca2 mutants completely lacked TH immuno-
reactivity (Fig.2-5A-B’), whereas expression of calretinin, Tbr1 and Tbr2 (markers for other 
subtypes of PGN (Kosaka et al., 1995; Toida et al., 2000; Panzanelli et al., 2007; Parrish-
Aungst et al., 2007) were still present (Fig.2-5). Besides a potential increase in the number 
of reelin expressing mitral cells (Fig.2-5D,D’), the overall structural organization of the olfac-
tory bulb layers appeared normal in Pax6Leca2 mice with mild olfactory bulb reduction (all ex-
amples in Fig.2-5). However in severely reduced olfactory bulbs, the structural organization 
of the bulb was lost (Fig.2-6). These data suggest an important role of the RED-subdomain 
in Pax6 mediated fate specification of dopaminergic periglomerular interneurons. However, 
it is important to mention that the role of the PAI-subdomain in this context remains unexp-
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lained, as this was not analysed due to the neonatal death of Pax6Leca4 mice. 
Taken together, the above described observations suggest that both the PAI and the RED 
subdomain are required for eye, craniofacial and olfactory bulb development. 
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Figure 2-4 Mice harbouring a mutation in the PAI-subdomain or in the RED-subdomain 
of the Paired DNA-binding domain of Pax6 do not develop an OBLS. 
(A-C’) Immunofluorescence for reelin (red) combined with DAPI staining (blue) on coronal sections 
of E14 dorsal telencephalon of Pax6Leca4, Pax6Leca2, Pax6Sey and control mice. Note that no aberrant 
accumulation of reelin positive cells, the OBLS, is found in the ventral-lateral telencephalon of both 
Leca mutant mice in contrast to Pax6Sey mice. 
Abbreviations: CTX, cortex; GE, ganglionic emincence; OBLS, olfactory-bulb like structure. Scale 
bars in A-C: 100 µm, in C‘: 100µm.
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Figure 2-5 Expression of neuronal subtypes in the adult Pax6Leca2 mutant olfactory 
bulb
(A-B‘) Micrographs depicting immunoreactivity for Thyroxin-Hydroxylase (TH) in sagittal sections of 
the olfactory bulb of adult brains of Pax6Leca2 and corresponding wild-type (WT) control littermate. 
Note the absence of TH+ cells in Pax6Leca2 mutant OB. (C-D‘) Micrographs of adult sagittal sections 
immunoreactive for calretinin (C,C‘) or reelin and Tbr1/2 (D,D‘) in Pax6Leca2 and their WT control 
littermate. Scale bars: 50µm. 
Abbreviations: GL, glomerular layer; EPL, external plexiform layer; MC, mitral cells; GCL, granule 
cell layer.
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2.2.2 Telencephalic development in Pax6Leca4 (PAI-domain) and Pax6Leca2 (RED-  
 domain) mutant mice
In order to investigate defects in telencephalic development, gross analysis of the cereb-
ral cortex of Pax6Leca4 and Pax6Leca2 mutant mice were performed. Anatomically matched, 
DAPI stained coronal sections from rostral to caudal regions of E14 mutant and control te-
lencephali were compared. Pax6Leca4 mutants showed a clear reduction in cortical thickness 
compared to controls, while no reduction was observed in Pax6Leca2 mutant mice (Fig.2-7). 
Because a proliferation phenotype observed in the Pax6Leca2 mutant (see below) was only 
detected in rostral regions and in order to compare both mutants, all analysis of both mu-
tants were performed on rostral regions only. Therefore also the quantification of the radial 
thickness in the Pax6Leca4 mutant cortex was performed at rostral levels. The entire cortex 
at lateral and central positions of the dorsal telencephalon was measured at E14, revealing 
a mild but significant reduction in radial length at lateral position and reduction of about 
one third at midcortex position in Pax6Leca4 mutant cortices (Fig.2-8A-A’’). A similar reduc-
tion of radial thickness has also been observed in the functional Pax6 null allele (Asami et 
al., 2011). In contrast, no reduction in radial thickness was found in the Pax6Leca2 mutant 
(Fig.2-8B-B’’). Taken together, this result suggests, that the thickness of the cerebral cortex 
mainly depends on a functional PAI subdomain.
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Figure 2-6 Example of a disturbed olfactory bulb structure of an adult Pax6Leca2 
mutant mouse
(A,A‘) Micrographs of a representative sagittal section of a disturbed olfactory bulb of adult Pax6Leca2 
and corresponding control WT littermate. Some Pax6Leca2 olfactory bulbs have lost their structural 
organization completely as shown in the presented example. Scale bars: 100µm.    
Abbreviations: GL, glomerular layer; EPL, external plexiform layer; MC, mitral cells; GCL, granule 
cell layer; RMS, rostral migratory stream.
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Figure 2-7 Overview telencephalic development in the PAI and in the RED-  
subdomain mutants
(A-D‘‘) Micrographs of representative coronal sections from rostral to caudal of the E14 telencephalon 
of Pax6Leca4 (B-B‘‘), Pax6Leca2 (D-D‘‘) and their WT littermates (A-A‘‘,B-B‘‘).  
Scale bars: 100 µm.  
Abbreviations: CTX, cortex; GE, ganglionic eminence.
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Figure 2-8. Telencephalic development in the PAI and in the RED-subdomain mutants 
at midneurogenesis
(A,A‘,B,B’) Micrographs of representative coronal sections of the rostral E14 telencephalon of 
Pax6Leca4 (A’), Pax6Leca2 (B’) and their WT littermates (A, B).  
(A’’,B’’) Histograms depicting radial length of the cerebral cortex at the two positions (a, b) indica-
ted by red lines in A-B’. Note the reduction in radial cortical length in the Pax6Leca4 but not Pax6Le-
ca2 mutant mice. Data are shown as mean ± SEM, n (embryos analysed) ≥ 3 ; *p<0.05, **p<0.01. 
Scale bars: 100 µm.  
Abbreviations: Ob, olfactory bulb; tel, telencephalon; mb, midbrain. CTX, cortex; GE, ganglionic 
eminence.
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2.2.3 Progenitor proliferation is differently affected in the cerebral cortex of         
 Pax6Leca4 (PAI domain) and Pax6Leca2 (RED domain) mutant mice
As Pax6 controls progenitor proliferation in the developing cortex, alterations in proliferation 
may account for the observed reduction of radial thickness in the Pax6Leca4 mutant. In order 
to examine proliferation of apical and basal progenitors, immuno-histochemistry against 
phospho-Histone 3 (PH3) was performed in both mutants. PH3 marks cells in G2/M-phase 
of the cell cycle (Hendzel et al., 1997) and as the two progenitor populations divide at dif-
ferent positions thus allows the discrimination between apical and basally dividing cells 
(Haubensak et al., 2004; Miyata et al., 2004; Noctor et al., 2004). Dividing precursors were 
quantified per hemisphere in several sections at rostral positions at two developmental sta-
ges – E12, when the first SVZ cells begin to show and at E14, representing midneurogene-
sis. Quantifications at E12 were performed across the entire dorsal wall length from lateral 
to medial position. At E14, a 150-µm wide radial stripe was examined (see also Material 
and Methods). In the Pax6Leca4 mutant proliferation was significantly decreased compared 
to their wild-type siblings at both precursor positions and at both developmental stages 
analysed (Fig.2-9). Interestingly, clustering of apical PH3 positive cells was observed in the 
Pax6Leca4 mutants at E12. Conversely, apical and basal mitosis were significantly increased 
in the cerebral cortex of Pax6Leca2 mutants compared to controls with almost double the 
number of proliferating cells at the apical surface and double the number at basal position 
at embryonic day E14 (Fig.2-10D-F). However, this increase in proliferating progenitors was 
not yet significant at E12 (Fig.2-10A-C). Intriguingly, these proliferation phenotypes in both 
the Pax6Leca4 and the Pax6Leca2 mutant cerebral cortex deviate from the proliferation pheno-
type observed in full Pax6 mutants such as Pax6Sey or after conditional Pax6 deletion, which 
show a normal number of apical, but increased number of basal progenitors (Gotz et al., 
1998; Haubst et al., 2004; Tuoc et al., 2009).
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Figure 2-9. Progenitor proliferation in the PAI subdomain mutant Pax6Leca4
(A-B’,D-E‘) Micrographs of E12 and E14 coronal telencephalic sections depicting cells immunoreactive 
for phosphohistone H3 (PH3, white) in the Pax6Leca4 mutant and its WT littermate. (C, F) Histograms 
showing the number of PH3-positive progenitors in Pax6Leca4 and their WT littermates at E12 (C; per 
entire ctx) and E14 (F; per 150µm thick radial stripe). Data are shown as mean ± SEM, n (embryos 
analysed) ≥ 3 ; *p<0.05, **p<0.01. Note the significant decrease in VZ and SVZ progenitors in the 
Pax6Leca4 mutant. Scale bars: 100 µm. Abbreviations: CTX, cortex; GE, ganglionic eminence; SVZ, 
subventricular zone; VZ, ventricular zone
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Figure 2-10 Progenitor proliferation in the RED subdomain mutant Pax6Leca2
(A-B’,D-E‘) Micrographs of E12 and E14 coronal telencephalic sections depicting cells immunoreactive 
for phosphohistone H3 (PH3) in the Pax6Leca2 mutant and its WT littermate. (C, F) Histograms showing 
the number of PH3-positive progenitors in Pax6Leca2 and their WT littermates at E12 (C; per entire CTX)
and E14 (F; per 150µm thick radial stripe). Data are shown as mean ± SEM, n (embryos analysed) 
≥ 3 ; *p<0.05, **p<0.01. Note the increase in VZ and SVZ progenitors in the Pax6Leca2 mutant. Scale 
bars: 100 µm.  Abbreviations: CTX, cortex; GE, ganglionic eminence; SVZ, subventricular zone; VZ, 
ventricular zone 
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2.2.3.1     Progenitor identity in Pax6Leca4 and Pax6Leca2 mutant mice
In order to examine whether the changes in progenitor proliferation observed in the 
Pax6Leca4 and Pax6Leca2 mutant cortices are accompanied by changes in progenitor identity, 
their molecular fate and morphology were examined next. As described before, the api-
cally and basally proliferating cells present two distinct types of progenitors. The first type 
is radial glial cells which are specified by Pax6 and undergo mitosis at the apical surface 
(Malatesta et al., 2000; Miyata et al., 2001; Noctor et al., 2001b; Heins et al., 2002; Miyata 
et al., 2004). The second population, basally dividing SVZ progenitors arise from the radial 
glia cells and were previously characterized as neuronal progenitors (Haubensak et al., 
2004; Miyata et al., 2004; Noctor et al., 2004). On molecular level it has been shown that 
the transition from radial glial cells to basal progenitors is associated with the up-regulation 
of the T-domain transcription factor Tbr2 (Bulfone et al., 1999) directly controlled by Pax6 
and sub-sequentially associated with the down-regulation of Pax6 protein levels (Englund 
et al., 2005). Thus immunohistochemistry against Pax6 and Tbr2 allowed examining the 
molecular fate of VZ progenitors that divide apically and SVZ progenitors that divide ba-
sally, respectively. Remarkably, expression of Tbr2 was maintained in the cortices of both 
subdomain mutants (Fig.2-11), which is in contrast to the loss of Tbr2 expression in Pax6Sey 
mice (Stoykova et al., 2000; Toresson et al., 2000; Sansom et al., 2009). Moreover, Pax6+ 
and Tbr2+ progenitors were detected at their proper localization (Fig.2-11). However in line 
with the observed changes in proliferation of the cortex, the number of Pax6+ cells in the VZ 
and Tbr2+ cells in the SVZ appeared decreased in the Pax6Leca4 mutant (Fig.2-11A,A’) and 
increased in the Pax6Leca2 mutant cortex (Fig.2-11B,B’). 
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Figure 2-11 Progenitor identity in Pax6Leca4 and Pax6Leca2 mutant mice
(A-D’) Micrographs depicting immunoreactivity for Pax6 (A-B’) and for Tbr2 (C-D’) on coronal 
sections of E14 dorsal telencephalon of Pax6Leca4, Pax6Leca2 and their WT littermates. 
Scale bars: 50 µm. Abbreviations: VZ, ventricular zone; SVZ, subventricular zone.
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In addition to the molecular fate and localization of Pax6+ radial glial cells, their morphology 
was examined next by immunohistochemistry against RC2. RC2 recognizes posttranslati-
onal modifications of nestin in Pax6+ radial glial cells (Park et al., 2009) and hence labels 
their radial processes. For the Pax6Leca4 as well as the Pax6Leca2 mutant grossly normal radial 
glia morphology in the cerebral cortex was detected (Fig.2-12). Taken together, progenitor 
number, but not identity, is distinctly affected in the Pax6Leca4 and Pax6Leca2 mutants, sugges-
ting that the PAI domain may promote and the RED domain may inhibit proliferation.
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Figure 2-12  Radial glial morphology in Pax6Leca4 and Pax6Leca2 mutant mice
(A-B’) Micrographs depicting immunoreactivity for RC2 on coronal sections of E14 dorsal 
telencephalon of Pax6Leca4, Pax6Leca2 and their WT littermates. 
Scale bars: 50 µm. Abbreviations: CP, cortical plate; VZ, ventricular zone.
2.2.4 The role of the PAI and the RED subdomain in dorso-ventral patterning of the  
 telencephalon
One possible explanation for the strikingly different proliferation phenotypes between the 
Leca mutants and the functional Pax6 null mice are differences in dorso-ventral patterning. 
As mentioned in the introduction, Pax6 functions also as regulator of dorso-ventral patter-
ning and loss of functional Pax6 leads to the up-regulation of transcription factors in the 
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dorsal telencephalon which are normally restricted to the ventral telencephalon (Stoykova 
and Gruss, 1994; Stoykova et al., 1996; Stoykova et al., 1997; Toresson et al., 2000; Yun 
et al., 2001; Heins et al., 2002). Indeed the proliferation behaviour observed after complete 
loss of Pax6, with an increase in basal but not apical progenitors resembles one charac-
teristic of the endogenous proliferation properties in the ventral telencephalon, namely a 
particularly high number of proliferating basal progenitors (Bhide, 1996). In order to assess 
if the observed proliferation differences between the Leca mutants and the functional Pax6 
null mice correlate with patterning defects, the expression of the ventral transcription factors 
Gsx2, Olig2 and Mash1 were analysed by immunohistochemistry at E14. Localization of 
TF-positive cells was characterized according to their expression in the different regions of 
the dorsal telencephalon (pallium) as depicted in Fig.2-13. In contrast to the Pax6Sey cere-
bral cortex, no Gsx2 positive cells were detected in the medial (not shown) and dorsal pal-
lium of the Pax6Leca2 and Pax6Leca4 mutants (Fig.2-14). However, in the region of the ventral 
and lateral most pallium scattered Gsx2 positive cells were found in the Pax6Leca4, but not 
Pax6Leca2 mutant (Fig.2-14A-B’). The same expression pattern was observed for Olig2, with 
no expression change in the Pax6Leca2 mutant compared to controls and similar spread of 
Olig2-immunoreactive cells at the ventral and lateral pallium in the Pax6Leca4 mutant (Fig.2-
15). The few scattered Olig2-immunoreactive cells detected in all cortices at dorsal pallium 
position (indicated by red arrowheads in Fig.2-15A,B,C) are Olig2+ oligodendrocyte proge-
nitors that normally migrate into the dorsal telencephalon at subventricular zone positions. 
Thus in the Pax6Leca4 mutant the ventral transcription factors Gsx2 and Olig2 do not respect 
the pallial-subpallial boundary (PSB) leading to ventralisation of the ventral and lateral most 
pallium epithelium, which is reminiscent to the phenotype observed in the Pax6Sey mutant. 
However expression of these transcription factors in the largest pallial regions – the dorsal 
and medial pallium - was absent in the Pax6Leca4 mutant. In contrast, dorso-ventral patter-
ning in all pallial regions was entirely preserved in the Pax6Leca2 mutant telencephalon. 
Figure 2-13  Expression patterns of dorso-vent-
ral patterning factors
Model summarizing the expression patterns of the 
transcription factors Neurog2, Gsx2, Olig2 and Mash1 in 
a WT telencephalon, including depiction of the different 
regions of the dorsal telencephalon (pallium) and ganglionic 
eminence (subpallium).
Abbreviations: CTX, cortex; LGE, MGE, GE, lateral-, 
medial-, ganglionic eminence respectively; MP, DP, VP, 
LP, medial-, dorsal-, ventral-, lateral-pallium respectively. 
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Figure 2-14  Gsx2 expression in Pax6Leca4 and Pax6Leca2 mutant mice
(A-C’) Micrographs depicting immunoreactivity for Gsx2 on coronal sections of E14 dorsal 
telencephalon of Pax6Leca4, Pax6Leca2, Pax6Sey and their WT littermates. Note the broad spread of 
Gsx2 into the cortex in Pax6Sey mutants. 
Scale bars: 100 µm. Abbreviations: CTX, cortex; GE, ganglionic eminence; 
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Figure 2-15 Olig2 expression in Pax6Leca4 and Pax6Leca2 mutant mice
(A-C’) Micrographs depicting immunoreactivity for Olig2 on coronal sections of E14 dorsal 
telencephalon of Pax6Leca4, Pax6Leca2, Pax6Sey and their WT littermates. Red arrowheads indicate 
naturally migrating Olig2+ oligodentrocyte precursors. 
Scale bars: 100 µm. Abbreviations: CTX, cortex; GE, ganglionic eminence.
B‘B
A A‘
C‘C
D
A
P
I /
 O
lig
2
WT E14
CTX
GE
CTX
GE
CTX
GE
Pax6 Leca4 E14
CTX
GE
Pax6 Leca2 E14
GE
Pax6 Sey E14
CTX
GE
D
A
P
I /
 O
lig
2
D
A
P
I /
 O
lig
2
CTX
WT E14
WT E14
- 60 -
Results
In contrast to Gsx2 and Olig2, expression of Mash1 is normally detected in dorsal and ven-
tral progenitors although its highest expression is in the ventral telencephalon. Remarkably, 
immunostaining against Mash1 revealed an up-regulation in a rather wide-spread manner 
in both Pax6Leca2 and Pax6Leca4 mutant cerebral cortices (Fig.2-16A-B’). However compared 
to the Pax6Sey cerebral cortex Mash1 was up-regulated in fewer cells (Fig.2-16).     
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Figure 2-16  Mash1 expression in Pax6Leca4 and Pax6Leca2 mutant mice
(A-C’) Micrographs depicting immunoreactivity for Mash1 on coronal sections of E14 dorsal 
telencephalon of Pax6Leca4, Pax6Leca2, Pax6Sey and their WT littermates.  
Scale bars: 100 µm. Abbreviations: CTX, cortex; GE, ganglionic eminence. 
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Given that in the dorsal progenitors Mash1 and the bHLH transcription factors Neurog1/2 
(Fode et al., 2000; Britz et al., 2006) counter regulate each other and that Neurog1/2 ex-
pression were not only down-regulated in the Pax6Sey cerebral cortex (Haubst et al., 2004) 
but also Neurog2 had been shown to be a direct target of the paired domain of Pax6 (Scar-
digli et al., 2003), prompted the analysis of Neurog2 expression as possible cause for the 
increase in Mash1 expression. In situ hybridisation with a Neurog2 specific probe was per-
formed at E12 and E14 in both Pax6Leca2 and Pax6Leca4 mutant cortices and on Pax6Sey E14 
cortex as control. Strikingly, at both embryonic stages strong Neurog2 mRNA signal was 
present throughout the cerebral cortex of both Pax6Leca4 and Pax6Leca2 mutants (Fig.2-17A-
D’) in pronounced contrast to the Pax6Sey cerebral cortex (Fig. 2-17E,E’). 
Taken together, these data suggest that both the PAI and RED subdomains may be requi-
red to restrain Mash1 expression from the cerebral cortex, while either of them appears 
sufficient to allow relatively normal Neurog2, Gsx2 and Olig2 expression in the medial and 
lateral pallium. However, the PAI, but not RED subdomain plays a pivotal role for the proper 
specification of the ventral and lateral most pallial regions.    
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2.2.4.1     Molecular specification in Pax6Sey/Gsx2 double mutants
The severe ventralization in the cortex of Pax6Sey mutants likely contributes to some defects 
seen in this mutant. Indeed, analysis of double mutants for Pax6 and Gsx2 had shown 
that Gsx2 is required to repress Pax6 and that cortical and striatal development is much 
improved in these mice compared to their respective single mutants (Toresson et al., 2000). 
However, although LGE specification (distorted in the Gsx2 single mutant) was restored 
in the double mutants, remaining ectopic expression of Mash1 and Dlx factors in cortical 
progenitors and reduced levels of Neurog2 were reported (Toresson et al., 2000). In order 
to evaluate the restoration of molecular specification of the loss of Tbr2 in the telencepha-
lon of Pax6Sey mice and ectopic Olig2 expression, their expression was assessed in the 
double mutants at E14 and their respective single mutants as control. Interestingly, Olig2 
expression was not affected in the Gsx2 single mutant, however high ectopic expression of 
Olig2 throughout the cortex was detected in the double mutant (Fig.2-18). Furthermore, the 
almost complete loss of Tbr2 expression observed in the Pax6Sey mutant was also present 
in the double mutant (Fig.2-18). Interestingly, similar to the reported ectopic expression of 
Neurog1&2 in mutant LGE cells in the Gsx2 single mutant (Toresson et al., 2000), also Tbr2 
expression was detected ectopically in the Gsx2 single mutant (Fig.2-18C). Taken together, 
although the deletion of the ventral transcription factor Gsx2 can rescue some defects ob-
served in the Pax6Sey mutant (Toresson et al., 2000), it did not restore ventralization of the 
dorsal telencephalon. Thus, loss of functional Pax6 is predominant in the double mutant 
and comparison to the Leca mutations reveals that a single subdomain (PAI or RED) is 
sufficient to maintain dorsal telencephalon identity.  
Figure 2-17  Neurog2 expression in Pax6Leca4 and Pax6Leca2 mutant mice
(A-E’) Micrographs showing the representative Neurog2 (marking dorsal telencephalon) mRNA in 
situ hybridization on coronal sections of E12 and E14 dorsal telencephalon of Pax6Leca4, Pax6Leca2, 
E14 Pax6Sey and their WT littermates. Note that Neurog2 mRNA expression is maintained in the 
Pax6Leca4 and Pax6Leca2 mice. 
Scale bars: 100 µm. Abbreviations: CTX, cortex; GE, ganglionic eminence. 
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Figure 2-18 Patterning of the telencephalon in Pax6Sey/Gsx2 double mutants
(A-D)  Micrographs of E14 coronal telencephalic sections depicting cells immunoreactive for Tbr2 
(green) , Mash1 (red) and Olig2 (red) in WT, Pax6Sey, Gsx2-knockout mice and Pax6Sey/Gsx2 double 
knockout mice. 
Scale bars: 50 µm. Abbreviations: CTX, cortex; GE, ganglionic eminence.
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2.2.5 The role of the PAI and the RED subdomain in the regulation of neurogenesis
The presence of the two neurogenic genes Neurog2 and Tbr2 and the reduction in progeni-
tor numbers in the Pax6Leca4 cerebral cortex raised the question to which extent neurogene-
sis is affected in both Pax6 subdomain mutants. Neurogenesis was first examined by immu-
nostaining against the neuronal marker protein Map2 labelling all differentiating neurons in 
the cortical plate (CP) and against the T-box protein Tbr1, which is found enriched in layer 
6 neurons. While in the Pax6Leca4 cerebral cortex both stainings showed that the thickness 
of the cortical plate was notably thinner compared to wild-type littermates (Fig.2-19), the 
mutation in the RED subdomain in the Pax6Leca2 mutant had now effect on cortical plate 
thickness (Fig.2-19). The latter was further confirmed by NeuN staining in the adult Pax6Leca2 
mutant cortex (Fig.2-19C,C’). As described before, during neurogenesis different neuronal 
subtypes are generated at distinct developmental stages, migrate from the proliferative zo-
nes towards the pial surface and settle there in an in-side out manner forming the cortical 
plate. Given the decrease in CP thickness in the Pax6Leca4 cerebral cortex, the generation 
of different neuronal layer subtypes was examined next. Immunohistochemical analysis 
of the Foxp2 protein present in layer 6 neurons, the layer 5b neuron marker Ctip2 and the 
layer 2-4 neuronal marker Cux1 revealed a reduction of neurons in each layer at E17 in 
the Pax6Leca4 cerebral cortex (Fig.2-20). Consistent with the normal thickness of the CP, all 
layers were of normal size in E17 Pax6Leca2 mutants (Fig.2-20). Taken together, neurons are 
reduced in number in the cortical plate of Pax6Leca4 mutants, but not affected in the Pax6Leca2 
mutant. This suggests that the PAI subdomain and not the RED subdomain of Pax6 plays a 
key role in the regulation of neurogenesis in the cerebral cortex.
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Figure 2-19  Cortical plate reduction in the PAI-subdomain deficient (Pax6Leca4) but 
not in the RED-subdomain deficient (Pax6Leca2) mutant mice
(A-B’) Representative micrographs of cells immunoreactive for Tbr1 marking layer 6 neurons (green) 
and Map2 marking the cortical plate (red)  in the coronal sections of E14 dorsal telencephalon of 
Pax6Leca4, Pax6Leca2, and their littermates. Note the cortical plate reduction in the Pax6Leca4 mice. 
Dashed lines indicate the ventricular surface. (C,C‘) Immunofluorescence for NeuN (red) combined 
with DAPI staining (blue) on sagittal sections of the cortex of eight week old Pax6Leca2 and control 
mice. Scale bars: 100 µm.
Abbreviations: CTX, cortex; CP, cortical plate; VZ, ventricular zone. 
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Figure 2-20  Neurogenesis is impaired in the PAI-subdomain deficient (Pax6Leca4) 
mice but not in the RED-subdomain deficient (Pax6Leca2) mice
(A-F‘) Immunofluorescence for Ctip2 (red) or Foxp2 (green) or Cux1 (white) combined with DAPI 
staining (blue) on coronal sections of E17 dorsal telencephalon of Pax6Leca4, Pax6Leca2 and control 
mice. Note the reduced expression of all three layer markers in the cortical plate of Pax6Leca4 but not 
Pax6Leca2 mice. Scale bars: 100 µm. 
Abbreviations: CP, cortical plate; IZ, intermediate zone. 
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2.2.5.1     Effect of Pax6Leca4 and Pax6Leca2 mutation on neurogenesis in-vitro 
In order to understand whether the impaired neurogensis in the Pax6Leca4 mutant cerebral 
cortex is linked to the reduced proliferation of progenitors or is caused by additional defects 
of neurogenesis as previously described for the full Pax6 mutant Pax6Sey (Heins et al., 2002; 
Haubst et al., 2004), the direct neurogenic capacity of the Pax6 Leca mutant forms was 
analysed in gain-of-function experiments. Dissociated primary cultures of WT E14 cerebral 
cortex cells were infected with replication incompetent MLV-based retroviruses expressing 
either only an eGFP reporter, or eGFP together with the Leca4 or Leca2 mutant form of 
Pax6 or the wild-type form of Pax6 used as positive control. The retrovirus reverse transcri-
bed DNA integrates only in the genome of dividing cells and then is inherited to the daughter 
cells. Hence with an infection at clonal density (less than 50 clones per coverslip) the pro-
geny of a single infected cell represents a clone. To assess the direct neurogenic capacity, 
the fate of the progeny of single progenitor cells seven days after infection was determined 
using immunocytochemistry for the neuronal marker NeuN. Depending on the compositi-
on, the clones were classified as pure neuronal clone, when only neurons were present in 
the clone, as mixed clone when it contained both NeuN+ and NeuN-negative cells and as 
pure non-neuronal clone when exclusively NeuN-negative cells were detected (examples 
are shown in Fig.2-21A and Fig.2.22A). Consistent with previous data (Heins et al., 2002; 
Haubst et al., 2004), overexpression of wild-type Pax6 significantly increased the fraction 
of pure neuronal clones (Fig. 2-21). Similarly, after forced expression of the Leca2 mutant 
form of Pax6 a comparable, significant increase in the percentage of pure neuronal clones 
was determined (Fig. 2-21). In contrast, the PAI deficient Leca4 mutant form of Pax6 did 
not influence clone composition compared to the GFP-only vector control (Fig. 2-21). Thus 
the mutation in the PAI but not the mutation in the RED subdomain affects the neurogenic 
capacity of Pax6, suggesting a selective role for the PAI subdomain in neurogenic fate ins-
truction in these cells.    
Figure 2-21 The PAI-subdomain has a selective role in neurogenic fate instruction 
(A) Representative images of neuronal, mixed and non-neuronal clones derived from the progenitors 
isolated from the E14 cerebral cortex and infected with the CAG control retrovirus. Arrows indicate 
double labelled cells and arrowheads only GFP positive cells. Scale bar: 50 µm. (B) Schematic 
drawings of the retroviral constructs used for the overexpression experiments. 
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To further investigate this conclusion, the same clonal analysis was performed in cultures 
isolated from E14 Pax6Leca4 and Pax6Leca2 mutant cerebral cortices infected with a GFP con-
trol virus as reporter. In line with the previous results, a reduction of pure neuronal clones 
compared to those from their wild-type littermates was found in cultures from the Pax6Leca4 
mutant cortex (Fig. 2-22B). Furthermore, no change in clone composition was detected 
from the cells of the Pax6Leca2 mutant cortex (Fig. 2-22C). These results therefore further 
support a role of the PAI subdomain of Pax6, but not the RED subdomain for neuronal fate 
specification in progenitors of the cerebral cortex.
Pure neuronal clones normally consist of one or two neurons only compared to mixed or 
pure non-neuronal clones that on average possess a larger clone size (examples see Fig.2-
21A,Fig.2-22A). Hence, consistent with the generation of fewer pure neuronal clones from 
Pax6Leca4 cultures, a significant increase in the overall clone size was determined (p<0.05; 
Appendix Table 5-1). Furthermore, no reduction in clone size was detected in cultures from 
the Pax6Leca2 mutant (Appendix Table 5-1). The size of the clones after forced expression 
of the Leca mutant forms of Pax6 showed a trend in line with the in-vivo proliferation data. 
Overexpression of Pax6Leca4 decreased the size of clones generated from infected proge-
nitors, while forced expression of the RED subdomain mutant Leca2 was no longer able 
to reduce clone size (Appendix Table 5-1). Thus, these data further support the selective 
effects of the RED and the PAI domain on proliferation with an increased proliferation after 
loss of function of the anti-proliferative RED domain and decreased proliferation seen after 
loss of function of the pro-proliferative PAI domain, respectively.
Figure 2-22 Pax6Leca4 but not Pax6Leca2 progenitors show deficiency in neuronal fate 
commitment  
(A) Representative images of neuronal, mixed and non-neuronal clones derived from the progenitors 
isolated from the E14 cerebral cortex and infected with the Pmxig control retrovirus. Arrows indicate 
double labelled cells and arrowheads only GFP positive cells. Scale bar: 50 µm. (B,C) Histograms 
depicting the clone types generated from the E14 cortical progenitors isolated from the Pax6Leca4 
mutant (B), Pax6Leca2 mutant (C) or their WT littermates. Note the significant decrease of pure 
neuronal clones and increase of non-neuronal clones (blue bars) in the cultures isolated from the 
Pax6Leca4 mutant cortex compared to the corresponding WT control. Data are shown as mean ± 
SEM; n (coverslip analysed) >= 6; **p<0.01, ***p<0.001; one-way Anova test.
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2.2.6 Cell death analysis in the Pax6Leca2 and Pax6Leca4 mutant cortex at    
 midneurogenesis
One possible explanation for the increase in mitotic progenitors in the Pax6Leca2 mutant 
cortex but apparently normal neuronal output might be changes in cell survival as Pax6 
has also been implicated to play a role in this context (Nikoletopoulou et al., 2007; Ninkovic 
et al., 2010). Therefore programmed cell death was examined in WT and both Pax6 Leca 
mutant cortices using activated-Caspase3 staining. Although Nikoletopoulou et al. reported 
increased cell death in Pax6Sey mice only at E12, programmed cell death was analysed at 
E14 in the Leca mutants. This is because the significant increase in mitotic progenitors in 
the Pax6Leca2 mutant was observed at E14 and not at E12. Indeed, in the Pax6Leca2 mutant 
cortex the number of apoptotic cells was significantly increased by almost two-fold compa-
red to the corresponding wild-type littermate (Fig.2-23C-D). Interestingly, when subdividing 
the cortex into the progenitor zones (VZ/SVZ), the intermediate zone (IZ) and cortical plate 
(CP), the significant increase in activated-Caspase3 positive cells was specifically located 
in the VZ/SVZ of the Pax6Leca2 mutant cortex (Fig.2-23D), the regions of increased PH3+ 
cells (Fig.2-10). In contrast, the number of apoptotic cells was unchanged in the cerebral 
cortex of Pax6Leca4 mutants compared to its respective wild-type littermate at embryonic 
day E14 (Fig.2-23A-B). Thus, the increased proliferation observed in the Pax6Leca2 mutant 
cortex goes along with an increase in cell death of progenitors, possibly accounting for the 
observed normal cortical size.
Figure 2-23 Increased cell death in the Pax6Leca2 mice (RED-subdomain) but not in 
the Pax6Leca4 mice (PAI-subdomain)
(A,A’,C,C’)  Micrographs of E14 coronal telencephalic sections depicting cells immunoreactive 
for activated Caspase-3 (green) in Pax6Leca4, Pax6Leca2 and their WT littermates. (B,D) Histograms 
showing the number of activated Caspase-3 -positive cells in the VZ/SVZ, IZ, CP and per total CTX 
in Pax6Leca4, Pax6Leca2 and their WT littermates at E14. Data are shown as total numbers per 10 
sections ± SEM, n (embryos analysed) ≥ 3; (av. 15 sections per embryo) *p<0.05. Note the increase 
in apoptotic cells in the VZ7SVZ in Pax6Leca2 but not Pax6Leca4 mutants. SVZ, subventricular zone; IZ, 
intermediate zone; CP, cortical plate; CTX, cortex. Scale bars: 10 µm.
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2.2.7 Genome-wide expression analysis in the Pax6Leca4 (PAI domain) and Pax6Leca2  
 (RED doamin) mutant cerebral cortex
The distinct effects of the PAI and RED subdomain mutations on neurogenesis and proge-
nitor proliferation observed in both Leca mutants prompted the analyses of genome-wide 
expression changes in the developing cerebral cortices of these mutants. To get further 
insight into the specific molecular changes and to which extent they reflect the phenoty-
pes observed, microarray analysis in rostral regions of E14 wild-type and mutant cerebral 
cortices were performed. The time point E14 was chosen as the phenotype in Pax6Leca2 
mutants was not yet fully apparent at E12 and analysis of the rostral cortex was selected 
to avoid indirect influences by potential changes in arealisation. RNA was hybridised to 
whole-genome Affymetrix MOE430 2.0 arrays and gene expression differences between 
WT and mutants were determined applying the following three criteria: first, genes consi-
dered significantly changed in their expression, were tested significant (FDR<10%) in se-
veral statistical tests performed (see Material and Mehtods); second, genes were selected 
based on a 1.4 fold change difference between wild-type and mutant cortices and thirdly, 
by an average absolute expression level of >50. This analysis revealed in the PAI domain 
mutant Pax6Leca4 416 probe sets with significantly altered expression, of which 179 (43%, 
Appendix Table 5-2) showed a reduced expression level (Fig.2-24A). In comparison, in the 
RED-subdomain mutant Pax6Leca2 94 differentially expressed probe sets were deteced, of 
which 59 (63%, Appendix Table 5-3) were down-regulated (Fig.2-24B). From the Pax6Leca4 
and Pax6Leca2 transcriptome, several genes were selected for q-PCR confirmation analysis. 
All of the selected genes were significantly validated by q-PCR, showing the same up- or 
down-regulation as detected in the array (Fig.2-24C-D’). The linear ratios measured by q-
PCR, were in most cases higher than the ratios detected in the array. 
Figure 2-23 Increased cell death in the Pax6Leca2 mice (RED-subdomain) but not in 
the Pax6Leca4 mice (PAI-subdomain)
(A,A’,C,C’)  Micrographs of E14 coronal telencephalic sections depicting cells immunoreactive 
for activated Caspase-3 (green) in Pax6Leca4, Pax6Leca2 and their WT littermates. (B,D) Histograms 
showing the number of activated Caspase-3 -positive cells in the VZ/SVZ, IZ, CP and per total CTX 
in Pax6Leca4, Pax6Leca2 and their WT littermates at E14. Data are shown as total numbers per 10 
sections ± SEM, n (embryos analysed) ≥ 3; (av. 15 sections per embryo) *p<0.05. Note the increase 
in apoptotic cells in the VZ7SVZ in Pax6Leca2 but not Pax6Leca4 mutants. SVZ, subventricular zone; IZ, 
intermediate zone; CP, cortical plate; CTX, cortex. Scale bars: 10 µm.
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Figure 2-24 Transcriptome analysis of Pax6Leca4 mice (PAI-subdomain) and Pax6Leca2 
mice (RED-subdomain)
(A,B) Heatmap representations of expression values of genes deregulated in the (A) Pax6Leca4 or 
(B) Pax6Leca2 E14 rostral cortex compared to the corresponding WT littermates. Red/blue indicate 
higher/lower expression values. (C,C’ and D,D’) Histograms depicting the linear fold change of gene 
expression levels between Pax6Leca4 or Pax6Leca2 and the corresponding WT littermates measured 
by Affymetrix array analysis or quantitative RT-PCR; Data are shown as mean± SEM; *p<0.05, 
**p<0.01, ***p<0.001; one-way Anova test.
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2.2.7.1     Differentially expressed genes in the Pax6Leca4 mutant cortex
Consistent with the neurogenesis defect in the Pax6Leca4 mutant, the transcriptome analy-
sis of this mutant revealed several deregulated genes known to play a role in regulation 
of neurogenesis. Amongst them, multiple components of the retinoic acid (RA) signalling 
pathway, such as the recently identified direct Pax6 target Rlbp1 (Boppana et al., 2012) as 
well as the cellular retinol binding protein 1 (Rbp1) and the carrier of the retinol metabolite 
RA (Crabp2). Furthermore, molecules of the Wnt-signalling pathway, which play essen-
tial roles in coordinating cortical neurogenesis showed altered expression levels. Amongst 
these, the Wnt7a ligand, which has been implicated to promote neurogenesis, was found 
down-regulated (Hirabayashi et al., 2004). Whereas the inhibitor of differentiation 3 (Id3) 
known to inhibit precocious differentiation of cortical progenitors and the Wnt5a ligand, a 
representative of non-canonical Wnt ligands implicated in regulating neurogenesis through 
maintenance of progenitors were both found up-regulated (Lyden et al., 1999; Endo et 
al., 2012). Besides signalling pathways, many mRNAs encoding for transcription factors 
involved in neurogenesis were found to be down-regulated in the Pax6Leca4 mutant cortex 
compared to the control. Amongst these, for example, the Pou3f4 (Brn4) transcription factor 
required for neuronal differentiation and maturation of newborn neurons (Shimazaki et al., 
1999), the Cux2 transcription factor important for controlling proliferation rates of intermedi-
ate progenitors and the number of upper layer neurons (Cubelos et al., 2008) or the Tcfap2c 
(AP-2gamma) transcription factor involved in regulating basal progenitor and laminar fates 
(Pinto et al., 2009). Others comprise the transcription factors Dmrt1a, Meis1, Sall3 or Pbx3 
(Knoepfler and Kamps, 1997; Huang et al., 2005; Harrison et al., 2008; Heine et al., 2008; 
Heng et al., 2012). Taken together, signalling pathways and transcription factors all known 
to be involved in regulation of neurogenesis were deregulated in the Pax6Leca4 cortex reflec-
ting changes of the PAI-mediated neurogenic program, which were in line with the observed 
neurogenic defect. 
Further consistent with the distinct functions of the Leca4 mutation, genes promoting cell 
cycle exit such as Gadd45 were up-regulated in the Pax6Leca4 mutant cerebral cortex. On 
the other hand pro-proliferative factors like Id2 (Uribe and Gross, 2010) or tenascin C (von 
Holst et al., 2007) were decreased in expression. Moreover, the mRNA of the bcl-2 gene, 
which in its phosphorylated status constitutes an M-phase marker (Ling et al., 1998), was 
decreased. 
Taken together, in line with the observed decrease of proliferating cells in the Pax6Leca4 
mutant cortex, the transcriptome analysis of this mutant furthermore revealed expression 
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changes of several molecules involved in positive or negative regulation of proliferation, 
which were down or up regulated respectively. This supports the PAI mediated pro-prolife-
rative function of Pax6 in cortical progenitors.
2.2.7.2    Differentially expressed genes in the Pax6Leca2 mutant cortex
Consistent with the less severe phenotype observed in the Pax6Leca2 mutants, the transcrip-
tome analysis of the Pax6Leca2 mutant revealed fewer gene expression changes compared 
to the Pax6Leca4 mutant cortex (94 vs. 416). In correlation with the increase of mitotic cells 
observed in the Pax6Leca2 mutant cortex, transcription factors known to promote proliferati-
on, such as Zic1 (Pourebrahim et al., 2007; Brill et al., 2010; Watabe et al., 2011) and Zic3 
(Inoue et al., 2007) were found to be up-regulated. Noteworthy, the up-regulated genes in 
the Pax6Leca2 mutant cortex furthermore revealed two mRNAs encoding for pro-apoptotic 
genes. Both genes, the Harakiri (Hrk) and the Bcl2-like-11 (Bcl2l11; also known as Bim) 
belong to the BH3-domain only containing subgroup of pro-apoptotic Bcl2-family members 
and facilitate apoptosis (Putcha et al., 2001; Ghosh et al., 2011). Interestingly, it has been 
shown that changes in the phosphorylation status of Bcl2l11 during mitosis are implicated 
to correlate with prolonged mitotic arrest which precedes cell death (Mac Fhearraigh and 
Mc Gee, 2011). 
Consistent with the in vivo and in vitro results described above, the transcriptome analysis 
of the Pax6Leca2 mutant did not reveal major changes of neurogenic molecules, further sup-
porting the role of the PAI but not the RED subdomain in regulation of neurogenesis during 
forebrain development. 
Taken together, the transcriptome analysis of the Pax6Leca2 mutant correlates with the ob-
served phenotype in this mutant, including support for an anti-proliferative role of the RED 
subdomain of Pax6. 
2.2.7.3     Comparison of differentially expressed genes between the Pax6Leca4 and         
      Pax6Leca2 mutant cortex
As depicted in the Venn-diagram (Fig.2-25A), the comparison of both mutant transcripto-
mes revealed only 17 probe sets commonly regulated in both mutants (Appendix Table 
5-4). Thereof, 15 probe sets were regulated in the same manner in both mutants and the 
majority of which were down-regulated. Noteworthy, amongst these one recently identified 
direct Pax6 target, the Rlbp1 gene (Boppana et al., 2012) was found. Furthermore, only two 
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probes, of Neurogenin1 and Dnajc1 (Appendix Table 5-4) showed opposite regulation being 
down- or up-regulated in the cerebral cortex of Pax6Leca2 or Pax6Leca4 embryos, respectively. 
Thus, the comparison of both transcriptomes revealed little overlap supporting that the PAI 
and the RED domain of Pax6 regulate distinct genes independently.
A B
Figure 2-25 Comparison of transcriptome data from Pax6Leca4, Pax6Leca2 and Pax6Sey 
mice
(A,B) Venn diagrams depicting the overlap between the deregulated probe sets observed in the 
Pax6Leca4 and Pax6Leca2 cortices (A) and Pax6Sey cortices (B). Note the small proportion of commonly 
regulated genes in Pax6Leca2 and Pax6Leca4 cortices.
2.2.7.4     Comparison of differentially expressed genes between the Pax6 Leca mutant     
     cortices and the functional Pax6 null mutant Pax6Sey 
In order to further understand the individual expression differences the same microarray 
was performed for the functional null mutant Pax6Sey. Consistent with the more severe phe-
notype in Pax6Sey mutants, a much larger number of genes was significantly altered in ex-
pression (1898; data set not shown) as compared to the transcriptomes of the Leca mutants 
(Fig.2-25B) and the total overlap between all three mutants was very low (10 probe sets; 
see within Appendix Tables 5-5 and 5-6). In fact, in line with the severe ventralization of the 
dorsal telencephalon present solely in the Pax6Sey mutant and absent in the Leca mutant 
cortices, the set of genes deregulated in the Pax6Sey mutant cortex comprised many ventral 
factors. Notably, amongst them the highly up-regulated transcription factors Olig2, Gsx1/2, 
Mash1 and the Dlx transcription factor family, while both in line with the protein data (Fig.2-
14,15,16), only Ascl1/Mash1 was increased in both Leca mutant cerebral cortices. Although 
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Olig2 mRNA was found elevated also in the Leca2 mutant cortex, this was not detected 
on protein levels (Fig.2-15). Moreover, many genes encoding for centrosome associated 
proteins and normally strongly expressed in the ventral telencephalon, were up-regulated 
in the Pax6Sey mutant but were not affected in either of the Leca mutants. For example, the 
expression of the direct Pax6 target Spag5 which regulates the orientation of cell division 
(Asami et al., 2011) or Aspm, a protein known to control spindle orientation (Fish et al., 
2006) was not changed in both Leca mutant cortices. However, further consistent with the 
phenotypes, the genes involved in regulation of neurogenesis affected in the Pax6Leca4 mu-
tant (see above) were similarly affected in the Pax6Sey, but not in the Pax6Leca2 mutant cortex. 
Taken together, this comparison further supports that the distinct sets of regulated genes 
found in these mutant cortices in fact correspond to the distinct roles of Pax6 reflected by 
the individual phenotypes.
2.2.7.5     Comparison of the differentially expressed genes in the Pax6 Leca mutant       
     cortices and Pax6-Chip data
In order to evaluate the potential abundance of direct and indirect targets of Pax6 amongst 
the genes found altered in the PAI and RED domain mutant cerebral cortices, the transcrip-
tomes were compared with Pax6 chromatin-immunoprecipitation (ChIP) data provided from 
our collaborator Ales Cvekl. He obtained Pax6 ChIP data from E15 WT cerebral cortex, lens 
and pancreas cells (Xie et al. 2012, submitted). Interestingly, the comparison showed an 
overlap of about 20% for the deregulated genes found in the Pax6Leca4 (82/416) but also for 
the deregulated genes found in the Pax6Leca2 mutant (20/94). Amongst these, few previously 
described direct targets were found, like Cspg2, Rlbp1 or Pax6 itself (Appendix Table 5-2 
and 5-3). Interestingly only three genes with positive Pax6-ChIP signal were determined in 
both Leca mutant transcriptomes (Rlbp1, Neurogenin1, Ccdc80). Whereas most were de-
tected either in the pool of genes only regulated in the Pax6Leca4 mutant (e.g. Cdh8, Crabp1 
and Tnc) or in the Pax6Leca2 mutant (e.g. Bcl2l11, Neurod4, Id4, Zic1 and Zic3). Thus, this 
once more supports the individual regulations exerted by the PAI and the RED subdomain 
of Pax6 and reveals Pax6 direct target genes dependant on PAI or RED domain mediated 
function.  
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2.2.8 Superactivation by the RED domain mutation of Pax6
Given that the PAI and RED domain mutants display distinct phenotypes including the abo-
ve described different gene expression changes, implies that the two subdomains may 
distinctly regulate gene expression. However cooperative effects have also been observed 
between the PAI and RED, but also with the other domains of Pax6 (Jun and Desplan, 1996; 
Singh et al., 2000; Mikkola et al., 2001; Mishra et al., 2002; Xie and Cvekl, 2011). In order 
to investigate the transactivation properties of the Leca mutant proteins, luciferase assays 
were performed on different published Pax6 consensus sites (Epstein et al., 1994a). When 
examining the transactivation potential of the Leca2 mutant form of Pax6 on two Pax6 con-
sensus sites, gain of transcriptional activation was measured (Fig.2-26). Luciferase reporter 
assays on constructs containing the paired domain consensus site P6CON together with 
the homedomain consensus site P3 as well as on a reporter construct containing only the 
P3 binding site, resulted in a significant superactivation by the Leca2 mutant form of Pax6. 
Moreover, this result was independent from the level of endogenous WT Pax6 protein, as 
superactivation was detected in both P19 cells (which contain endogenous Pax6 protein) 
and HEK cells (which are devoid of endogenous Pax6 protein) (Fig.2-26). Conversely, the 
Leca4 mutant form of Pax6 showed no enhanced transactivation on the P6CON-P3 and 
P3 constructs compared to WT Pax6. Thus, gain of function exerted by the Leca2 mutation 
may result in superactivation, potentially dependent on the cellular environment. 
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Figure 2-26 Transactivation analysis on the Pax6-consensus sites P3-P6CON an P3 
(A-B‘) Histograms depicting the transactivation properties on the published Pax6 consensus sites 
P3-P6CON (A,A‘) and P3 (B,B‘) by WT Pax6, Pax6Leca2 and Pax6Leca4 measured as reporter 
gene activation in luciferase assay in P19 and HEK cells. Data are shown as the mean ± SEM. 
*p<0.05, **p<0.01. 
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2.3 Fate determinants at post-transcriptional level: microRNA expression  
 during neuronal differentiation
The transcription factor Pax6 may not only regulate mRNA coding genes, but also control 
the expression of microRNA molecules. These have been shown to play a role in CNS 
development and have been implicated in controlling various cellular processes including 
self-renewal and fate specification (Fineberg et al., 2009; Shi et al., 2010). However the 
expression and role of single microRNAs is still poorly understood. To identify new miRNAs 
involved in radial glia specification and differentiation, potentially controlled by the transcrip-
tion factor Pax6, a miRNA and mRNA profiling was performed at different stages during 
neuronal differentiation with a differentiation system generating Pax6+ progenitors.
2.3.1 The screening system: in-vitro differentiation from ESC to glutamatergic   
 neurons
In order to identify microRNAs that are differentially expressed during neuronal differentia-
tion an in-vitro differentiation culture was used. It has been previously shown that homoge-
nous populations of Pax6+ cells with radial glia properties can be derived from embryonic 
stem cells (ESC) that can be further differentiated into neurons (Bibel et al., 2004; Conti et 
al., 2005; Pollard et al., 2006; Bibel et al., 2007; Gaspard et al., 2008). Using the culture sys-
tem according to Bibel et al. 2007, highly proliferative embryonic stem cells were exposed 
to retinoic acid (RA) at the cellular aggregate (CA) stage, inducing their differentiation into a 
relatively homogeneous population of Pax6 positive radial glia cells. When further differenti-
ated, these cells gave rise to functional glutamatergic neurons very much similar to neurons 
derived of Pax6 expressing precursors in the developing mammalian cortex. To analyse 
microRNA expression, five different time points covering the course of differentiation were 
selected (Fig.2-27). After depletion of feeder cells, the embryonic stem cells were cultured 
in a medium that induced formation of cellular aggregates (CA). The first sample was coll-
ected four days after beginning of aggregate formation, just before the first addition of RA. 
Thus the cells at this stage reside in an undifferentiated ESC like state (sample 1: CAd4). 
The cellular aggregates were cultured over eight days and treated twice with the inductive 
stimulus retinoic acid at day four and six. The next samples were collected at day six (befo-
re the 2nd addition of RA; sample 2: CAd6) and day eight (sample 3: CAd8). At CAd8, the 
cells resembled neural precursors with some radial glia properties, such as the expression 
of Pax6. After dissociation of the aggregates and plating on Poly-dL-Ornithine (PORN) and 
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laminin coated dishes, the neural precursors adopted the distinct, spindle-shaped morpho-
logy of radial glial cells. The fourth sample was taken at this stage, 14 hours after plating 
(sample 4: P14h). Finally as differentiation was continued with different culture media, these 
progenitors differentiated into a homogenous population of glutamatergic neurons and the 
last sample was collected seven days after plating of the aggregates (sample 5: N7). 
Embryonic stem cells on feeder cells
Embryonic stem cells on gelatine; 
removal of feeders
Formation of cellular aggregates (CA): 
differentiation by retinoic acid induction
1. sample CA day 4 (CAd4) + RA
2. sample CA day 6 (CAd6) + RA
3. sample CA day 8 (CAd8)
A
B
C
Differentiated radial glial cells plated on PORN-Laminin
4. sample progenitors 14 hours past plating (P14h) 
D
RC2 / DAPI
Glutamatergic neurons 
5. neurons 7 days past plating (N7)
E
vGlut1 / ß3Tubulin
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Figure 2-27 Scheme depicting the embryonic stem cell differentiaion protocol 
according to Bibel et al., 2007 for miRNA profiling
(A-D) Micrographs depicting the different stages of differentiation from mouse ESC (A) to 
glutamatergic neurons (E). (A,B) Brightfield images of ESC (potato shaped colonies) on a dense 
feeder layer (A) and of ESC cultured on gelatine, depleted of feeder cells (B). (C) Brightfield image 
of cellular aggregates eight days after aggregate formation induced by addition of retinoic acid 
(RA). (D) Differentiated radial glial like cells 14 hours after plating on PORN-Laminin coated dishes, 
stained for the radial glial marker RC2 (red). (E) Glutamatergic neurons seven days after plating 
stained for beta3Tubulin (green) and vGlut1(red). Note the five different time points selected for 
miRNA profiling are described under C-E.  
2.3.2 Differentially expressed microRNAs during differentiation
For microRNA profiling, total RNA (including all mRNA and microRNA species) was ext-
racted from three replicates of each of the five different time points and microRNA array 
analysis was performed using the miRCURY LNATM platform (Exiqon, Denmark). Briefly, 
miRNAs were hybridized to miRCURY™ LNA Arrays (v.11.0) that contained capture probes 
for all microRNAs in human, mouse, rat and their related viruses as annotated in miRBa-
se Release v.11.0. Quantified signals were normalized using the global Lowess (LOcally 
WEighted Scatterplot Smoothing) regression algorithm and expression differences between 
the different sample groups were determined. For mRNA profiling, total RNA from the same 
samples were DNase I digested and hybridized to whole-genome Affymetrix MOE430 2.0 
arrays and gene expression was determined as described before.  
The miRNA analysis revealed 89 microRNAs that are differentially expressed over the time 
course of differentiation (Fig.2-28). A clear change of miRNA expression was most noted 
between the more undifferentiated stages (CAd4, CAd6) and the first neural progenitor 
stage CAd8 (Fig.2-28). Moreover, several patterns of expression were identified. These 
include ESC specific microRNAs that are down-regulated during differentiation and neuron 
specific microRNAs that are up-regulated during differentiation. While these two expression 
patterns comprised most differentially regulated miRNAs, some miRNAs showed a peak 
expression at the progenitor stage or had a minimal expression at the progenitor stage. 
Amongst the ES-cell specific miRNAs, members belonging to the miR-290-295 cluster co-
ding for a family of microRNAs were identified. This cluster has been linked to a number of 
functions in mouse embryonic stem cells, such as maintenance of pluripotency or prolife-
ration (Benetti et al., 2008; Wang et al., 2008c). In line with previous results its expression 
decreased during differentiation. Furthermore, miR-9 was found amongst the miRNAs that 
started to be expressed at the progenitor stage. MiR-9 is an important regulator of neural 
progenitor cell differentiation (Shibata et al., 2011). Moreover, consistent with its in-vivo ex-
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pression the brain specific microRNA-124 was found up-regulated at highest levels in the 
neuronal fraction. However, the most interesting candidates are miRNAs that showed an 
alternating expression pattern as this most likely plays a specific role in regulation of neural 
stem cell proliferation and differentiation. The miRNAs up-regulated and with peak expressi-
on in radial glia like progenitors comprised four molecules: miR-193; miR-126-3p; miR-92b 
and miR-219. These were strongly down-regulated at the neuronal stage. Amongst them 
only miR-92b has been reported to be expressed in neural precursors in the developing 
zebrafish brain (Kapsimali et al., 2007), however its function in these cells remains elusive. 
Recent studies have identified miR-219 as an important regulator of oligodentrocyte diffe-
rentiation in the brain (Dugas et al., 2010; de Faria et al., 2012), while miR-193 has not been 
described in any neural tissue yet. The most studied and the only non-intergenic miRNA of 
these four (located within an intron of the EGFL7 (EGF-like domain-containing protein 7) 
gene) is miR-126-3p. MiR-126-3p has been implicated in regulation of angiogenesis and 
vascular integrity amongst other roles (Wang et al., 2008a). The expression of these mi-
croRNAs correlated with the expression pattern of Pax6, however it remains to be identified 
whether these microRNAs are under the control of Pax6. 
For several miRNAs from the screen - comprising different expression patterns - LNA-
based in-situ hybridization was performed in order to test their expression in the developing 
forebrain. The distinct expression patterns of miR-9, miR-124, miR-92b and miR-126-3p 
observed in the screen were investigated on E14 forebrain tissue sections (Fig.2-28B). The 
expression observed of all of them correlated with their expression determined in the array 
(Fig.2-28). 
Taken together, the miRNA profiling at different stages of neuronal differentiation has re-
vealed interesting expression patterns and novel candidate miRNAs, especially those only 
expressed in progenitor cells. Moreover, including the mRNA profile of the same samp-
le groups provides a good starting point for future microRNA - gene regulation analysis. 
Further studies will elucidate the function of these miRNAs during brain development and it 
will be necessary to show their importance.    
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Figure 2-28 Differentially expressed miRNAs 
during differentiation
(A) Heatmap representation of the miRNAs found 
differentially expressed over the time course of 
differentiation. Arrows indicate miRNAs performed 
in-situ habridization (red) and candidate microRNAs 
with high expression only in progenitors (black). (B) 
Micrographs showing miRNA in situ hybridisation of 
miR-9, miR-124, miR-92b and miR-126-3p on coronal 
sections of E14 dorsal telencephalon. Abbreviations: 
CTX, cortex; GE, ganglionic eminence. 
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3 Discussion
3.1 Summary
The main aim of this work was to dissect the distinct roles of the DNA-binding domains of 
the transcription factor Pax6 in the developing cerebral cortex. Towards this end the indi-
vidual functional impacts of the DNA-binding domains were assessed by the analysis of 
domain-specific mouse mutants. As a first result I could confirm that Pax6 utilizes its paired 
domain (PD) to exert its distinct functions during cortical development, while the homeodo-
main plays no important role. I demonstrated that the PAI subdomain of the PD is crucial 
for the regulation of neurogenesis by Pax6 which is not dependent on RED-subdomain 
function. In contrast, both subdomains are necessary and sufficient to control progenitor 
proliferation in opposing manners with the PAI-subdomain promoting proliferation and the 
RED-subdomain inhibiting proliferation. Genome-wide expression analysis of both PD sub-
domain mutants furthermore revealed distinct molecular changes in agreement with the in-
dividual phenotypes observed. Consistent with the neurogenic defect in the PAI subdomain 
mutant, key neurogenic regulators such as the transcription factors Meis1, Tcfa2c, Dmrt1a 
or Cux2 were altered in their expression, thus unraveling these factors as candidate Pax6 
PAI-mediated targets. Moreover I show that the function of Pax6 in regard to patterning 
during telencephalic development is achieved by both subdomains in a largely redundant 
manner. Taken together, my work demonstrated a modular function of Pax6 with even the 
subdomains exerting distinct roles, thus further leading to the identification of novel targets 
likely mediating the distinct functions of Pax6.
Towards identifying novel targets of Pax6, I also performed a screen for microRNAs in 
Pax6+ radial glia. This screen was conducted at different stages of neural differentiation of 
embryonic stem cells that recapitulates Pax6+ neurogenesis similar to neurogenesis seen 
in the developing telencephalon. This analysis revealed a number of microRNAs induced 
during differentiation from neural progenitors to neurons. In conjunction with Pax6 up-regu-
lation, I successfully identified four microRNA candidates that were exclusively expressed 
at the neural progenitor stage when Pax6 levels are highest.  
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3.2 The paired subdomains - PAI and RED - of Pax6 are crucial for Pax6   
 function and show selective roles during cortical development 
3.2.1 The PAI and the RED subdomain of Pax6 regulate dorso-ventral patterning in  
 a redundant manner
The loss of full Pax6 function leads to severe changes in patterning of the dorsal telence-
phalon (Stoykova et al., 2000; Toresson et al., 2000; Yun et al., 2001; Haubst et al., 2004). 
Dorsal progenitor cells ectopically miss-express ventral genes in the Pax6 deficient condi-
tion such as the transcription factors Gsx2, Olig2, Mash1 or the Dlx family of TFs, thereby 
reducing the expression of dorsal factors like Ngn2 and Tbr2. As a consequence the neu-
ronal fate changes from glutamatergic to GABAergic neurogenesis in the absence of Pax6 
(Stoykova et al., 2000; Toresson et al., 2000; Heins et al., 2002; Muzio et al., 2002a; Scar-
digli et al., 2003; Kroll and O'Leary, 2005; Quinn et al., 2007; Tuoc et al., 2009). This has 
been observed not only in the Pax6 mutant Pax6Sey (lacking the transactivation domain of 
this TF), but also after cortex-specific deletion of Pax6 (Emx1-Cre Pax6flx/flx) (Tuoc et al., 
2009), in Pax6Sey deficient cells in mouse chimeras (Quinn et al., 2007) or even upon acute 
deletion of Pax6 by Cre electroporation in the Pax6flx/flx mouse line (Asami et al., 2011). In 
pronounced contrast, the present work revealed that this phenotype was not visible in both 
Pax6 Leca mutant mice. As observed in immunohistochemical and the transcriptome analy-
sis, none of the ventral transcription factors Gsx2, Olig2 or Dlx1/2/5/6 were miss-expressed 
in a wide-spread manner in the Leca mutant dorsal cerebral cortex. However one exception 
was the transcription factor Mash1, which was ectopically up-regulated in both mutants. 
This observation was rather surprising as the expression of Ngn2, which represses Mash1 
expression in the dorsal telencephalon was maintained in both Leca mutants (Fode et al., 
2000; Parras et al., 2002; Schuurmans et al., 2004). In addition, the expression of the dorsal 
transcription factor Tbr2 was also normal in the cerebral cortex of the Leca mutant mice. As 
these transcription factors are involved in specifying the glutamatergic phenotype (Schuur-
mans et al., 2004; Sessa et al., 2008) and no increase in GABAergic neurons or accumu-
lation in white matter ectopias was seen (data not shown), this explains why glutamatergic 
neurogenesis could be maintained in both Leca mutants. These data reveal that relatively 
normal gene regulation in dorso-ventral patterning is sufficiently achieved by either the PAI 
or the RED subdomain of Pax6.
However, PAI mediated gene regulation seems to have a more dominant function in subdo-
mains of the dorsal telencephalon. This is because ectopic expression of the transcription 
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factors Gsx2 and Olig2 were detected in the small compartments closest to the ventral te-
lencephalon - the lateral and ventral pallium in the PAI deficient mutant Pax6Leca4, but not in 
the RED domain mutant Pax6Leca2 (for summary see Fig.3-1). Between the ventral pallium 
and the dorsal most part of the subpallium lies the genetically and morphologically defined 
pallial-subpallial boundary (Shimamura et al., 1997; Shimamura and Rubenstein, 1997). In 
addition to the spread of Gsx2 and Olig2 positive cells across this boundary, the microar-
ray analysis revealed a profound up-regulation of the transcription factor Dbx1, which is 
expressed in this region (Teissier et al., 2010). Likewise Dbx1 expression was also highly 
up-regulated in the Pax6Sey mutant cortex, but its expression was unaffected in the Pax6Leca2 
mutant cortex, further supporting a PAI-mediated control by Pax6 in this region. However, 
no change of the Wnt-inhibitor SFRP2, which is absent after full Pax6 deletion or after 
disruption of the homeodomain of Pax6 was detected (Haubst et al., 2004). Moreover glial 
fascicles at the PSB are formed normally in the Leca mutants, which is in contrast to the 
failure of fascicle formation observed in the functional Pax6 null mice (Haubst et al., 2004). 
Taken together, these data suggest that the correct formation and specification of the PSB 
and the ventral pallium involves distinct regulatory mechanisms exerted specifically by the 
PAI-subdomain and the homeodomain of Pax6.   
It is important to note, that this relatively normal patterning observed in both mutants has 
a considerable benefit for the mutation analysis. It simplifies the analysis of individual sub-
domain specific contributions to the observed phenotypes and thus allows more precise 
identification of PAI or RED domain mediated functions of Pax6. It also improves the discri-
mination of direct effects from indirect effects that would occur due to changes in patterning.
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Figure 3-1  PAI- and RED-subdomains are largely redundant in controlling dorso-
ventral telencephalic patterning
(A-D) Models summarizing the expression results of the transcription factors Neurog2, Gsx2, Olig2 
and Mash1 in all mutants compared to their expression in WT telencephalon. Note the ectopic 
expression in the ventral and lateral pallium in the Pax6Leca4 mutant (indicated with an arrow).
Abbreviations: CTX, cortex; LGE, MGE, GE, lateral-, medial-, ganglionic eminence respectively; 
MP, DP, VP, LP, medial-, dorsal-, ventral-, lateral-pallium respectively. 
A
B C D
3.2.2 The PAI and the RED subdomains of Pax6 exert distinct and opposing  
 functions on progenitor proliferation
Cortical development is characterized by the presence of two distinct types of progenitor 
cells. Surprisingly, proliferation of both of these progenitor pools is affected in an opposite 
manner in the PAI subdomain mutant Pax6Leca4 versus the RED subdomain mutant Pax6Le-
ca2. These two progenitor types present in the developing cortex can be distinguished by 
their location during mitosis. While apical ventricular zone progenitors that originate from 
the neuroepithelium exclusively undergo mitosis at the apical surface, basal progenitors 
that arise from apical progenitors divide only in the subventricular zone. The quantification 
of dividing cells in the PAI mutant Pax6Leca4 revealed a decrease in the number of apically 
and basally dividing cells already from E12 on, while the RED mutation in the Pax6Leca2 mu-
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tant increased the number of proliferating cells of both progenitor fractions during midneu-
rogenesis (E14). Interestingly, these phenotypes diverge from the proliferation phenotype 
observed after loss of full Pax6 function, which affects only the basal progenitor pool. The 
selective increase in basally dividing cells after loss of Pax6 function (Gotz et al., 1998; 
Haubst et al., 2004; Tuoc et al., 2009) most likely is the consequence of several alterations. 
Amongst them the most influential is the ventralization of the dorsal cortex in these Pax6 
deficient mice. Supporting this fact is the evidence that ventral telencephalic progenitors 
possess a faster cell cycle (Bhide, 1996) and are present in a much higher number in 
the subventricular zone of the ventral forebrain (Bhide, 1996). The ventralization moreover 
includes the loss of Tbr2 expression in the basal progenitors and thus this population is 
likely not correctly specified in Pax6 deficient cells (Haubst et al., 2004; Quinn et al., 2007). 
In addition, a recent analysis from our lab has shown that apical progenitors increasingly 
delaminate from the apical surface in Pax6Sey mice and show alteration in the mode of cell 
division but no defects in cell cycle length (Asami et al., 2011). In contrast to these findings 
in full Pax6 mutants, the proliferation phenotypes observed in the Leca mutants show no 
patterning defects and allow normal Tbr2 expression. This suggests that Pax6 may re-
gulate basal progenitors by a different, indirect mechanism as Pax6 is not expressed in 
basal progenitors and as no ectopic expression was observed in the Leca mutants. The 
observed opposing effects on apical progenitors in the Leca mutants together with the lack 
of any effect on this progenitor subtype in full Pax6 mutants suggests, that the effects of 
both subdomains largely outcompete each other in these progenitors. Taken together the 
present analysis of the specific paired subdomains unravels how Pax6 can exert apparently 
opposing functions in the same cortical progenitor population with the intact RED subdo-
main inhibiting and the intact PAI subdomain promoting proliferation. Interestingly, available 
transcriptome data after loss or gain of Pax6 function and chromatin-immunoprecipitation 
data have provided evidence that Pax6 regulates pro- and anti-proliferative factors even 
within the same cell type (Holm et al., 2007; Osumi et al., 2008; Sansom et al., 2009).
Further consistent with the above, the genome-wide transcriptome analysis of the Pax6Leca4 
mutant cortex indeed revealed expression changes of some genes that have been linked 
to regulating proliferation, such as Gadd45, Lmo4, Id2 or tenascin C. In this context, the 
Gadd45 mRNA, which is considered to play an important role in negative growth arrest 
control is up-regulated in the Pax6Leca4 cortex (Yang et al., 2009). Conversely, the inhibitor 
of differentiation (Id2), which exhibits a potent self-renewal and proliferation potential in 
cortical neural progenitors (Jung et al., 2010), is down-regulated. It has been shown that 
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overexpression of Id proteins in cortical progenitors leads to inhibition of expression of 
neuron-specific genes (Cai et al., 2000). Moreover, expression of Tenascin C, another pro-
proliferative factor, whose expression has been known to be controlled by Pax6 (Stoykova 
et al., 1997; von Holst et al., 2007) was decreased in the Pax6Leca4 mutant cortex. All these 
factors may explain the observed decrease in proliferation in the Pax6Leca4 mutant. Interes-
tingly, none of these factors were regulated in an opposite direction in the Pax6Leca2 mutant 
cortex, suggesting that the PAI and the RED subdomain exert their opposing roles through 
distinct molecular control and their targets do not overlap. Accordingly, distinct transcription 
factors promoting proliferation were found increased in the Pax6Leca2 mutant cortex, such as 
Zic1 and Zic3 (Inoue et al., 2007; Pourebrahim et al., 2007; Brill et al., 2010; Watabe et al., 
2011). Zic3 overexpression in cortical radial glial cells inhibits neuronal differentiation (Inoue 
et al., 2007). Altogether, mutation of the RED subdomain affects different genes involved in 
cellular proliferation as compared to the mutation of the PAI subdomain.  
While in both Pax6 subdomain mutants changes in genes involved in proliferation were 
observed, changes in genes encoding for centrosome associated proteins were not ob-
served. This is interesting as these are distinctively regulated in both the Pax6Sey cerebral 
cortex and after acute deletion of Pax6 (Holm et al., 2007; Asami et al., 2011). Moreover, 
one such protein - Spag5 (or mAstrin;(Cheng et al., 2007; Thein et al., 2007)) has previously 
been identified as direct Pax6 target, regulating differences in orientation and mode of cell 
division (Asami et al., 2011). However, this and other genes were not affected in either of 
the Leca mutants. Similarly, the RED subdomain mediated effect on proliferation seems to 
be uncoupled from the role of Pax6 in fate decisions. Although proliferation of apical and 
basal progenitors is profoundly increased in the Pax6Leca2 mutant cortex, neither a change 
in progenitor identity, nor in the later neuronal ouput were observed (see below). However, 
although there was no evidence from the microarray analysis, it can’t be ruled out that the 
increase or decrease in mitotic cells observed in the Leca mutants may also result from 
M-phase problems such as defects in M-phase progression. In order to discriminate this 
possibility, analysis needed would be time-laps microscopy of mutant progenitors.     
In summary, using mutants with specific disruption of either the PAI or the RED subdomain 
respectively, allowed to unravel opposing roles of the transcription factor Pax6 on prolifera-
tion of neural stem cells during cortical development. This finding provides for the first time 
a molecular explanation on how Pax6 can balance proliferation versus differentiation, a 
previously proposed Pax6 function (Sansom et al., 2009).  
These findings are particularly remarkable, as Pax6 is implicated in distinct regulation of 
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proliferation in specific cell types and regions of the nervous system (Haubst et al., 2004) 
(Marquardt et al., 2001; Sakurai and Osumi, 2008; Sansom et al., 2009). In this context, one 
previous study showed that the absence of Pax6 leads to aberrant proliferation of postnatal 
glial progenitor cells (Sakurai and Osumi, 2008). Moreover, loss of Pax6 in the developing 
retina (Marquardt et al., 2001) or diencephalon (Warren and Price, 1997) results in decrea-
sed proliferation, while basal proliferation is increased in the thalamus (Wang et al., 2011a) 
and the telencephalon (as described above). These cell-type and region specific proliferati-
on effects of Pax6 may reflect the distinct molecular control utilized by different domains of 
Pax6 as shown in the present work for the PAI and RED domain in the developing cortex, 
however this remains to be examined for the different regions.   
  
3.2.3 The PAI subdomain of Pax6 is responsible for its neurogenic function
Neurogenesis is tightly linked to proliferation and likewise depends on Pax6 function. Loss 
of Pax6 protein during cortical development results in reduced number of cortical neurons 
(Schmahl et al., 1993; Heins et al., 2002; Haubst et al., 2004; Tuoc et al., 2009). Here I 
addressed the question if one or if both PD-subdomains of Pax6 would be involved in regu-
lation of cortical neurogenesis. The gross morphological analysis of the PAI-mutant Pax6Le-
ca4 showed that the overall cerebral cortex of this mutant was smaller and shorter, including 
the presence of a thinner cortical plate with reduced number of neurons. Interestingly, this 
overall morphology is reminiscent of the phenotype observed after loss of full Pax6 function 
(Schmahl et al., 1993; Heins et al., 2002; Asami et al., 2011), even despite the absence 
of mispatterning in the Pax6Leca4 mutant. In contrast, analysis of the cerebral cortex of the 
Pax6Leca2 mutant mice did not reveal an aberrant phenotype in cortical neurogenesis. Even 
at adult stages, cortical neuron numbers appeared normal in the RED-subdomain mutant. 
These distinct neurogenic effects were furthermore confirmed by clonal analysis of isolated 
mutant progenitor cells in vitro, which showed a reduced production of neuronal progeny 
from Pax6Leca4 cells but not Pax6Leca2 mutant cells. This suggests that the PAI-subdomain, 
but not the RED-subdomain plays an important role in regulating neurogenesis. Moreover, 
neurogenesis elicited by forced expression of Pax6 (Heins et al., 2002; Hack et al., 2004a; 
Haubst et al., 2004) in vitro could still be increased by Pax6 carrying the Leca2 mutation 
in the RED domain, but not by Pax6 carrying the Leca4 mutation in the PAI domain. Thus, 
the PAI domain is essential for neuronal fate instruction, while the RED domain does not 
participate in this function of Pax6 in embryonic progenitors.
The absence of a neurogenic phenotype in the RED-subdomain mutant is not entirely un-
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expected, as a previous analysis of the Pax6(5a)-/- mouse mutant (which is characterized 
by deficiency of producing the 5a-isoform of Pax6 which exerts its paired domain mediated 
function solely through the RED-subdomain) revealed no cerebral cortex phenotype in this 
line (Haubst et al., 2004). Moreover, even forced expression of the 5a-isoform of Pax6 in 
vitro failed to show a neurogenic effect (Haubst et al., 2004). However, of course it would 
not have excluded a neurogenic function of the RED-subdomain mediated by the canonical 
isoform of Pax6, which the present analysis of the Leca2 mutant now also addressed. 
Consistent with the PAI-mediated function in regulation of cortical neurogenesis, the mic-
roarray analysis revealed deregulation of some mRNAs encoding neurogenic factors only 
in the Pax6Leca4 mutant but not the Pax6Leca2 mutant cortex, including members of the Wnt-
signalling and the RA-signalling pathway as well as the transcription factors Meis1, Brn4 or 
Dmrta1. For example, the RA-signaling pathway is important during cortical neurogenesis 
and altered RA signalling affects the size of the telencephalon and influences expression 
of neurogenic markers (Giardino et al., 2000; Smith et al., 2001; Haskell and LaMantia, 
2005). Notably three members of this pathway were down-regulated in the Pax6Leca4 cortex 
– Rlbp1, Rbp1 and Crabp2. While Rlbp1 has been recently identified as a direct Pax6 target 
gene (Boppana et al., 2012), Rbp1 and Crabp2 interestingly were identified as candidate 
target genes in the Pax6 ChIP performed by our collaborator Ales Cvekl. This concerted 
regulation of several molecules of the RA-signalling pathway, may be an important new pa-
thway controlled by Pax6. Notably, while Rbp1 and Crabp2 are possibly dependent only on 
PAI-subdomain mediated regulation, Rlbp1 was similarly down-regulated also in the Pax-
6Leca2 mutant. However, the other still expressed RA-pathway proteins may compensate for 
loss of Rlbp1 function in the Pax6Leca2 mutant as similar to the Pax6Leca2 mutant no defects in 
neurogenesis were observed in Rlbp1 single mutants (Boppana et al., 2012).      
Neurons within the cortical plate are generated at different time-points during differentiation 
from apical and basal progenitors. This way distinct subtypes of neurons arise that can be 
distinguished by their laminar position and marker expression. These subtypes of neurons 
can be placed into two broad classes – deep layer neurons born earlier during neurogene-
sis and upper layer neurons generated later (Molyneaux et al., 2007). As mentioned before, 
loss of Pax6 function in the Pax6Sey mutant leads to a reduction in neuron numbers. Inte-
restingly this affects specifically upper layer neurons (Stoykova et al., 1996; Schuurmans 
et al., 2004). A similar phenotype was observed after conditional deletion of Pax6 with an 
early expressing Cre-line, with almost complete absence of late born neurons and an incre-
ased number of early born neurons (Tuoc et al., 2009). Remarkably, layer marker analysis 
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in the Pax6Leca4 mutant revealed that different neuronal sub-lineages seem to be reduced 
equally in their abundance. There are several reasons that may explain this phenotype and 
its discrepancy to the phenotype after loss of full Pax6 function. The most likely explanation 
is the existence of a relatively normal specification of basal progenitors in the Pax6Leca4 mu-
tant, which give rise to the majority of upper layer neurons. In the Pax6 deficient cortex, the 
identity of basal progenitors is altered as they fail to express several factors – Tbr2, Cux2, 
Satb2 and Svet1 (Tarabykin et al., 2001; Nieto et al., 2004; Zimmer et al., 2004; Englund et 
al., 2005; Cubelos et al., 2008; Cubelos et al., 2010). These factors are involved in specifi-
cation and differentiation of upper layer neurons from basal progenitors and except for Cux2 
are not affected in their expression in the Pax6Leca4 mutant. The transcription factor Cux2 
regulates the cell-cycle exit rate of basal progenitors and thereby controls in particular the 
number of upper cortical neurons generated (Cubelos et al., 2008). Moreover, expression 
of the deep layer subtype marker Foxp2 is decreased in the Pax6Leca4 mutant. In contrast 
it is increased in the Pax6Sey mutant cortex, which is consistent with the observed increa-
se of deep layers after conditional deletion of Pax6 (Tuoc et al., 2009). In this line it was 
suggested that the increase in basal proliferation and an increase in the cell-cycle exit rate 
especially seen in the SVZ region leads to the depletion of the progenitor pool contributing 
to the loss of upper layer neurons after loss of Pax6 function (Tuoc et al., 2009). Consistent 
with this, when Pax6 was deleted at a later time-point during cortical neurogenesis (when 
early born neurons were already specified), the subsequent formation of upper-layer neu-
rons was not affected (Tuoc et al., 2009). Although cell-cycle exit rate was not analyzed in 
the Pax6Leca4 mutant, Leca4 mutant progenitors possess a different proliferation phenotype 
– a decrease in apical and basal proliferation – which likely accounts for the decrease in 
neuron numbers of all layers. In this context the presence of misspatterning also adds on 
the phenotype in the Pax6 deficient cortex.
Taken together, the PAI subdomain is important for Pax6 function in specifying both deep- 
and upper layer identities, like for example the Cux2 or Foxp2 lineage and its disruption af-
fects these subtypes. However, analysis of the cell-cycle exit rate of progenitors and quan-
titative data of neuronal birth dates would help clarifying the role exerted by the PAI domain 
in laminar specification.  
One remaining question is how the profound increase in progenitor proliferation in the Pax-
6Leca2 mutant cortex can be explained without a subsequent increase in neuron numbers? 
One possibility could be that the increase of progenitors is counter regulated via apoptosis. 
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Indeed, it has been shown that neuronal progenitor cells possess a caspase-dependant 
apoptotic pathway, which may regulate progenitor numbers (D'Sa-Eipper and Roth, 2000). 
Moreover, Pax6 has been implicated to play a role in cell survival and decreased as well as 
increased Pax6 levels lead to profound apoptosis (Nikoletopoulou et al., 2007; Ninkovic et 
al., 2010). In order to test for this possibility we used a specific antibody against the activa-
ted caspase-3 – a procaspase of the apoptotic pathway. This analysis showed that apopto-
sis is increased in the Pax6Leca2 mutant cortex. Moreover the increase is detected mainly in 
the progenitor zones. In agreement with this finding, expression of two pro-apoptotic genes 
– Bcl2l11 and Hrk - was found up-regulated in the transcriptome of the Pax6Leca2 mutant 
cortex. In addition, these two pro-apoptotic genes were detected in the Pax6-Chip analysis 
from Ales Cvekl. This may suggest that Pax6 is able to suppress the activation of the apop-
totic machinery. Indeed, it has been shown that Pax6 is able to do so in adult olfactory-bulb 
interneurons (Ninkovic et al., 2010). However, in this context suppression was achieved not 
via direct regulation of genes of the apoptotic pathway, but indirect through controlling the 
expression of the crystalline alphaA gene, which in turn is able to block apoptosis by inhibi-
tion of procaspase-3. If Pax6 may not directly control apoptotic genes, it is also conceivable 
that the increase in apoptosis is caused by the misspecification of the progenitors, as repor-
ted for an earlier stage in Pax6Sey mice (Nikoletopoulou et al., 2007).   
As the reduction in cortical size of the Pax6Leca4 mutant might also be the consequence of 
concomitant cell death, apoptosis was also examined in this mutant. However, I did not ob-
serve a significant increase in apoptosis in the PAI-subdomain mutant, suggesting that the 
reduced proliferation accounts for the phenotype.
3.2.4 The Leca mutations in the PAI and the RED subdomain of Pax6 affect its   
 function through distinct binding sites
In general mutations leading to amino acid changes (which don’t lead to nonsense-medi-
ated decay mutations) can have variable effects on the function of a protein depending on 
the changes occurring with its secondary structure. The fact that the PAI/ Leca4 mutation 
and the RED/ Leca2 mutation lead to distinct phenotypes, implicate that these mutations 
do not have a deleterious effect on Pax6 protein function. If this would be the case, these 
mutations would have resulted in phenocopies of the complete null mutant. Predictions of 
structural changes regarding the DNA-binding properties of the PAI and RED subdomains 
propose selective disruptions of the DNA-binding activities, which is in agreement with the 
distinct expression changes observed in the Leca mutants. The amino acid mutated in the 
- 97 -
Discussion
Pax6Leca4 mutant (N50) is the first amino acid residue in the DNA-contacting helix of the PAI-
subdomain. Moreover, crystallographic analysis of the paired domain has shown that this 
amino acid makes a direct contact with an invariant T –residue that has been found in many 
Pax6-binding site motifs (Xu et al., 1999; Xie and Cvekl, 2011). Also, the N50 amino acid is 
present in a cluster of seven amino acid residues which make up Pax6’ unique DNA-binding 
specificity of this domain compared to other Pax proteins (Czerny and Busslinger, 1995).     
Along this line, our collaborator Dierk Niessing predicted the N50K mutation to disrupt 
the interaction of the PAI-subdomain and DNA. For the R128 amino acid mutated in the 
Pax6Leca2 mutant, bioinformatic calculations (by Dierk Niessing) suggested a perfect DNA-
binding distance of 2.1Å of this amino acid to DNA and hence the mutation is predicted 
to disrupt the DNA-binding capacity of the RED-subdomain. In line with these predictions 
EMSA studies revealed decreased or absent DNA-binding of the RED-subdomain after 
R128C mutation (Yamaguchi et al., 1997; Chauhan et al., 2004). These studies also show-
ed that the RED-subdomain mutation has no impact on the PAI-subdomain DNA-binding 
properties as the mutated protein was still able to bind to P6CON consensus site (PAI-
domain specific consensus sequence). The selective effect of the mutations on each sub-
domain without affecting the other domain was further confirmed by gene expression repor-
ter assays performed by our collaborator Ales Cvekl. Using his previously identified novel 
Pax6-binding site motifs which harbour different combinations of PAI and RED (and some 
with HD) binding sites (see Introduction Fig. 1.7), he could show that the Leca4 mutation 
within the PAI-subdomain affected mainly transcriptional activation of PAI-site motifs, but 
not of RED-site motifs (Fig.3-2). Likewise, the Leca2 RED-subdomain mutation disrupted 
transcriptional activation mediated via the RED domain. However, one of the novel motifs 
was affected by both mutations with decreased activation (Fig.3-2I). Indeed, cooperation of 
the PAI and the RED domain has previously been observed (Yamaguchi et al., 1997; Chau-
han et al., 2004). Nevertheless, still bearing indirect effects in mind, the luciferase experi-
ments described above and the genome-wide expression analysis performed in the present 
study corroborate a rather discrete modular function of the individual subdomains. Further-
more, the comparison of the Pax6 ChIP data (Xie et al., unpublished) with all transcripto-
mes – of the Leca mutants and of the Pax6Sey mutant – revealed an overlap of 23% of the 
genes (Appendix Table 5-7). As almost all of them were regulated in the same direction in 
the mutants, this suggests that they are direct targets of Pax6, rather than indirectly affected 
by mispatterning of the Pax6Sey cerebral cortex.
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** Figure 3-2. Leca4 and Leca2 mutations in 
Pax6 affect its transactivation properties 
on Pax6 DNA-binding motifs (data A.C.)
(A-J) Histograms depicting the transactivation 
activity by WT Pax6, Pax6Leca2 and Pax6Leca4 
on the DNA-binding motifs regulated by Pax6 
(Epstein et al., 1994; Xie and Cvekl et al., 2011) 
measured as reporter gene activation in luciferase 
assay in P19 cells (by our collaborator Ales Cvekl 
/Xing Qie). Data are shown as the mean ± SEM. 
*p<0.05, **p<0.01, ***p<0.001.
A B C
D E F
G H I
J
- 99 -
Discussion
3.2.5 The Leca mutation in the RED subdomain of Pax6 leads to enhanced   
 transcriptional activation in vitro  
In contrast to the reporter assays performed on the novel Pax6 DNA-binding motifs (Ales 
Cvekl; (Xie and Cvekl, 2011)), reporter assays on classical Pax6 consensus sites in vitro 
showed superactivation by Pax6 with the RED domain mutation, but not with the PAI do-
main mutation. Most notably here, besides enhanced activation of the paired domain target 
sequence P6CON (performed by Ales Cvekl; Fig. 3-2J) and the combined PD and homeo-
domain target sequence (P6CON-P3), even the construct containing only the HD target se-
quence P3 showed increased transcriptional activation. One possible explanation for these 
results may be changes of the secondary structure affecting the homeodomain of the Pax6 
Leca2 mutant protein. Indeed, a recent publication using bionformatic tools to predict chan-
ges of the secondary structure through the Leca2 mutation suggested that the R128C mu-
tation not only affects the RED-subdomain, but changes the structure of the homeodomain 
and the transactivation domain: creating an altered homeodomain with an additional helix 
as well as two short additional helices in the transactivation domain (Shukla and Mishra, 
2012). In regard to the homeodomain, although it has been shown by loss of HD function 
that the HD of Pax6 plays no important role in the developing cerebral cortex (Haubst et al., 
2004; Ninkovic et al., 2010), it cannot be ruled out that enhanced independent binding of 
the HD of Pax6 may well have an effect. And consequently may be involved in the observed 
Leca2 cerebral cortex phenotype. Taken together, structural changes of the Pax6 protein 
might influence the transcriptional activation potential of the distinct DNA-binding domains. 
However, experimental proof for structural changes affecting the DNA-binding domain has 
yet to be done. 
A second possibility for the superactivation by the RED-subdomain mutation on the PD 
and HD consensus sequences is that protein-protein interactions are affected. In pancreas 
development, it has been shown that Pax6 interacts for example with the Maf transcription 
factor leading to synergistic activation of the glucagon promoter (Planque et al., 2001). Like-
wise, Pax6 cooperates with other transcription factors during lens development, such as 
Sox2 (Kamachi et al., 2001). Moreover, Pax6 has also been proposed to recruit chromatin 
remodelling complexes to gene loci (He et al., 2010). 
However a different type of protein-protein interaction – between Pax6 and its nuclear im-
port protein is for example likely not affected by the Leca2 RED subdomain mutation. It has 
previously been shown that the paired-domain harbours a non-classical nuclear localization 
sequence (Dames et al., 2010). Deletion of this sequence resulted in cytoplasmic localiza-
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tion of Pax6. However, some Pax6 staining was still visible in the nucleus, suggesting that 
Pax6 harbours an additional NLS. In any case, the Leca mutations do not affect localization 
of the mutant Pax6 protein as immunostaining for Pax6 revealed exclusive nuclear locali-
zation in Pax6 Leca mutant cortices as observed for the wild-type Pax6 protein. This shows 
that the secondary structure of the Leca mutant proteins is preserved for interaction with 
certain proteins such as its nuclear-import proteins.  
Another possibility is that the interaction of Pax6 with a repressor-complex is disturbed, lea-
ding to abnormal transcriptional levels of certain genes. Possibly also interactions of Pax6 
important to exert a repressive role might be affected. For example Pax6 has been shown 
to negatively affect the androgen receptor (AR) activity, competing with a transcriptional 
activator for AR-interaction on AR target genes (Elvenes et al., 2011).
In conclusion, several possibilities, affecting domain binding or protein interactions might be 
the cause for the superactivation observed by the Leca2 mutation on Pax6 consensus sites 
in vitro. In any case, different activation levels were detected using different cell lines in this 
and previous reported studies (Chauhan et al., 2004; Shukla and Mishra, 2012) suggesting 
that effects might vary depending on the cell type and context.  
Taken together, superactivation of Pax6 targets through the Leca2 mutation were observed 
on the classical Pax6 consensus sites in vitro but not on any of the recently identified novel 
Pax6 motifs. Nevertheless, it cannot be ruled out that gain-of transcriptional activity contri-
butes to the observed phenotype in the Pax6Leca2 mutant. 
3.3 The role of the homeodomain and region-specific differences of the   
 function of the different DNA-binding domains of Pax6
A previous study in our lab using a Pax6 homeodomain mutant mouse line (Pax64NEU car-
rying a point-mutation in the HD), revealed that this domain of Pax6 plays only a minor role 
during cortical development with subtle effects on the specification of the PSB (Haubst et 
al., 2004). These findings suggest a dominating regulatory function of the paired domain of 
Pax6 during cortical development. Indeed, the attempt to identify possible candidates for 
HD-mediated function in the present study by microarray analysis of the Pax64NEU line did 
not reveal gene expression changes. This further corroborates a PD-specific regulatory 
function in the developing forebrain. In contrast, the homeodomain of Pax6 does play an 
important regulatory role in other regions of Pax6 expression, e.g. during eye development, 
homeodomain and paired domain function are both essential. In agreement, all Pax6 mu-
tant mice independent of the localization of the mutation show defects in eye development, 
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including both Leca mutants (Favor et al., 2001; Thaung et al., 2002; Favor et al., 2008; 
Ramaesh et al., 2009). However, the distinct domain disruptions result in different pheno-
types. Besides Pax6 activity levels, which play an important role in the manifestation of the 
distinct eye defects (Favor et al., 2008) the different phenotypes are also attributable to loss 
of the individual DNA-binding domain function. Moreover, even distinct regulatory elements 
controlled by the homeodomain or the paired domain of Pax6 have been identified in genes 
expressed in the eye. While the homeodomain exclusively recognizes regulatory elements 
of the rhodopsin genes (Sheng et al., 1997), paired domain binding sites have been map-
ped to cis regulatory elements of the crystalline gene family (Piatigorsky, 1998; Niimi et al., 
1999). Moreover, the homeodomain and the paired domain of Pax6 have been shown to 
be able to act both independently or cooperatively to control the expression of different ge-
nes (Sheng et al., 1997). While during eye development, the homeodomain controls gene 
expression, it possesses a modulating role of Pax6 function during alpha-cell development 
in the pancreas (Dames et al., 2010). These findings suggest that a selective usage of diffe-
rent DNA-binding domains of Pax6 may reflect one mechanism, which contributes to the re-
gion-specific differences of Pax6 function. It has been recently shown by Fong et al., 2012, 
that there are three different levels of gene regulation: 1. DNA-binding site recognition; 2. 
Epigenetic/ chromatin accessibility; 3. Co-factor availability in different cell-types/ tissues. 
This maybe one explanation why the Pax6 domains have altered roles in different tissues. 
This study further corroborates that the paired domain itself is subdivided into two domains 
that target independent genes, thereby giving another level of combinatorial possibilities. 
In summary, Pax6 can control gene expression by the PAI, the RED and the HD in diffe-
rent combinatorial and modulatory ways. The identification of PAI and RED domain target 
candidates reveal a clear level of regulation through Pax6. The selective function of those 
domains may depend on the above mentioned prerequisite for gene expression regulation 
(chromatin accessibility and co-factor availability; (Fong et al., 2012)).
In this study, I dissected domain specific functions of the transcription factor Pax6 during ce-
rebral cortex development. Human cases of Pax6 mutations are known to suffer from brain 
and/or eye defects or develop diabetes later in life. Therefore understanding the complex 
molecular function exerted by Pax6 is especially relevant in regard to such human diseases. 
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3.4 Identification of new microRNA candidates during neuronal    
 differentiation
The process of neuronal differentiation not only involves the regulation of distinct protein-
coding genes by transcription factors like Pax6, but also depends on the control and ex-
pression of distinct microRNAs. In this study, a microRNA profile was carried out to identify 
novel microRNA candidates associated with neuronal differentiation. I utilized an ESC-diffe-
rentiation system (Bibel et al., 2004; Bibel et al., 2007), which allowed to analyze relatively 
homogenous key stages during neuronal differentiation. These included an ESC-like stage, 
two neural progenitor stages characterized by Pax6 positive radial glia like progenitors and 
lastly a stage containing differentiated glutamatergic neuronal progeny. I found different 
expression patterns of microRNAs expressed over the time course of differentiation. ESC 
specific microRNAs, such as the known miR-250 cluster important for maintenance of pluri-
potency and proliferation (Benetti et al., 2008; Wang et al., 2008b) were down-regulated at 
the progenitor stage, while most of the microRNAs which started to be expressed at the pro-
genitor stage, such as the well-studied miR-9/9* showed an enrichment of expression at the 
neuronal stage. These patterns were expected as shown for previous expression profiles of 
other neuronal differentiation systems (Sempere et al., 2004; Huang et al., 2009). However, 
remarkably few microRNA candidates with exclusive expression at the neuronal progenitor 
stage were identified in the present screen. Amongst them one microRNA (miR-92b), which 
has previously been shown to be expressed in the proliferative zones of the adult and larval 
zebrafish brain (Kapsimali et al., 2007). In line with the screen and the zebrafish expression 
pattern, I detected exclusive localization of miR-92b also in the proliferative zone of the de-
veloping mouse forebrain. Furthermore, miR-126-3p, miR-193 and miR-219 were identified 
as novel candidates expressed exclusively in neuronal progenitors. The role of miR-126-3p 
is most studied in endothelial cell development. Together with its host gene Egfl7, miR-126-
3p is expressed in endothelial cells and both play important roles in vascular development 
(Fish et al., 2008; Wang et al., 2008a). Moreover, miR-126-3p has been shown to inhibit 
proliferation of breast cancer cells or human embryonic kidney cells (Iorio et al., 2005). In 
contrast, the miR-193 has been reported to exert a pro-proliferative effect in mesenchymal 
stem cells after laser irradiation, indirectly regulating the cyclin-dependant kinase 2 (CDK2) 
(Wang et al., 2012). Several studies of the microRNA miR-219 have identified its role in 
regulation of oligodendrocytes differentiation in the brain (Dugas et al., 2010; de Faria et 
al., 2012). Further studies will be necessary and it will be interesting to investigate the role 
of the novel miRNA candidates in neuronal progenitors identified within the present screen. 
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Loss and gain-of function experiments could be useful to understand their role in neuronal 
progenitor cells.
Compared to the number of microRNAs which are down-regulated at the progenitor stage 
or which start to be expressed from this stage on, the progenitor only expressed microRNAs 
are surprisingly very few. This may suggest an important function of these specific candida-
tes in targeting genes expressed at this stage, which either need to be cleared to allow the 
cell to further differentiate or to facilitate robustness to progenitor specific gene expression 
programs. Indeed, it has been shown that microRNAs can act as switch or fine-tuners of 
gene expression (Mukherji et al., 2011). Moreover, the combination of the microRNA and 
mRNA profile generated in this study together with computational methods will help identify 
targeted genes. The expression of miRNAs and their targeted mRNAs are often largely 
non-overlapping with temporal or spatial separation (Farh et al., 2005; Stark et al., 2005). 
In such mutual exclusive expression, the microRNA is thought to function to maintain low 
levels of target gene expression. Indeed, many examples have been reported that show 
mutual exclusive expression of the miRNA and its targeted mRNA in temporal or spatial 
domains (Stark et al., 2005).
Lastly, given the importance of Pax6 in neuronal progenitors, it would be interesting to unra-
vel whether Pax6 may be involved in the control of distinct microRNA genes. As key ES cell 
transcription factors have been shown to bind to promoters of microRNAs, which are domi-
nantly expressed in ES cells (Marson et al., 2008), it is likely that Pax6 as a key determinant 
during neuronal differentiation also controls the expression of distinct microRNAs important 
for proliferation of progenitors and or their differentiation.
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4.2 Methods
4.2.1 Animals and genotyping
4.2.1.1    Animals
All animals were kept in the animal facility of the Helmholtz Zentrum München. Experimen-
tal procedures were performed in accordance with German and European Union guideli-
nes. Animals were maintained on a 12h light-dark cycle and the day of vaginal plug was 
considered as embryonic day 0 (E0). The Pax6Leca2 and Pax6Leca4 mouse lines (Thaung et 
al., 2002) were obtained from the GlaxoSmithKline Research & Development Limited (UK). 
Animals were crossed two generations with the CD1 wild type strain; afterwards maintai-
ned by interbreeding (original background: 129S6). Small-eye (Sey, designated Pax6Sey) 
mutant mice (Hill et al., 1991) were maintained by interbreeding on a mixed background 
(C57BL/6J×DBA/2J). Interbreeding between Gsx2EGFP (designated Gsx2; maintained on 
a mixed background) kockin (Wang et al., 2009a) and Pax6Sey heterozygote mice was per-
formed to generate Gsx2;Pax6 double heterozygotes, which were subsequently crossed to 
generate Gsx2;Pax6 double homozygous mutants. 
4.2.1.2    Mouse tail DNA extraction
Parental animals were maintained in a heterozygote allelic state and crossed to obtain all 
three possible genotypes (WT/WT, WT/-, -/-) from the same litter. To sort out the different 
genotypes and maintain the colonies, Pax6Leca4 and Pax6Sey mice were distinguished by 
their eye phenotypes. Gsx2 mice were genotyped for mutant and wild-type alleles by ge-
nomic PCR. In case of the Pax6Leca2 mice, homozygote animals were also distinguished by 
their eye phenotype; wild-type and heterozygote animals were genotyped by PCR, followed 
by sequencing on tail DNA. Tail DNA Extraction was performed with the Gentra Puregene 
Mouse Tail Kit (Qiagen) according to the manufacturer’s instructions. Briefly, 5mm long tail 
clips from ear marked mice (3-4 weeks old) were incubated overnight at 55°C in 0.3ml of 
lysis buffer supplemented with 1mg/ml of Proteinase K. The next day, samples were briefly 
cooled down on ice and 100µl protein precipitation solution was added. Next, samples were 
vortexed and hair and tissue residues were removed by centrifugation at 13.000 rpm for 
3min. The supernatant was poured into 0.3ml isopropanol and mixed well. The precipitates 
were washed in 0.3ml 70% ethanol and dissolved in 50µl hydration buffer. To solve the DNA, 
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For Pax6Leca2:
  94°C    2 min
  30 x  94°C  50 sec
  57°C  50 sec
  72°C  50 sec
  72°C    5 min
samples were incubated for 1h at 65°C and diluted 1:100 with H2O for the PCR reaction.
4.2.1.3    PCR Genotyping
Genotyping of the Pax6Leca2 and Gsx2 mice was performed with a standard PCR mix con-
taining 0.2µM of each required primer, 0.2mM of each dNTP (dATP, dCTP, dGTP, dTTP), 
0.5µl MgCl2, 1.5 U of Taq DNA polymerase (Qiagen), 2.5µl 10xPCR buffer and 2µl (~100ng) 
of genomic DNA in a final volume of 25µl per reaction. The DNA was amplified under the 
following cycling conditions:
250 bp
500 bp
Expected size: 295 bp
pd
M
Figure 4-1 Example of PCR products for Pax6Leca2 genotyping
For Leca2 genotyping, first a PCR was performed on gDNA from adult 
mice or embryos using primers to amplify a 295 bp product including the 
Leca2 mutation, followed by sequencing of this PCR product.
Abbreviations: bp, base pairs; M, DNA marker; pd, primer dimmer. 
The following primers were used: 
Pax6Leca2_for:  TCCAGGATGGCTGGGAGCTT. 
Pax6Leca2_rev: TTGCGTGGGTTGCCCTGGTA  
PCR product size: 295bp. 
The following primers were used:
Gsx2Int5B:  CCACGGAGATTCCACTGCC
Gsx2-1437: GCATCCACCCCAAATCTCAGTC
PCR product size specific for wild-type allele: 298bp
Gsx2Int2: CCTAGGAATGCTCGTCAAGAAG
Gsx2Int5A: CATCACCATCACCAGCCCC
PCR product size specific for knockin allele: 225bp
For Gsx2:
   94°C     2 min
  30 x   94°C     1 min
   58°C     1 min
   72°C     2 min
   72°C     5 min
250 bp
500 bp
Expected size:  WT-allele: 298 bp 
          Gsx2-mut allele: 225 bp
pd
M
Figure 4-2 Example of PCR products for Gsx2 genotyping
Animals were genotyped according to the protocol by Wang et al., 2009: using a primer pair to 
detect the Gsx2EGFP allele (product: 225 bp) and using another pair of primers that include one 
sequence in the deleted region of the first exon (product: 298 bp).+/+, WT; +/-, hetero; -/-, mutant. 
Abbreviations: bp, base pairs; M, DNA marker; pd, primer dimmer. 
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4.2.1.4     Sequencing
Prior to sequencing the PCR product was cleaned from the PCR reaction mix by gel ext-
raction including clean up using the QIAquick Gel-Extraction Kit (Qiagen) according to the 
manufacturer’s instructions. For the sequencing PCR reaction the following reagents were 
used:
 0,5µl                            Big Dye (contains polymerase)
 2,0µl                                Big Dye – buffer
 10pM  (0,5µl from 100µM stock)      primer (sense or antisense)
   2µl     template-DNA
And the sequencing PCR was performed under the following cycling conditions:
 
   96°C        1 min
  35 x     96°C      10 sec
   50°C        5 sec
   60°C        4 min
     4°C           ∞
Finally the sequencing PCR was cleaned using DyeEX 2.0 Spin columns (Qiagen) accor-
ding to the manufacturer’s instructions and filled into the sequencing plate. The sequencing 
was then performed at the Sequencing Core Facility of the Helmholtz Zentrum München 
and for sequence analysis the Vector NTi program (Invitrogen) was applied.
 
4.2.1.5     Fixation of mouse brains and cryosectioning
Mice used in this study were anesthetized by CO2 and sacrificed by cervical dislocation. 
Embryos were immediately placed into Hanks Balanced Salt Solution (HBSS (Gibco); sup-
plemented with 10mM Hepes (Gibco)) and dissected. Embryonic brains or heads were then 
fixed at 4°C in 4% PFA (paraformaldehyde) dissolved in PBS, under constant rotation. Ac-
cording to their age, fixation time lasted: 2h – E12 whole heads; 2h – E14 brains; 3.5h – E14 
whole heads; 2.5h – E15 brains; 3h – E16 brains and 4h – E18 brains. After fixation, brains 
or heads were rinsed with PBS and cryoprotected in 30% sucrose/PBS at 4°C over night, 
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4.2.2 Immunostainings
Immunostaining was performed either on fixed tissue culture samples (Immunocytoche-
mistry) or cryosectioned brain slices (Immunohistochemistry). Prior to the staining proce-
dure, coverslips stored in azide-PBS were washed in normal PBS and cryosections were 
shortly rehydrated by incubation in PBS at RT. 
In general, antibodies were diluted in a solution containing 0.5% Triton-X100/PBS and 10% 
normal goat serum (NGS) as blocking agent. Under normal staining procedures primary 
antibodies were applied O/N at 4°C, followed by three washing steps in PBS and seconda-
ry antibody staining at RT for 2h. To visualize nuclei, Dapi (4’, 6’ Diamidino-2-phenylindole, 
Sigma) was included in the secondary antibody staining solution with a concentration of 
0.1µg/ml. Finally coverslips and sections were washed three times in PBS and mounted in 
Aqua Poly/Mount, a glycerol-based mounting medium that retains fluorescent stains. 
As secondary antibodies, subclass specific antibodies conjugated to Alexa-488, Alexa-543, 
Alexa-633 (dilution: 1:1000, Invitrogen) or Cy2, Cy3, Cy5 (dilution: 1:400, Jackson Immu-
no Research) were applied. For signal amplification, Avidin-Biotin interactions were used. 
Thus, after primary antibody labelling, sections were incubated with a biotinylated secon-
dary antibody (dilution: 1:400, Vector Laboratories) for 2h at RT, washed 3x in PBS and 
finally incubated with fluorochrome (Alexa-433,-543 or -633) conjugated Streptavidin (dilu-
tion 1:1000, Invitrogen) for 2h at RT. 
Certain primary antibodies required one of the following specific pre-treatments to retrieve 
the antigen:
Citrate-buffer pre-treatment:
Coverslips were boiled for 30sec and sections for 8min in 0.01M sodium citrate (pH6) at 
700V in a microwave, followed by brief PBS incubation prior to primary antibody staining.
HCl pre-treatment:
Sections were incubated in 2N HCl for 30min at RT, followed by 2x 15min incubation in 0.1M 
sodium-tetraborate (pH8.5).
If co-labelling with two different primary antibodies required pre-treatment for one antibody, 
normal staining was performed first, followed by post-fixation with 4% PFA for 15-30min at 
RT, before pre-treatment was applied for the second primary antibody. 
All antibody used in the present study and their dilutions and treatment conditions are listed 
under 4.1.6.
followed by freezing in Tissue Tek. Tissue was either stored at -20°C or immediately cut in 
12µm to 25µm thick sections on a Cryostate (Leica) and stored at -20°C. 
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4.2.3  In situ hybridization - mRNA
In situ hybridization was performed on 12-25µm thick cryosections under semi-sterile con-
ditions using sterile pipette tips and gloves. The procedure comprised two main steps: (a) 
generation of the digoxygenin (DIG)-labelled antisense RNA probe by in-vitro transcription 
and (b) hybridisation of the RNA probe followed by signal detection.
For in-vitro transcription the ISH-plasmid was first linearized over night using in general 1µl 
of the according enzyme for 20µg DNA and 5µl 10xbuffer in a final volume of 50µl. After 
digestions, the linearized plasmid was purified using phenol extraction. In vitro transcrip-
tion was then performed with 1µg linearized plasmid and the following reaction mix: 2µl 
digoxygenin labelled dNTPs (Roche), 2µl 10x transcription buffer (Stratagene), 1µl RNAse 
inhibitor (Roche) and 2.5µl of the appropriate RNA polymerase (T3, T7 or Sp6) (Roche). 
The reaction mix was incubated for 2h at 37°C followed by DNaseI treatment (addition of 
2µl DNaseI) for 30-45min at 37°C. Then cleanup of the RNA was performed by adding 10µl 
LiCL, 80µl RNase-free water and 300µl 100%EtoH and incubation at -20°C for at least 2h or 
over night followed by EtOH precipitation (resuspension of pellet in 25µl RNAse-free water). 
Finally the qualitity of the RNA probe was evaluated on a gel.
The hybridisation reaction on cryosections was performed in humidified chambers to avoid 
drying out of the sections. In general 1µl RNA probe per 150µl hybridisation buffer (50% 
formamide, 10xsalt, 50% dextransulfat, 50x Denhardt’s Soultion, 50 μg/mL yeast tRNA (Ro-
che) in H2O) was used. The RNA probe / hybridisation buffer mixture was first heated up to 
70°C for 4min in order to separate the RNA strands. After brief mixing, 150µl were applied 
per slide, covered with parafilm and incubated at 60-65°C overnight. The next day, the 
sections were placed into a sterile washing chamber and incubated once in pre-warmed 
washing solution (50% formamide, 4xSSC, 0.1% Tween20 in H2O) at 60-65°C for 10min 
followed by two washing steps for 30min at 60-65°C. Followed by two washing steps in 
1x MABT (100mM maleic acid, 150mM NaCl, 0.1% Tween20, pH 7.5 in H2O) for 30min at 
RT. Then the sections were incubated in blocking buffer (5xMABT, 10% blocking reagent 
(Roche), 5% FCS) for 1h at RT, followed by antibody staining (antidigoxigenin fab frag-
ments 1:2500 in ISH blocking buffer (Roche)) over night at 4°C. Antibody staining was again 
performed in a humidified chamber and slides were covered with parafilm. The next day, 
slides were washed 5 times in 1xMABT buffer and twice in freshly prepared AP staining 
buffer (100mM Tris (pH 9.5), 50mM MgCl2, 200mM NaCl, 0.1% Tween20 in H2O). Signal 
detection was performed by adding 3.5µl NBT (Roche) and 3.5µl BCIP (Roche) solutions 
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to 1ml AP staining buffer and incubation on the sections until the desired staining intensity 
was reached. The detection was stopped by washing the sections in autoclaved water and 
sections were mounted with Aqua Poly/Mount. 
The ISH-Plasmid for Ngn2 was kindly provided by Francois Guillemot.
4.2.4 In situ hybridization - microRNA
MicroRNA in situ hybridization was performed on 12-25µm thick cryosections under semi-
sterile conditions using sterile chambers, pipette tips, gloves and DEPC treated water for 
all solutions. DIG-labeled miRCURY LNATM microRNA detection probes were used to de-
tect the following miRNAs: miR-9 (TA: ~51°C; kind gift from G.Luxenhofer); miR-92b (TA: 
~63°C); miR-124 (TA: ~60°C); miR-126-3p (TA: ~52°C).
Cryosections stored at -20°C were dried at RT for 30min and post-fixed for 12-15min in 4% 
PFA. Next, the sections were washed three times for 3min in PBS followed by incubation in 
acetylationsolution (200ml H20, 2ml TEA, 250µl glacial acidic acid) for 10min under stirring 
conditions. To permeabilize the tissue, sections were incubated with 5µg/ml Proteinase K 
(dissolved in PBS) for 5-10min. After two additional washing steps (in PBS for 3min), sec-
tions were placed into 1xSSC solution for 30min. Prior to hybridisation, sections were incu-
bated for at least 2h in hybridisation buffer (5x Denhardt’s solution, 205ug/ml baker yeast 
tRNA, 5x SSC, 20% formamide) without probe at the appropriate hybridisation temperature 
(see above). After the detection probe was diluted (generally 1:200-1:500) in hybridisation 
buffer, 150µl were applied per slide, covered with parafilm and incubated at the appropria-
te temperature overnight. Also, all washing buffers for the next day were incubated at the 
same temperature overnight. The next day, sections were placed into a washing chamber 
and washed: 4 x 15min in 1xSSC buffer (1xSSC + 0.1% Tx-100) followed by 4 x 15min 
in 0.2xSSC buffer (0,2xSSC + 0.1% Tx-100), both at 60°C and finally once for 15min in 
0.2SSC buffer (0,2xSSC + 0.1% Tx-100; not pre-heated) at RT. For DIG staining, sections 
were incubated first in buffer 1 (100mM Tris, 150mM NaCl, pH 7.5) for 5min at RT, followed 
by blocking in 1% blocking reagent (Roche; prepared with buffer 1) for one hour. Then 200µl 
anti-DIG antibody (1:2000 in 1% blocking reagent) was applied per section and incubated 
for 2h at 37°C. Then sections were washed for 15min in buffer1 at RT, followed by an addi-
tional wash step of 10min in buffer 2 (100mM Tris, 100mM NaCl, pH 9.5). Signal detection 
was then performed by adding 3.5µl NBT (Roche) and 3.5µl BCIP (Roche) solutions to 1ml 
buffer 3 (buffer 2 +1M MgCl2), which was then incubated on the sections until the desired 
staining intensity was reached. The detection was stopped by washing the sections in TE 
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buffer or autoclaved water and sections were mounted with Aqua Poly/Mount.
4.2.5 Molecular Biology
4.2.5.1     Cloning of constructs
In order to overexpress the Pax6 Leca mutant forms in primary cell cultures, viral expres-
sion vector plasmids were constructed. The coding sequence of Pax6Leca4 and Pax6Leca2 
mutant forms were obtained by PCR using isolated cDNA from E14 cortex tissue of the 
respective mouse mutant as template. The PCR was performed with the following primers: 
PDlessr1_for: 5’-TCCCCGCGGTTACTGTAATCGAGGCC-3’; 
Delh3f1_rev: 5’-CGGGATCCATGCAGAACAGTCACAGC-3’.
The PCR product was then cloned into the Stratagene PCR cloning vector by ligation and 
transformed, both according to the manufacturer’s instructions. After confirmation of the 
correct sequence of this plasmid by sequencing, the Leca mutant forms were subcloned 
into the pENTRY1A vector (Invitrogen, Gateway System) by sequential digestion with XhoI 
and BamHI. Finally the Leca mutant cDNAs were shuttled into the pCAG-GFP destination 
vector (Invitrogen, Gateway System; kind gift by Paolo Malatesta) by LR reaction (Gateway, 
System). The resulting plasmid was checked by sequencing.
4.2.5.2     Transformation into chemically competent E.coli
A 50 μl aliquot of the chemo-competent cells (bacterial strains see under 4.1.4) was thawed 
on ice. LB medium was preheated to 42°C. Then 5 µl of the ligation reaction (~5 µg) was 
added, mixed and incubated on ice for 20 min. Cells were then heat shocked for 45 s at 
42°C, and cooled on ice for 2 min. 500 μl of the pre-heated LB medium was added and cells 
were incubated for 45-60 min at 37°C on a shaker. Afterwards, different volumes (50-500 
μl) were plated on bacterial agar plates containing the appropriate antibiotic and incubated 
over night at 37°C.
4.2.5.3     Bacterial liquid cultures and DNA purification
For small scale (4ml) or large scale (200ml) liquid cultures, a single colony was inoculated 
into 4ml or 200ml LB medium (supplemented with the appropriate antibiotic) respectively, 
and incubated over night at 37°C under vigorous shaking. Plasmid DNA was then isolated 
using Qiagen’s Mini Prep or Maxi Prep kit following the manufacturer’s instruction manuals. 
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4.2.5.4     Restriction digestion of DNA
A typical reaction was prepared as follows:
 1 µg  DNA plasmid
 2 µl  10x reaction buffer (NEB)
 0.5 – 3.0 µl Restriction enzyme (5-10 U) (NEB)
 ad 20 µl H2O
The reaction was incubated at the appropriate temperature (depending on the enzyme) for 
1 hour or overnight. Cleavage efficiency was investigated by gel electrophoresis.
4.2.5.5     Ligation
For ligations, the insert DNA was generally used in a 5-10 fold excess of vector DNA. The 
ligation reaction was incubated at 16°C overnight and transformed the next day. Colonies 
were picked, DNA extracted and analyzed by digestions or for the final vectors by sequen-
cing.
4.2.6 Cell Culture
4.2.6.1     Preparation of primary embryonic cerebral cortical cell culture
Timed-pregnant mice were anesthetized by CO2 and sacrificed by cervical dislocation. The 
embryos were removed by caesarean section and immediately placed into Hanks Balan-
ced Salt Solution (HBSS (Gibco); supplemented with 10mM Hepes (Gibco)). The brains 
were dissected out, the telencephalic hemispheres were separated and the meninges, the 
hippocampus (anlage) and the olfactory bulbs were removed. Then the dorsal telencepha-
lon (cortex) was separated from the ventral telencephalon and the cortex tissues of both 
hemispheres were transferred to a 15 ml falcon tube containing HBSS. The tissues were 
collected at the bottom of the falcon by centrifugation for 5 min at 1200 rpm. The tissue was 
incubated in 0.05% trypsin-EDTA for 15 min at 37°C. To stop the trypsin digestion and for 
dissociation, several ml DMEM (Gibco) with 10% fetal calf serum (FCS) were added and 
a fire polished Pasteur pipette (preincubated in DMEM/FCS to coat the glass) was used 
to mechanically disrupt the tissue. After two washing steps with DMEM/FCS 3x105 cortex 
cells were plated on poly-D-lysine coated glass coverslips in 24 well plates (NUNC) in 500µl 
DMEM/10%FCS/P/S. The following day 500µl of DMEM media without FCS supplemented 
with the B27 cocktail was added per well and each second day 500µl of the above DMEM/
B27 medium were replaced. 
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4.2.6.2     Clonal analysis in primary culture
For clonal analysis of the Pax6Leca4 and Pax6Leca2 cortices the plated cells of the mutants and 
the corresponding wild-type controls were infected 2 hours after plating with the pMXIG re-
trovirus to obtain no more than 50 clones per coverslip. For overexpression experiments of 
the Pax6 Leca mutant forms in BL6 wild-type cultures, the appropriate retrovirus (based on 
the viral plasmids: pCAG-Leca2-/Leca4-/Pax6wt- or Ctrl-IRES-GFP; see also under 4.1.5) 
was added 2 hours after plating. The cells were fixed after one week and clone composition 
and size was analyzed using immunocytochemistry. 
4.2.6.3     Dual-luciferase reporter assay
The reporter assays were performed in P19 carcinoma cells and Human Embryonic Kidney 
(HEK) cells, both cultured with DMEMGlutaMAX/10%FCS/P/S media. For all transfections, 
P19 or HEK cells were plated at a density of 8 x 105 cells per 24-well, 20 hours prior to trans-
fection in media without antibiotic. Transfections were performed with 1 µg expression plas-
mid, 1 µg of the promoter construct driving firefly (Photinus pyralis) luciferase and 0.1 µg 
of Renilla-TK luciferase plasmid (Promega) for control of transfection efficiency. As trans-
fection reagent Lipofectamine 2000 (Invitrogen) was used according to the manufacturer’s 
instructions. After 4 hours, medium was changed and after 48 hours cell extracts were 
prepared for luciferase activity measurment with a luminometer (Berthold Centro LB 960) 
according to the manufacturer’s instruction protocol (Promega). Relative light units were 
normalized to Renilla luciferase activity and then to the control transduced cells. 
As promoter constructs, the pGL3-based promoter plasmids containing the Pax6 consen-
sus sites P6CON-P3 (combination PD-binding site and HD-binding site) or P3 (HD-binding 
site) were analysed (see under 4.1.5). As expression plasmids, the retroviral vector const-
ructs, expressing wild-type Pax6 or the Leca4 or Leca2 mutant form of Pax6 under the CAG 
promoter were used. 
4.2.7 Embryonic stem cell differentiation culture protocol
Mouse embryonic stem cells (ESC; line J1) were cultured according to the Bibel et al., 2007 
protocol. Briefly, ESC were thawed on a layer of mouse embryonic fibroblasts (MEFs or fee-
der cells were prepared from E13 embryos). Importantly the feeder layer (thawed on 6cm 
dishes coated with 0.2% gelatine) had to be very dense so that the ESC formed potatoe-
shaped colonies on them. Before adding the ESCs, the feeder cells were inactivated with 
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Mitomycin C (Sigma) for 2h at 37°C and washed once with PBS. Feeder cells alone were 
grown in EB-Medium and with ESC in ES-Medium (see under 4.1.3.2). The density of the 
ESC cells grown on the feeder layer had to be adjusted so that the colonies, grown for two 
days on a feeder layer did not touch each other. After passaging the ESC 3-6 times on top 
of inactivated feeder cells, they were transferred to gelatine coated dishes (10cm) without 
feeders. On gelatine, ESC changed their morphology. They started to flatten, still forming 
colonies but rather in a monolayer. Importantly, the dish had to be 80% confluent after 48 
hours, thus cells had to be highly proliferative. Normally, at the 4th-5th passage on gelati-
ne, the ESC cultures contained no more feeder cells. From this point, 3 million cells were 
transferred to one 10cm bacterial dish and cultured in EB-Medium. This induced cellular 
aggregate formation (CA). 48h after plating, medium was changed by transferring the CAs 
to 50ml falcons. After they settled on the bottom of the tube, medium was exchanged. On 
day four and six, medium was replaced again and 5µM retinoic acid was added as inductive 
stimulus. On day eight cells were considered as neuronal progenitors. Then, cellular ag-
gregates were dissociated with freshly prepared trypsin (0.05% dissolved in 0.04% EDTA/
PBS) and 1.3 x 106 cells were plated on Poly-ld-ornithine (PORN) and laminin coated 6-well 
plates in N2 medium. Media were exchanged 2 hours and 24 hours after plating; cells ac-
quired radial glia elongated morphology. After two more days N2 medium was replaced by 
complete medium and the culture was kept up to five more days, leading to cultures with 
pure glutamatergic neurons.  
4.2.8  RNA isolation and microarray analysis
For the analysis of the Pax6 mutant cerebral cortices total RNA was isolated from E12 or 
E14 cortical tissue using the RNeasy Micro kit (Qiagen) or RNeasy Mini kit (Qiagen) ac-
cording to the manufacturer’s instructions including digestion of remaining genomic DNA. 
RNA concentration was measured at the Nanodrop (260nm / 280nm ratio) and to assess 
the RNA quality for microarray analysis the Agilent 2100 Bioanalyzer was used. The Agilent 
software assigns a specific quality number to the RNA sample based on its electrophoretic 
profile. This RNA Integrity Number (RIN) ranges from 1 (reflecting totally degraded RNA) 
to 10 (reflecting completely intact RNA). For microarray analysis only high quality RNA 
(RIN>7) was used. 
For each microarray chip total RNA (100 ng) was first amplified using the one-cycle Mes-
sageAmp Premier labeling kit (Ambion). And 10 µg of amplified aRNA were hybridized on 
Affymetrix Mouse Genome 430 2.0 arrays according to the manufacturer’s instructions. 
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The statistic analysis of the microarrays was then performed by utilizing the statistical pro-
gramming environment R (R Development Core Team (Team, 2006)) implemented in CAR-
MAweb (Rainer et al., 2006). The probe set summaries were calculated with RMA (default 
settings including quantile normalization and application of the Tukey's median polish algo-
rithm). Datasets were filtered for average expression>50 in at least one group (mutant or 
WT) and for linear ratios>1.1x (Mut/WT). Then, genewise testing for differential expression 
was done employing the limma t-test and Benjamini-Hochberg multiple testing correction 
(FDR<10%). Heatmaps were generated with CARMAweb.
The mRNA transcriptome analysis of embryonic stem cell derived radial glia and neurons at 
different stages during differentiation (Bibel et al., 2004; Bibel et al., 2007) was performed 
on the total RNA samples that were extracted and used for the microRNA-array analysis 
(see below). Prior to microarray analysis these samples of total RNA were loaded again onto 
RNeasy Mini columns (Qiagen) and treated with DNAse I to digest remaining DNA. Analysis 
was then performed the same way as described above for the cortical tissue arrays.
 
4.2.9  MicroRNA extraction and miRNA-array analysis
For the miRNA array screen, RNA including miRNAs and total RNA was extracted from the 
following five different time points of the embryonic stem cell differentiation system (accor-
ding to (Bibel et al., 2004; Bibel et al., 2007)): 
1.) Cellular aggregate stage: day 4 (CAd4); not treated with retinoic acid (RA)
2.) Cellular aggregate stage: day 6 (CAd6); once treated with RA
3.) Cellular aggregate stage: day 8 (CAd8); twice treated with RA
4.) Radial glia progenitor stage: 14 hours past plating of CAd8 cells (P14h)
5.) Neuronal stage: 7 days past plating of CAd8 cells (N7d)
Cells from each time point were collected three times from three independent cultures to 
receive three biological replicates.
From the three cellular aggregate stages, one 10 cm dish of the floating CAs was collected 
by brief centrifugation. Media was removed; cells were washed once with PBS, resuspen-
ded in 350µl RLT buffer and stored at -80°C. P14h radial glia and N7 neurons were plated in 
6-well plates and 3x 6wells were combined and collected in 300 µl RLT and stored at -80°C. 
After collection of all biological replicates, total RNA was extracted of all samples. Samples 
were thawed on ice and 2 x more RLT buffer was added prior to homogenization with a 26 G 
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syringe and needle. 1.5 x volume of 100% ethanol was added and thoroughly mixed by vor-
texing. 700µl of the sample was then loaded onto a RNeasy Mini spin column (Qiagen) and 
centrifuged 15 s at 10.000 rpm (flow-through discarded); precipitations were omitted. This 
step was repeated until the whole sample had been pipetted onto the spin column. The spin 
column was then transferred into a new 2 ml collection tube and washed twice with 500 µl 
RPE by centrifugation for 15 s at 10.000 rpm. The spin column was placed again into a new 
collection tube and centrifuged for 1 min at full speed to remove remaining buffer. Finally 
the column was placed into a sterile 1.5 ml eppendorf tube and miRNAs and total RNA were 
eluted in 30 µl RNase-free water by centrifugation at 10.000 rpm for 1 min. Concentration 
was determined at the nanodrop. 3µg of each sample were sent to the company Exiqon 
who performed qualitiy control with the Agilent Bioanalyzer 2100 and subsequent miRNA-
array analysis.  All samples from the stages 1-4 had a higher RIN value then 7, indicative of 
good quality RNA for array analysis. The RNA of the three replicates of the neuronal stage 
was of less good quality with RIN values of 3.6, 5.4 and 6.2. However this quality was still 
acceptable for array analysis. Array analysis performed by Exiqon included the labeling of 
the samples using the the miRCURY™ Hy3™/Hy5™ power labeling kit, hybridization on 
the miRCURY™ Array (v.11.0) and data analysis of the arrays as described in their manual. 
4.2.10 CDNA synthesis and quantative pcr analysis 
For qPCR, extracted RNA (500ng -1µg) was reverse transcribed to cDNA using the Su-
perScript IITM First-Strand Synthesis System (Invitrogen) according to the manufacturer’s 
instructions. Real-time PCR was performed using gene-specific primers (list of primers see 
under 4.1.7) and the SYBRGreen mastermix (Biorad) on a DNA Engine OpticonTM machi-
ne (Biorad). The melting temperature of primer dimers was determined in order to exclude 
primer dimers from the analysis. As reference gene for normalization of the target gene’s 
expression GAPDH was used. The relative expression of each mRNA was calculated 
using the delta CT method between the gene of interest and the reference gene (GAPDH) 
(E=1/2−(−ΔCt)).
4.2.11 Data analysis
Quantifications of cells in mitosis (PH3+) were performed at E12 across the entire dorsal 
wall from lateral to medial position and at E14 in 150 µm wide radial stripes covering the 
entire radial thickness with the ventricular surface. The radial length was measured in the 
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center and at lateral position of the cerebral cortex using ImageJ (NIH). All quantifications 
were performed on images from the dorsal telencephalon in rostral regions using level-
matched sections of at least three stage-matched embryos of each genotype, from at least 
three different litters. For the clonal analysis in vitro, clone composition and clone size of 
each clone per coverslip was determined and the mean was calculated per coverslips (6-9 
coverslips, 3 experiments). The number of activated-Caspase-3 positive cells was quan-
tified in an average of 15 sections per animal in rostral regions of the cerebral cortex (3 
animals per genotype).
4.2.11.1    Statistics
Calculations of the arithmetic average: 
the standard deviation (SD): 
and the standard error of the mean (SEM):  
were performed with Microsoft Excel. The one-way Anova test was used to examine whe-
ther data sets differed significantly. Data were considered as significant with p<0.05 (*), very 
significant with p<0.01 (**) and highly significant with p<0.001 (***).
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5    Appendix
5.1     Abbreviation
 %  Percent
 °C  Degree Celsius
 µg  Microgram(s)
 µL  Microlitre(s)
 A  Absorption
 aa  Amino acid
 bHLH  Basic helix-loop-helix
 bp  base pair
 BSA  Bovine serum albumine
 CR  Calretinin
 cDNA  Complementary DeoxyriboNucleic Acid
 CGE  Caudal ganglionic eminence
 cm  Centimeter(s)
 CNS  Central Nervous System
 CO2  Carbon Dioxide
 CP  Cortical Plate
 CSF  Cerebrospinal Fluid
 DAPI  4,6-diamidine-2-pheylidoledihydrochloride
 dd  double distilled (ultrapure)
 DMEM  Dulbecco's Modified Eagle Medium
 DNA  Deoxyribonucleic acid
 dNTP  DeoxyNucleoside TriPhosphate(s)
 e.g.  For example (Latin 'exempli gratia')
 EDTA  Ethylene-Diamine-tetra-Acetic-Acid
 EPL  External Plexiform Layer
 FCS  Fetal Calf Serum
 g  Gram(s)
 GABA  gamma-Amino Butyric Acid
 GAPDH GlycerAldehyde 3-Phosphate DeHydrogenase
 GCL  Granule Cell Layer
 GE  Ganglionic Eminence
 GFP  Green Fluorescent Protein
 GL  Glomerular Layer
 h  Hour(s)
 HBSS  Hank’s balanced salt solution
 HCL  Hydrochloric acid
 HEPES 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid
 INM  Interkinetic Nuclear Migration
 IRES  Internal Ribosomal  Entry Site
 ISH  In-Situ Hybridisation
 IZ  Intermediate Zone
 kb  Kilobase
 kDa  Kilodalton
 kg  Kilogram(s)
 LB  Luria-Bertani medium
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 Leca  LEns Corneal Adhesion
 LGE  Lateral Ganglionic Eminence
 LIF  Leukemia Inhibitory Factor
 LTR  Long Terminal Repeat
 MC  Mitral Cells
 mg  Milligram(s)
 MGE  Medial ganglionic eminence
 min  Minute(s)
 mL  Millilitre(s)
 MLV  Moloney Murine Leukemia Virus
 mRNA  Messenger Ribonucleic Acid
 miRNA Micro Ribonucleic Acid
 NaCL  Sodium chloride
 ng  Nanogram(s)
 OB  Olfactory Bulb
 OBLS  Olfactory Bulb Like Structure
 PBS  Phosphate buffered saline
 PCR  Polymerase chain reaction
 PDL  Poly-D-Lysine
 PFA  Paraformaldehyde
 RA  Retinoic Acid
 RMS  Rostral Migratory Stream
 RNA  Ribonucleic acid
 rpm  Rotations per minute
 RT  room temperature
 sec  Second(s)
 SEM  Standard Error of the Mean
 SVZ  Sub Ventricular Zone
5.2    Tables
Table 5-1: Mean size of clones in cultures from Pax6Leca4 and Pax6Leca2 mutant mice and 
after overexpression of GFP control, Pax6 and Pax6 Leca mutant forms in primary culture.
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Table 5-2: Probe sets differentially expressed between WT and Pax6Leca4 cortices
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Table 5-3: Probe sets differentially expressed between WT and Pax6Leca2 cortices
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Table 5-4:  Overlap of significantly altered probe sets between Pax6Leca4 and Pax6Leca2 
cortices 
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Table 5-5:  Overlap of significantly altered probe sets between Pax6Leca4 and Pax6Sey corti-
ces 
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Table 5-6:  Overlap of significantly altered probe sets between Pax6Leca2 and Pax6Sey corti-
ces 
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Table 5-7:  Comparison significantly altered probe sets between Pax6Leca4, Pax6Leca2 and 
Pax6Sey cortices and Pax6 ChIP data (Ales Cvekl unpublished data)
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